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Abstract 
Hydrogen peroxide has a diverse array of functions in cells. Not only as a 
mediator of oxidative stress, it is also involved in signalling in many pathways 
including tyrosine phosphorylation, sumoylation, proliferation and 
differentiation and cysteine oxidation [1]. There are a number of different 
producers of hydrogen peroxide in the cell including the NADPH oxidase (Nox) 
family of enzymes [2], the electron transport chain in the mitochondria [3] and 
disulfide bond formation in the endoplasmic reticulum (ER) [4]. In order to 
prevent a toxic build-up of hydrogen peroxide the cell also deploys a range of 
antioxidant enzymes including catalase, the glutathione peroxidases (GPxs) and 
the peroxiredoxins (Prxs) [5]. Therefore at all times a balance must be 
maintained to allow enough hydrogen peroxide production to allow for signalling 
to occur but at the same time ensuring the concentration does not increase 
enough to cause any oxidative damage.  
Oxidative damage is associated with aging in general and diseases including 
cancer, cardiovascular disorders and neurodegenerative diseases. For such 
diseases to occur the balance of hydrogen peroxide production and removal must 
be tipped and it is the elucidation of these processes with regards to the ER that 
we hope to achieve. 
We present the development and use of a novel sensor, BGB, which specifically 
detects hydrogen peroxide in the ER. BGB works in conjunction with the SNAP-
tag system to allow specific targeting of a small molecule probe to the ER. BGB 
is selective for hydrogen peroxide over other reactive oxygen species due to the 
use of a boronic acid group as the reactive moiety. We have developed MALDI-
TOF mass spectrometry methods for quantitative analysis of this probe when 
used both in vitro and in cellulo. 
Also included is the development of Pep-B, a probe which was designed to 
measure hydrogen peroxide in the ER, but using a peptide targeting system 
rather than SNAP-tag, an investigation into the synthesis of a fluorophore based 
probe and the development of an alternative method of analysis of BGB using an 
antibody based system which negates the requirement of MALDI-TOF.  
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5.0 Introduction 
5.1 The Role of Hydrogen Peroxide in the Cell 
Hydrogen peroxide is one of a group of chemicals in cells described as reactive 
oxygen species. These include radicals such as superoxide (O2
•—), hydroxyl (•OH) 
and peroxyl (RO2
•) and non-radicals that are oxidising themselves or that are 
converted into radicals including ozone (O3), singlet oxygen (
1O2) and hydrogen 
peroxide (H2O2). The production of reactive oxygen species generally begins with 
the production of superoxide which rapidly dismutates to hydrogen peroxide and 
molecular oxygen, spontaneously or catalysed by superoxide dismutase [6]. 
Other sources of reactive oxygen species in cells include the Fenton reaction 
which is the iron-catalysed generation of the hydroxyl radical and the reaction 
of superoxide with nitric oxide leading to the production of peroxynitrite [7]. 
Hydrogen peroxide has long been viewed as a dangerous and toxic free radical 
compound which damages proteins and DNA in cells, leading to apoptosis and 
cell death. Only in more recent times has the importance of hydrogen peroxide 
as a signalling molecule, which acts as a stimulus for a huge range of processes, 
come to be appreciated. These processes include cysteine oxidation, cell 
proliferation and differentiation, modification by the small ubiquitin-like 
modifier (SUMO), tyrosine phosphorylation and oxidative stress [8]. Intracellular 
levels of hydrogen peroxide must be tightly controlled as left unchecked this 
chemical will lead to cell death. Antioxidant proteins, therefore, play a vital 
role in maintaining the hydrogen peroxide levels high enough for signalling 
events but low enough to prevent damage. The Jekyll and Hyde nature of 
hydrogen peroxide is what makes it such a fascinating molecule to study and one 
which the more is known of, the more will be understood about what happens 
when the hydrogen peroxide balance tips the scale and aging and disease occur.  
5.2 Production of Hydrogen Peroxide by NADPH Oxidases 
One of the main sources of hydrogen peroxide in cells are the Nox enzymes [2]. 
The Nox family is composed of seven catalytic subunits termed Nox 1-5 and Dual 
Oxidases 1 and 2 (Duox 1 and 2). All of the members of the Nox family are 
transmembrane proteins that transport electrons across membranes for the 
reduction of oxygen to superoxide [9]. They have been shown to be capable of 
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producing millimolar concentrations of hydrogen peroxide [10]. They were first 
discovered when it was noted that cells were capable of producing a respiratory 
burst which resulted in the production of superoxide. It was then determined 
that the main substrate for this production was NADPH [11]. Nox enzymes can 
assemble at the plasma membrane for the production of hydrogen peroxide. 
They are found in a range of different tissue and cell types including endothelial 
cells, vascular smooth muscle cells, macrophages and fibroblasts. Nox enzymes 
work towards the production of hydrogen peroxide for a number of reasons. 
These include specific functions such as differentiation and angiogenesis [12]. 
There are a number of conserved features within the complex. These include the 
NADPH binding domain situated at the C-terminus, FAD-binding site, six 
conserved transmembrane domains and four conserved heme-binding histidine 
residues. The first member of the Nox family to be discovered was Nox2 which 
once activated uses NADPH to reduce molecular oxygen to superoxide and in 
particular is used by phagocytes to destroy microorganisms [13]. Nox enzymes 
differ from other reactive oxygen species producing proteins in that other 
proteins produce reactive oxygen species as a by-product, whereas the sole 
purpose of Nox enzymes is to produce hydrogen peroxide. 
Nox enzymes are stimulated by a wide variety of substrates to produce 
superoxide. Both inorganic and organic chemicals have the ability to stimulate. 
Heavy metals such as lead have been shown to stimulate Nox proteins, as a 
response to the toxicity of such metals [14]. With regards to organic chemicals, 
ethanol has been shown to be a stimulator of Nox [15]. Oxidised lipoproteins, 
known to have a role in atherosclerosis, have been shown to cause an up-
regulation in Nox activity and consequently an increase in hydrogen peroxide. 
Other stimulators include physical factors such as ionizing radiation, adverse 
environmental factors such as low nutrition and oxygen level changes, 
inflammatory stimuli such as the bacterial endotoxin lipopolysaccharide and 
stress response hormones have all been shown to influence the levels of reactive 
oxygen species produced from Nox enzymes [16]. 
As well as having a range of stimuli, the downstream effects of reactive oxygen 
species production by Nox enzymes is also far reaching. Signal regulating kinase-
1 (ASK-1) is activated as a response to cellular stresses and regulates apoptosis 
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[17]. Reactive oxygen species produced by Nox enzymes are also known to down-
regulate protein tyrosine phosphatases (PTPs) [18]. Interestingly, dependant on 
the Nox isoform involved and the intensity and type of stimulus, there can either 
be a cell survival or an apoptotic response, once again highlighting the 
complexities involved with hydrogen peroxide as a signalling molecule. 
5.3 Production of Hydrogen Peroxide in Mitochondria 
One of the other main cellular sources of hydrogen peroxide is the mitochondria. 
Within the mitochondria there is a highly reducing environment. The reduction 
potential required to reduce molecular oxygen to superoxide is -0.16 V. Various 
parts of the respiratory chain within mitochondria have the thermodynamic 
capability to service this reduction potential. There are, therefore, various 
sources of superoxide and consequently hydrogen peroxide in the mitochondria 
[19]. 
Complex IV within the mitochondrial respiratory chain does not produce 
superoxide as it does not release any intermediates until full reduction from 
oxygen to water has been achieved (Fig.1). Other complexes within the 
respiratory chain are not so efficient however and leak electrons, resulting in 
the partial reduction of oxygen and consequently superoxide. Superoxide 
dismutase within the mitochondria can go on to convert these sources of 
superoxide to hydrogen peroxide. It is believed that most of the superoxide 
produced in the mitochondrial matrix is converted within the matrix; superoxide 
produced within the intermembrane space may be allowed to travel to the 
cytosol via voltage dependant ion channels [20]. Monoamine oxidases are bound 
to the outer membrane of mitochondria and are also capable of producing 
hydrogen peroxide during the catalytic oxidative deamination of monoamines 
such as noradrenaline and adrenaline [21].  
 Figure 
III leak electrons as a by
the partial reduction of molecular oxygen. Superoxide dismutase is 
then capable of converting this superoxide to hydrogen peroxid
Complex IV is more efficient with no leakage, so is different from 
other mitochondrial complex proteins in that it does not result in 
the production of superoxide. Monoamine oxidase, situated on the 
outer mitochondrial membrane is also capable of produc
hydrogen peroxide as a by
monoamines.
Other than the respiratory chain, hydrogen peroxide can be produced in the 
mitochondria as a result of oxidative folding that occurs in the intermembrane 
space.  Newly synthe
are trapped in the intermembrane space by a disulfide relay. Imported proteins 
are in the reduced state and require disulfide bond formation. The protein Mia40 
contains a disulfide bond within the ac
substrate in a method analogous to that of PDI. Mia40 is in the reduced state 
after this process and is reoxidised by the protein Erv1. The electrons are then 
passed onto the FAD moiety of Erv1 and after this onto Cytoc
peroxidase. The final electron acceptor is oxygen as with the PDI
the ER and results in 
1 – Sources of superoxide in the mitochondria. Complexes I
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5.4 Production of Hydrogen Peroxide in the ER 
Hydrogen peroxide is produced in the ER as a result of disulfide bond formation. 
It is known that most secretory proteins which pass through the ER contain 
disulfide bonds. As a newly synthesised polypeptide chain crosses the ER 
membrane it comes into contact with a whole host of proteins whose function it 
is to guide the polypeptide chain into its native conformation. One of the most 
important groups of enzymes that exist within the ER is the protein disulfide 
isomerases (PDIs). Within a thioredoxin-like domain of PDI there exists a 
catalytic disulfide within a CXXC motif, the intermediate amino acids (X) 
contributing to the redox potential [23]. This catalytic disulfide is transferred 
onto the client protein as a step in the folding process (Fig. 2). As a result, PDI is 
left in the reduced thiol form. The PDI family members do not show specificity 
for forming native disulfides within the client protein and so often non-native 
disulfides will also be formed. PDI is however an isomerase so is capable of 
reducing non-native disulfides. During the folding process it is possible that many 
native and non-native disulfides are formed and removed until the native 
conformation is achieved, guided by the potential energy. 
Once PDI has passed on its catalytic disulfide to the client protein it is in the 
reduced thiol form and so must be reoxidised to carry on its catalytic role in 
protein folding [24]. Originally, it was believed that glutathione was responsible 
for the reoxidisation of the PDI proteins. The environment within the ER is an 
oxidising one, with the ratio of glutathione disulfide (GSSG) to glutathione (GSH) 
around 1:3, higher than that of the cytosol, suggesting GSSG is capable of 
oxidising PDI [25]. It has been shown, however, that in the ER the protein ER 
oxidoreductin 1 (Ero1) is actually the main source of oxidising equivalents for PDI 
[26].  
Ero1 is a flavoprotein which contains a number of disulfide bonds, including one 
which reoxidises PDI. Once this action has been performed Ero1 uses the newly 
reduced thiols in the reduction of molecular oxygen to produce hydrogen 
peroxide [27]. Ero1 also contains a number of regulatory disulfides which act to 
control its activity [28], [29]. This is important as some PDI must be maintained 
in the reduced form for reduction of non-native disulfides in newly synthesised 
 proteins and also to prevent the ER concentration of hydrogen 
becoming too great.
Figure 
formation. PDI passes its catalytic disulfide to newly synthesised 
proteins and as a result becomes reduced. Ero1 combines th
reoxidation of PDI with the reduction of molecular oxygen to 
produce hydrogen peroxide.
5.5 Removal of Hydrogen Peroxide in Cells
With all the hydrogen peroxide being produced in cells, there must be methods 
of removing this molecule as the toxicity would soon cause severe damage to 
cells if left unchecked.
The most well
catalase (Fig. 3). Catalase is a heme protein and is found in nearly all organisms 
exposed to oxygen. It reacts with two molecules of hydrogen peroxide to 
produce two molecules of water and 
incredibly efficient enzyme with a high turnover number
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vital role in protecting cells from the toxic effect of too much hydrogen 
peroxide. 
When catalase reacts with the first molecule of hydrogen peroxide it is oxidised 
to a high valent iron intermediate known as Compound [I] [31]. This is 
characterized by an oxoferryl porphyrin cation radical. After compound [I] is 
formed it rapidly reacts with a further molecule of hydrogen peroxide to 
produce water and oxygen. 
Most catalase found in mammalian cells is found in the peroxisomes. This is an 
organelle whose main function is the degradation of long chain fatty acids 
through oxidation. As a result a lot of hydrogen peroxide is produced in the 
peroxisomes, requiring catalase for removal. There is a high concentration of 
catalase found in the liver of mammals. This is due to the fact that peroxisomes 
in the liver are responsible for the degradation of various toxic substances that 
are in the blood of the mammal. Catalase activity can also be regulated by 
tyrosine phosphorylation, which is suggestive of a mechanism specifically for 
high levels of hydrogen peroxide [32]. 
Another group of enzymes which are capable of removing hydrogen peroxide is 
the glutathione peroxidases (GPxs) (Fig. 3). In humans there are eight members 
of the family of GPx family and they can be found in most parts of the cell [33]. 
Gpx proteins contain either a cysteine or selenocysteine which can be oxidised 
by hydrogen peroxide or lipid peroxides to form cysteine sulfenic acid or 
selenenic acid. Glutathione then reacts with the oxidised residue to form a 
disulfide or Se-S bond and a molecule of water. The bond formed can then be 
resolved by a further molecule of glutathione. 
GPxs 7 and 8 are localised to the ER. It was shown in a bimolecular fluorescence 
complementation (BiFC) experiment that they are capable of interacting with 
Ero1 [34]. This means that hydrogen peroxide produced by Ero1 as a result of the 
oxidation of PDI can be directly removed by GPx 7 and 8, therefore preventing a 
build-up that could cause toxicity. It has also been shown that GPx 7 and 8 are 
capable of oxidising PDI directly, a mechanism which could aid the folding 
process. 
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The third class of enzymes which is capable of utilising hydrogen peroxide in 
cells are the peroxiredoxins (Prxs) (Fig. 3). The typical 2-Cys Prxs are composed 
of 5 or 6 dimers [35]. Each Prx monomer contains two cysteine residues within 
the active site. One of these is known as the peroxidatic cysteine and the other 
is the resolving cysteine. The peroxidatic cysteine reacts with hydrogen peroxide 
and forms the sulfenic acid intermediate. The resolving cysteine then reacts 
with the sulfenic acid forming a disulfide and a molecule of water. The disulfide 
can be reduced by thioredoxin which in turn is reduced by thioredoxin 
reductase. When the Prx intermediate sulfenic acid has been formed further 
reaction with hydrogen peroxide is also possible. This leads the enzyme to form 
sulfinic acid (SO2H) or sulfonic acid (SO3H) [36]. Once in these forms the enzyme 
is inactivated as the resolving cysteine cannot form a disulfide.  
PrxIV is the only Prx resident in the ER. PrxIV is different from other Prx 
enzymes in that it contains extra residues at the N-terminus. Within these 
residues there is a third cysteine residue which forms a disulfide between the 
dimeric units of the Prx structure. PrxIV has shown to be capable of metabolising 
hydrogen peroxide produced by Ero1 and can play a role in de novo disulfide 
formation by the direct oxidation of PDI [37]. 
 
 
 
 
 
 
 Figure 
heme protein that reacts with hydrogen peroxide to from a high
valent iron intermediate. A second molecule of hydrogen peroxide 
can then react forming two molecules of water and oxygen. The
GPx group of enzymes containing a cysteine residue which forms 
sulfenic acid after reaction with hydrogen peroxide. This forms a 
disulfide with glutathione, releasing a molecule of water. The 
disulfide can be reduced by a second molecule of glutathione. T
Prxs contain two cysteines in the active site. The peroxidatic 
cysteine reacts with hydrogen peroxide forming sulfenic acid. This 
is resolved by the resolving cysteine which forms a disulfide. The 
disulfide can be reduced by thioredoxin.
5.6 Hydrogen Pe
Previously it was believed that hydrogen peroxide was free to move around cells 
and that all membranes were permeable to hydrogen peroxide. It has now been 
discovered that different membranes have different hydrogen peroxide 
permeability and some are fairl
3 – Removal of hydrogen peroxide in cells. Catalase is a 
roxide Movement in Cells
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concentration of hydrogen peroxide inside cells is tightly regulated, a fact which 
is also suggested by the presence of antioxidant proteins. The concentration of 
hydrogen peroxide in a cell can be calculated as the amount entering the cell 
plus the amount being produced in the cell minus the amount being removed by 
antioxidant enzymes and the amount leaving the cell. It is believed that 
variations in membrane permeability to hydrogen peroxide could be due to 
differences in lipid composition or the presence of hydrogen peroxide selective 
channels or a combination of both [39]. 
Antunes et al. made an estimate of hydrogen peroxide permeability via 
measurement of the enzyme latencies of catalase and GPx. They showed that 
hydrogen peroxide gradients were formed when membranes separated the site 
of hydrogen peroxide production and consumption [38]. The time taken for 
hydrogen peroxide to diffuse was measured by the delay in the reaction of the 
enzyme. They found significant gradients which were attributed to the capacity 
of the enzymes consuming hydrogen peroxide and the permeability of the 
membranes involved. 
Hydrogen peroxide permeability of membranes has been shown to have some 
dependence on the lipid composition of membranes. Experiments in yeast have 
shown that hydrogen peroxide permeability is five times higher when the yeast 
are actively growing compared to when the cells are in stationary phase [40]. 
This difference is suggestive of different membrane composition during different 
phases in the life cycle. Though it is likely that membrane composition does 
affect the diffusion of hydrogen peroxide it is unlikely to be the main influencer 
in the process. Changing membrane lipid composition is a slow process and is 
more of a long term strategy. Also if cells were to rely on this as the only 
method of hydrogen peroxide diffusion regulation then it is likely that many 
other cellular processes would be affected as well. 
Aquaporins are diffusion channels situated in cellular membranes that allow 
diffusion of water and other small non-charged solutes including carbon dioxide 
and ammonia [41]. Water can of course diffuse through membranes but the 
diffusion rates of water through aquaporins are far greater. Aquaporins have, 
therefore, been studied as a potential mechanism for hydrogen peroxide 
transport. One factor which suggests that hydrogen peroxide also is capable of 
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entering aquaporins is that on a molecular level it has very similar properties to 
water. These properties include dipole moment and hydrogen bond forming 
capacity. The mean diameter of a hydrogen peroxide molecule is around 0.25-
0.28 nm [42]. Some typical aquaporins have pore diameters of between 0.3 and 
0.4 nm suggesting size is not a barrier to the transport of hydrogen peroxide 
through aquaporins [43]. 
Yeast mutants expressing various aquaporins from plants and mammalian 
systems were created to investigate the differential selectivity of aquaporins to 
hydrogen peroxide [44]. A total of 24 mutants were created but only two saw 
increases in hydrogen peroxide sensitivity. The increase was found to be up to 
10-fold. The aquaporins which showed sensitivity were AtTIP1, an Arabidopsis 
aquaporin and APQ8, a mammalian aquaporin. APQ8 is found in the plasma 
membrane but also in the inner mitochondrial membrane [45]. This suggests that 
aquaporins are certainly capable of transporting hydrogen peroxide but that they 
are selective and there may be aquaporins which have the specific role of 
hydrogen peroxide transport. 
5.7 Hydrogen Peroxide in Signalling 
One of the main responses to increased levels of hydrogen peroxide in the cell is 
increased expression of antioxidant enzymes such as peroxiredoxins and 
glutathione peroxidases. However, hydrogen peroxide is also an important 
signalling molecule and a wide variety of responses is produced. With regards to 
multicellular organisms the responses can include differentiation [46], 
proliferation [47], migration [48] and apoptosis [49]. The fact that one 
compound can generate such a range of responses is intriguing and the ability to 
do so is due to the careful control of the hydrogen peroxide concentration inside 
cells. 
In mammalian cells it has been shown that low levels of hydrogen peroxide 
stimulate the expression of antioxidant enzymes whereas high levels stimulate 
the expression of pro-oxidant enzymes which encourage apoptosis [50]. It seems 
that at levels where the cellular antioxidant enzymes will not be able to cope 
and damage is inevitable the cell propels itself towards apoptosis by the further 
production of hydrogen peroxide and other reactive oxygen species. 
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One process where hydrogen peroxide concentrations are important and can 
change the response is modification of proteins by SUMO proteins. SUMO proteins 
are small proteins around 12 kDa that can be covalently attached or removed 
from other proteins, leading to a change in action of the substrate protein. They 
are indicated in a wide range of processes including cell cycle progression, stress 
response, protein stability, transcriptional regulation, nuclear cytosolic transport 
and apoptosis. It has been found that in lower concentrations of hydrogen 
peroxide then the conjugation of SUMO proteins to substrates is reduced 
whereas in high concentrations the removal of SUMO proteins from substrates is 
inhibited [51]. 
Another important process affected by hydrogen peroxide is that of protein 
tyrosine phosphorylation. All protein tyrosine phosphatases (PTPs) contain a 
cysteine residue within the active site. Importantly this cysteine residue is 
predominantly in the thiolate anion form at pH 7.4. It is normally part of a thiol-
phosphate intermediate, formed as part of the catalytic cycle, but when free it 
is predominantly in the thiolate form and so it is easily oxidised by hydrogen 
peroxide or other reactive oxygen species [52]. The thiolate anion forms sulfenic 
acid after reaction with hydrogen peroxide as in the cases of the peroxiredoxins 
and glutathione peroxidases. The oxidised PTP which is inactivated can be 
reduced by glutathione back to the active form. 
It has been shown that when a high level of tyrosine phosphorylation is required 
in a cell, the activation of receptor protein tyrosine kinases by substrates such 
as epidermal growth factor may not be enough to allow the required amount of 
phosphorylation to occur [53]. As receptor protein tyrosine kinases are 
stimulated then PTPs may also be inactivated by oxidation of the cysteine 
thiolate within the active site which prevents the thiol-phosphate reaction 
intermediate being formed and hence no removal of phosphate groups. 
5.8 Hydrogen Peroxide in Cell Death 
A range of factors can cause a cell to undergo apoptosis. These include a loss of 
nutrients required for cell survival, oxidative stress, radiation and infection by a 
virus. Due to the well characterized toxicity of hydrogen peroxide and other 
reactive oxygen species, it has long been known that too much can cause cell 
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damage and eventually death. However, the mechanism by which this occurs 
and the concentrations required have not always been so well studied. 
A study was carried out by Clément et al. which aimed to determine the 
mechanisms by which hydrogen peroxide caused cell death [54]. They found that 
upon addition of hydrogen peroxide to mammalian cells the amount of cell death 
increased as the concentration of hydrogen peroxide increased. When the 
concentration of hydrogen peroxide was between 0.25 mM and 0.5 mM then the 
cells went into apoptosis, whereas if the concentration was above 1 mM the cells 
went into necrosis, suggesting two different mechanisms. It was found that 
hydrogen peroxide mediated apoptosis also required caspase activity. Caspase 
proteins have been termed “executioner” proteins due to their role in apoptosis 
and are a form of protease [55]. 
The level of intracellular superoxide was measured when cells were treated with 
apoptotic concentrations of hydrogen peroxide. It was found that the 
intracellular concentration of superoxide dropped as much as 50% when cells 
were treated. It was also shown that necrotic concentrations of hydrogen 
peroxide caused no alteration to the intracellular superoxide concentration. To 
further correlate the hydrogen peroxide and superoxide levels cells were again 
treated with the apoptotic concentration of hydrogen peroxide along with an 
inhibitor of superoxide dismutase, the main superoxide scavenging protein. It 
was found that the levels of superoxide did not decrease as much as when the 
cells were treated with hydrogen peroxide alone. The amount of caspase activity 
and apoptotic cell death was also reduced due to the maintenance of higher 
superoxide levels [54]. 
The effect of reduced levels of superoxide on the intracellular redox state was 
also investigated. In the cytosol the GSH:GSSG ratio is usually between 100 and 
200:1 [56]. Any increase in cellular superoxide would be expected to cause an 
increase in the amount of GSSG compared to GSH and conversely any decrease in 
superoxide would be expected to cause a decrease in the amount of GSSG 
compared to GSH. It was found that when high concentrations of hydrogen 
peroxide were added to cells and necrosis was caused then the amount of GSSG 
relative to GSH increased whereas when apoptotic concentrations of hydrogen 
peroxide were added to cells then the amount of GSSG decreased relative to 
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GSH. An acidification of the cell was also associated with apoptotic cell death, 
in comparison to necrotic cell death which was associated with an increased 
alkalinity. 
These results are not, however, without any contradiction. Tochigi et al. found 
that treatment of mammalian cells with concentrations of hydrogen peroxide 
between 30 µM and 100 µM stimulated apoptotic cell death and activation of 
caspase enzymes, in agreement with Clément et al., but they found that this 
caused an increase in intracellular superoxide [57]. It was found that the 
increase in superoxide caused by apoptosis activated the ER stress response and 
ER associated cell death. 
What can be deduced is that at lower concentrations hydrogen peroxide can 
cause apoptotic cell death and that at concentrations of 1 mM or above the cells 
will undergo necrotic cell death. The mechanism of how hydrogen peroxide 
causes apoptosis is unclear but almost certainly involves activation of caspase 
enzymes amongst others. The contradiction in the discussed results is a further 
testimony to the complex nature of the role of hydrogen peroxide in cells. 
5.9 Measuring Hydrogen Peroxide in Cells 
As has been shown, hydrogen peroxide is undoubtedly an interesting molecule, 
but the roles it plays within cells have not been fully deduced. With regards to 
the ER in particular, the measurement of hydrogen peroxide is a particularly 
fascinating prospect. It is known that Ero1 is a producer of hydrogen peroxide in 
the ER and PrxIV, Gpx7 and Gpx8 are capable of reacting with this source [58]. 
What is unknown is what happens to the levels of hydrogen peroxide in the ER if 
conditions are stressful, for example during the unfolded protein response (UPR) 
when changes within the ER occur to cope with the extra load of protein folding 
required [59]. 
There have been previous probes created to measure hydrogen peroxide inside 
cells. A number of these have been small molecule probes but there has also 
been protein based methods. 
The commercially available Amplex Red is an organic compound that is not 
fluorescent but becomes fluorescent after reaction with hydrogen peroxide (Fig. 
4). Amplex Red will only work in the presence of a peroxidase enzyme. Amplex 
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Red reacts in a stoichiometric manner to produce resorufin, a highly fluorescent 
compound. The reliance of Amplex Red upon the presence of a peroxidase 
enzyme is where the disadvantage of the method lies. The requirement for a 
peroxidase makes analysis of complex biological samples and analysis in cells 
difficult as the enzyme activity can be affected by many factors, resulting in an 
effect on the resorufin fluorescence [60]. Amplex Red has also been shown to be 
susceptible to photo oxidation [61]. Nevertheless Amplex Red is used for a range 
of applications including microwell plate based assays. 
 
Figure 4 – The reaction of Amplex Red. Amplex Red 1, a 
commercially available sensor reacts with hydrogen peroxide in the 
presence of peroxidase to form Resorufin 2, a highly fluorescent 
compound.  
Another of the earlier methods of measuring hydrogen peroxide used the small 
molecule probe dichlorofluorescein (DCF) as a reporter (Fig. 5). The reduced 
form of DCF, DCFH, is not strongly fluorescent is used as an oxidation sensitive 
probe. After reaction there is an increase in fluorescence up to 20-fold at 525 
nm [62]. It was first used to study the reactive oxygen species released from 
neutrophils and has gone on to be used in neutrophil disease diagnosis [63]. It is 
important to note that oxidation sensitive DCFH is not a hydrogen peroxide 
specific probe and it has a number of disadvantages. 
 
Figure 5 – The reaction of DCFH. DCFH 3 is an oxidation sensitive 
probe that reacts with hydrogen peroxide and to give DCF 4 and so 
displays a fluorescence increase after reaction. 
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DCFH is capable of photo-oxidation which can lead to a false signal or a more 
intense signal than what is real. One of the main issues is that hydrogen 
peroxide does not directly react with DCFH. It requires a transition metal 
catalyst which can be found in proteins such as peroxidases [64]. There is 
consequently a correlation between catalyst availability and level of oxidation. 
Upon autooxidation of DCF by molecular oxygen the superoxide radical is 
generated which is readily converted to hydrogen peroxide, resulting in a self-
amplification of signal. It has also been shown the cytochrome c and other 
factors are capable of oxidising DCFH [65]. Though several factors must be taken 
into account when using DCFH as an oxidative stress indicator, it is suitable for 
use in a simple or first-look assay. 
Since the reliance of DCF and Amplex Red on enzymes acts as a disadvantage to 
their use as probes, further probes have been developed which use the 
fluorescence of fluorescein but do not require any enzyme activity to do so. 
Once such example is a fluorescein derived probe that is modified as a 
perfluorobenzenesulfonate ester (Fig. 6) [66]. This acts to quench the 
fluorescence until after reaction with hydrogen peroxide. The probe is cell 
permeable but the reaction is strongly dependent upon pH. If the pH rises above 
the optimum of pH 7.4 then hydrolysis of the probe that is independent of 
hydrogen peroxide can occur, leading to a false signal. The reaction was also 
found to be a rather slow one, around 60 min. It was also found that cleavage of 
the perfluorobenzenesulfonate ester is not specific to hydrogen peroxide and 
will reactive with other reactive oxygen species. Therefore the probe is useful as 
an oxidation sensor, as long as the limitations are taken into account in the 
design of the experiment. 
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Figure 6 – The reaction of of 2’,7’-dichlorofluorescein 
pentaflurobenzenesulfonate ester. Perhydrolysis of 2’,7’-
dichlorofluorescein pentaflurobenzenesulfonate ester by hydrogen 
peroxide results in the release of the fluorophore. 
Another issue of the previously discussed small molecule probes is that they are 
not ratiometric. They function purely as ON-OFF probes which are only able to 
show a relative increase. This makes determination of concentration of hydrogen 
peroxide nigh on impossible. HyPer was developed as a ratiometric genetically 
encoded protein based method for hydrogen peroxide measurement in cells. 
HyPer is based on a fusion of the regulatory domain of OxyR, an E.coli protein 
sensitive to hydrogen peroxide, and a circularly permuted yellow fluorescent 
protein (cpYFP) [67]. 
OxyR has two key cysteine residues, Cys199 and Cys208. Cys199 can react with 
hydrogen peroxide and goes on to form cysteine sulfenic acid. This causes a 
conformational change whereby Cys199 moves into the proximity of Cys208 and 
a disulfide bond is formed [68]. Circularly permuted proteins such as cpYFP have 
been found to be particularly sensitive to conformational change, and display 
this sensitivity in fluorescence changes. HyPer therefore consists of cpYFP 
inserted into OxyR with an excitation peak at 420 nm and emission at 500 nm. As 
HyPer becomes oxidised the peak at 420 nm decreases in intensity and the 
intensity of the peak at 500 nm increases, giving the probe a ratiometric quality. 
It was shown that HyPer was selective for hydrogen peroxide over other reactive 
oxygen species and the sensitivity was shown to be in the nanomolar range in 
vitro. HyPer was also expressed in E.coli and mammalian cells and can be 
targeted to different organelles by incorporating targeting sequences (Fig. 7). In 
both E.coli and mammalian cells the lowest hydrogen peroxide concentration 
detectable was 5 µM. 
 Figure 
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Criticism of HyPer as a method for measuring intracellular hydrogen peroxide has 
been due to the fact that most cpYFP proteins are sensitive to pH, as HyPer has 
been shown to be. There has also been debate about whether HyPer is sensitive 
to superoxide as well as hydrogen peroxide
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In water the trigonal planar boronic acid is in equilibrium with the anionic 
tetrahedral form produced by formal reaction with a hydroxide anion. Thus, 
boronic acids have acidic character in water with the pKa of phenylboronic acid 
in water being 8.8 (Fig. 8). This is similar to the acidity of a phenol [73]. 
 
Figure 8 - The ionization of a boronic acid in water. The boronic 
acid 7 is ionized to the borate anion 8, showing the acidic 
character. 
Boronic acids are commonly synthesised as the ester derivatives to make 
handling and purification easier due the reduction in polarity caused by caging 
the acid [74]. In aqueous systems, however, the ester form is in equilibrium with 
the acid. 
Aryl boronic acids are known to react with hydrogen peroxide forming the 
corresponding phenol (Fig. 9) [75]. This has been exploited as a selective 
reaction to measure hydrogen peroxide in biological systems. The boron atom 
first acts as an electrophile to form a tetrahedral complex with the peroxide. 
The C-B bond then acts as a nucleophile and an oxygen atom is inserted between 
the carbon and boron. The final step is loss of boric acid and production of the 
corresponding alcohol. 
 
Figure 9 - Reaction of phenylboronic acid with hydrogen peroxide.  
Boric acid is lost from the boronic acid 9 after -OOH inserts and 
phenol 12 is produced. 
This molecular feature has been utilised in the production of hydrogen peroxide 
sensitive probes for use in cells. A range of intensity based fluorescent probes 
incorporating a boronic acid have been developed. The response of boronic acids 
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to hydrogen peroxide has been shown to be selective over other reactive oxygen 
species [76]. 
Fluorescence is the rapid emission of energy converted from absorbed radiation. 
After absorption of energy by a molecule, the molecule reaches an excited 
state. The excited molecule is eager to give up this energy. Collisions with 
nearby molecules result in non-radiative decay and the energy drops down 
vibrational levels. When the energy reaches the lowest vibrational level of the 
excited state, if the nearby molecules are not capable of accepting the larger 
energy difference between the excited state and the ground state, then the 
emission of a photon may occur (Fig. 10). Fluorescence is emitted at longer 
wavelengths than the absorption of energy occurs due to the fact that it happens 
after the non-radiative decay resulting from collisions with surrounding 
molecules. This explains why solvent choice can affect the fluorescence of a 
compound, as if the solvent molecules are capable of receiving the large energy 
difference between the lowest vibrational level of the excited state and the 
ground state then the fluorescence is quenched [77]. 
 
 Figure 
energy leading to an excited singlet state. Internal conversion (IC) 
occurs which is a radiationless procedure between energy levels in 
the same spin state. When the photon is emitted in the same spin
state fluorescence is produced. If intersystem crossing (ISC) occurs 
and the photon is released from a different spin state, the triplet 
state, then it is termed phosphorescence.
Fluorescence microscopy is a key technique in biology used for studying a wh
range of cellular processes.
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The ability and efficiency with which a compound fluoresces is measure by the 
quantum yield (Φ), defined as the ratio of photons absorbed to photons emitted 
via fluorescence [79]. Quantum yields can be sensitive to environmental factors 
such as solvent, something which must be considered when designing a 
fluorescent probe. A common problem facing the use of fluorescent probes is 
photobleaching. This is irreversible removal of the fluorophore under high 
intensity light by chemical reactions of the excited fluorophore.  
The Stokes shift of a fluorophore is the difference between the absorption and 
emission wavelengths. If this difference is small it becomes impossible to 
achieve the optimum excitation of the probe while differentiating the 
fluorescence emission from any scattered light from the absorption. The ideal 
fluorophore must have a large Stokes shift along with high quantum yield and 
low incidence of photobleaching [80]. 
One of the early boronic ester incorporating probes was Peroxyfluor-1 (PF1) [81], 
which relies on reaction of two boronic esters to produce fluorescein (Fig. 11). 
This is highly fluorescent, however due to the quenching nature of boron; it is an 
off-on probe and cannot be used ratiometrically. It has been shown to have 
selectivity for hydrogen peroxide over most other reactive oxygen species [82]. 
The sensitivity of PF1 was improved upon by the design of a second generation of 
probes which incorporated only one boronic ester. Peroxy Green 1 (PG1) (Fig. 
11) contains only one boronic ester group and showed a greater fluorescence 
response to hydrogen peroxide than that of PF1 [83]. As a result of only having 
one boron atom it also showed measurable fluorescence before reaction, though 
at the same wavelength as the reacted form so it cannot be said to be truly 
ratiometric. 
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Figure 11 – PF1 and PG1, two boronate ester based probes for 
hydrogen peroxide. PF1 13 relies on the deprotection of two 
boronate ester groups to release fluorescein 14. Due to the 
quenching nature of boron this probe gives an OFF-ON response. 
PG1 15 only contains one boronate ester group. This means it does 
display some fluorescence before reaction with hydrogen peroxide 
but at the same wavelength as after reaction when Tokyo Green 16 
is released. 
5.10 Targeting of Probes within Cells 
All the probes discussed have various advantages and disadvantages and with the 
exception of HyPer, none are targeted to specific areas of the cell, though they 
are cell permeable.  
For a probe to be targeted there must be a feature of the structure that 
determines the organelle or locale of the cell to which it is directed. Various 
methods have been designed which allow small molecules to have such a homing 
device incorporated into the structure. There is an electrochemical gradient 
across the mitochondrial inner membrane as a result of the movement of protons 
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out of the matrix by the electron-transport chain in the inner mitochondrial 
membrane. Thus there is charge separation with a build up of negative charge 
on the inside (matrix side) of the inner membrane, and this corresponds to a 
voltage. The triphenylphosphonium (TPP) cation has been used to great effect in 
the mitochondria because it is positively charged and so partitions across this 
membrane in accordance with the Nernst equation resulting in a several hundred 
fold accumulation on the negatively charged side at normal operating voltages 
(120-180 mV) [84]. The TPP cation is lipophilic and therefore easily crosses the 
phospholipid bilayer. Any small probe or chemical group attached to the TPP 
cation is selectively taken-up into the mitochondria as a consequence. One 
probe which uses this technology is MitoSox™, a TPP-containing mitochondria-
targeted fluorescent probe for superoxide [85]. However, this electrochemical 
gradient is a unique feature of the mitochondria and so different methods of 
targeting are required for other organelles. 
Recombinant proteins are commonly expressed with an extra peptide or tag. 
These extra peptides or tags are often used as an aid for purification or for 
detection of the protein. The most common examples being the use of the 
hexahistidine tag for purification [86] and green fluorescent protein (GFP) for 
detection [87]. Tag technology has expanded to allow a much wider range of 
chemistry to occur. This means that proteins can be imparted with properties 
which cannot be provided by genetic manipulation alone. 
One of the major developments has involved systems which allow site-specific 
incorporation of unnatural amino acids into proteins and can be used in living 
cells [88]. Other methods have involved the covalent modification of a tag with 
a range of molecules [89]. Covalent modification of a tag often involves the use 
of a chemical probe. The efficiency of expressing a tag inside a living cell in 
conjunction with the infinite number of possibilities provided by synthetic 
chemistry makes this a very powerful technique. 
To be successful, the reaction that occurs between the peptide or fusion tag and 
the synthetic compound must hold certain qualities. The reaction must be highly 
specific and fast, the synthetic probe must have bio-orthogonal properties [90] 
as any interference with the biochemical processes inside a living cell could be 
detrimental to the overall aim of the experiment. Also the substrate which 
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reacts with the peptide or fusion tag should not be affected by the probe or 
small molecule to which it is conjugated as the system must be universal. 
The incorporation of a tetracysteine (TC) tag allows for the specific binding of 
biarsenical compounds. An example is FlAsH, a fluorescein derivative (Fig. 12) 
[91]. The TC tag has the main advantage of being small and so is unlikely to have 
any adverse effects on the folding or processes of the protein in which the tag is 
incorporated. The main disadvantage of the TC tag is the risk of unspecific 
binding of the biarsenical compounds. This can be circumvented to some extent 
by co-incubation with dithiols. 
 
Figure 12 - The tetracysteine (TC) tag. Conjugation of FlAsH 17, a 
biarsenical substrate with a fluorescein derived fluorophore to a 
protein of interest which has been genetically manipulated to 
express the TC tag resulting in the conjugate 18. 
The issues associated with the TC tag have been overcome with the development 
of folded protein tags. Human O6-alkylguanine-DNA-alkyltransferase (AGT) 
repairs the damage incurred by alkylation of guanine to form O6-methyl guanine. 
The process of repair involves the transfer of the O6-alkyl group from O6-methyl 
guanine to the active site cysteine of AGT. This process is both irreversible and 
stoichiometric.[92] AGT is not hugely specific regarding its substrate choice and 
is also known to react with O6-benzylguanine derivatives [93]. 
AGT provides protection from alkylating agents such as dacarbazine and 
temoxolomide which are used in chemotherapy treatments [94]. O6-
Benzylguanine was found to be an inhibitor of AGT that sensitized tumours 
towards alkylating agents and so was researched as an agent to aid the success 
of chemotherapy compounds [95]. It was found that there was some natural 
resistance of AGT to the use of O6-benzylguanine in this treatment strategy. 
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Further investigation found that this natural resistance was due to natural 
polymorphism in the AGT gene. Various mutants of AGT were expressed in E.coli 
to determine the effects of such polymorphism. The mutant that was of most 
interest was G160R. G160R exists naturally in some individuals and causes AGT 
to be resistant to O6-benzylguanine. Interestingly it was found that the mutation 
G160W actually made AGT far more sensitive to O6-benzylguanine and caused 
enzyme inactivation [96]. 
Due to the targeting of AGT in anti-cancer therapy it was reasoned that if there 
was a simple method for studying the activity of AGT it would be of great use. 
Oligonucleotides were developed that used O6-benzylguanine and O6-alkylated 
guanine derivatives to bind to AGT. It was demonstrated that probes for AGT 
using the described derivatives could be used successfully and quantitatively to 
study the activity of AGT [97]. 
The knowledge garnered from the studies of probes investigating AGT activity 
and the effects of different mutants at the G160 position were utilised in the 
development of the SNAP-tag system. This lack of specificity with regards to 
substrates of AGT lead to this development [89]. SNAP-tag is a 23.5 kDa 
monomeric protein developed from the AGT mutant G160W which has a greater 
specificity for O6-benzylguanine derivatives and also accepts substrates with 
substituted benzyl rings (Fig. 13).  
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Figure 13 - The structure of SNAP-tag. 
The kinetics of the binding reaction of W160AGT with O6-benzylguanine derivatives 
in vitro have been studied and have a second order rate constant of 600 s-1 M-1. 
It is possible to express W160AGT as a fusion protein and it has been demonstrated 
in cellulo that it is completely labelled after the addition of an O6-benzylguanine 
derivative to the medium of the cells expressing the fusion protein [93]. SNAP-
tag substrates consist of an O6-benzylguanine derivative with a probe, 
fluorophore or other synthetic compound conjugated via a substituted benzyl 
ring (Fig. 14).  
 
 
Figure 14 - Probe conjugation to SNAP-tag. The active site cysteine 
of SNAP-tag performs a nucleophilic displacement specifically with 
benzylguanine derivatives 19. Guanine is released as a harmless 
by-product and the synthetic probe is covalently bound to the 
protein forming conjugate 20. 
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The SNAP-tag technology has been used widely and for varied purposes including 
protein distribution studies [98], protein immobilization [99], protein-protein 
interaction studies [100] and as a tool for locating a synthetic compound to a 
particular area or organelle of the cell [101]. 
SNAP-tag has been used in conjunction with a hydrogen peroxide sensor to target 
it to various areas of the cell, including the ER [101]. HEK293 cell lines were 
created which expressed SNAP-tag in regions including the plasma membrane, 
mitochondria, ER and nucleus. There are two different possible SNAP-tag 
substrates, O6-(4-aminomethyl)benzylguanine and benzyl-2-chloro-6-
aminopyrimidine, which were both synthesised in preparation for coupling to the 
fluorophore containing probe. The probes, SNAP-Peroxy Green 1 (SPG1) and 
SNAP-Peroxy Green 2 (SPG2), were a development on the previously discussed 
PG1 (Fig. 10) and so contained the same fluorophore and boronate ester group 
for hydrogen peroxide reactivity, but were conjugated to the SNAP-tag 
substrates to allow specific organelle localisation (Fig. 15). 
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Figure 15 – Two hydrogen peroxide sensors targeted to the ER. 
SPG1 21 and SPG2 24 are based on the fluorophore Tokyo Green 
and incorporated a boronate ester for hydrogen peroxide reactivity 
and SNAP-tag substrates to allow for intracellular localisation. Both 
probes diffuse into the cell and reacted with SNAP-tag wherever 
expressed. The probes are mildly fluorescent before reaction with 
hydrogen peroxide. After reaction the fluorophore is uncaged 
leading to an increase in fluorescence. 
Both SPG1 and SPG2 showed mild fluorescence before reaction with hydrogen 
peroxide but far more noticeable fluorescence after reaction, when the 
fluorophore had been uncaged. When the fluorescence of the probes was studied 
in vitro, without any SNAP-tag present, the O6-(4-aminomethyl)benzylguanine 
moiety was found to cause quenching, whereas the benzyl-2-chloro-6-
aminopyrimidine did not. These moieties are of course removed when the 
sensors bind to SNAP-tag and any extra quenching before then should not be an 
issue. When used in cells, a binding time was allowed before any excess probe 
washed out. Both probes showed reaction and localisation inside cells, though 
SPG2 was found to be more cell permeable. When used inside cells, the lowest 
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concentration of hydrogen peroxide detected was 100 µM, when added 
exogenously. 
SPG1 and SPG2 confirm the ability of SNAP-tag to be a useful tool on the 
localisation of small molecule sensors to different organelles of the cell, 
however, the use of the Tokyo Green fluorophore offers no significant 
improvement as the fluorescence is at the same wavelength before and after 
reaction with hydrogen peroxide and, therefore, is not a ratiometric readout. 
HaloTag is a 34 kDa monomeric protein labelling system which is based on a 
similar theory to SNAP-tag [102]. HaloTag employs a modified bacterial 
haloalkane dehalogenase. Haloalkane dehalogenases remove halides, such as 
chlorine, from alkanes by a nucleophilic displacement [103]. This involves 
nucleophilic attack of the haloalkane by an aspartate residue within the active 
site. This forms a covalent bond to the substrate. The enzyme is recycled by 
histidine mediated hydrolysis of the aspartate-alkane intermediate. In HaloTag 
the histidine is mutated to a phenyalanine preventing the hydrolysis, so that the 
alkane stays covalently bound to the protein. HaloTag can be expressed in 
mammalian cells as with SNAP-tag and the use of a bacterial system prevents 
cross-reactivity from occurring. 
HaloTag substrates can therefore be any small molecule as long as it is 
conjugated to a chloroalkane to provide reactivity (Fig. 16).  
 
Figure 16 – An example of a HaloTag substrate 27. The fluorophore 
is conjugated to the haloalkane for reactivity towards HaloTag. A 
nucleophilic displacement causes loss of the chlorine atom and 
leaves the fluorophore covalently bound to the protein. 
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Another possible method of targeting synthetic probes to different cellular 
locations is the use of targeting peptides. Targeting peptides are short 
sequences of amino acids that act as a method of directing a protein to a 
particular area of the cell such as the nucleus, ER, mitochondria or plasma 
membrane. Almost all proteins that traverse the secretory pathway contain N-
terminal signal sequences and proteins destined specifically for the ER often 
carry the C-terminal ER retention sequence, KDEL [104]. The KDEL receptor 
exists within the Golgi apparatus with the function of binding to proteins with 
the retention sequence and retrotransporting them back to the ER [105]. 
The advantage of using a peptide targeting method over a protein based one, 
such as SNAP-tag, is that no transfection of cell lines is required. This can be a 
slow process with varying efficiency. Peptides have been used extensively in 
therapeutics and molecular imaging techniques [106]. The advances in 
combinatorial chemistry have meant that a hugely diverse array of peptides can 
be created. 
Peptides have been used successfully with small molecule probes. The zinc 
sensors Palm-ZP1 and Palm-ZQ make use of a peptide containing a palmitoyl 
moiety which mimics palmitoylation [107]. Palmitoylation is a post-translational 
modification of residues such as cysteine with the fatty acid, palmitic acid, 
which directs proteins to be membrane associated. 
The majority of ER targeted probes that use peptide based systems incorporate 
the ER retention sequence; however Hwang et al. made use of the peptide NYTC 
[108]. The analyte involved was glutathione and this was studied by the 
disulfides it formed with the cysteine residue of the short peptide, so strictly the 
peptide itself was the probe, but a local concentration of the peptide did build 
up in the ER since the peptide contained an acceptor site for N-linked 
glycosylation. Once glycosylated the peptide did not leave the ER, because the 
hydrophilic oligosaccharide prevented diffusion across the ER membrane. 
The majority of proteins that travel through the secretory pathway undergo N-
linked glycosylation on Asn residues that are part of an Asn-X-Ser/Thr sequence 
[109]. These hydrophilic modifications can dramatically alter the properties of 
the protein. Glycosylation usually occurs co-translationally once the polypeptide 
chain is at least 12-14 amino acids in length and extends into the lumen of the 
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ER. This acts to align the amino acids with the oligosaccharyltransferase (OST). 
The OST attaches a ready-made carbohydrate which consists of three glucoses, 
nine mannoses and two N-acetylglucosamines to the Asn residue of the Asn-X-
Ser/Thr sequence (Fig. 17).  
 
Figure 17 - The glycosylation process. The ribosome comprised of 
large and small subunit, binds to the ER membrane at the Sec61 
complex. The mRNA is translated into the polypeptide chain which 
passes through the Sec61 complex into the ER lumen. The signal 
sequence is cleaved and the OST glycosylates at Asn residues that 
are part of the Asn-X-Ser/Thr sequence. 
The main part of the OST consists of a dimer and within each dimeric subunit, 
there are numerous different parts [110]. Studies have shown that glycosylation 
is more likely to occur on flexible regions of the polypeptide [111]. This is due to 
the fact that during the process of N-glycosylation, the hydroxyl group on either 
the Ser or Thr must be mobile enough to move into a position whereby it 
increases the nucleophilic properties of the Asn residue.  
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6.0 Aims 
 To synthesise a novel sensor for hydrogen peroxide.  
o Inclusion of a moiety to allow the sensor to be targeted to the ER 
specifically and a moiety to give the sensor hydrogen peroxide 
reactivity.  
 Incorporate hydrogen peroxide reactivity that causes a structural change 
in the molecule 
o If fluorescence was to be used as the detection method then the 
sensor would also require the incorporation of a fluorophore within 
the structure. 
 In vitro testing of the probe to give an indication of the reactivity of the 
sensor to hydrogen peroxide.  
o Assess the sensor for ratiometricity. 
 Use of the probe in cellulo 
o Show the probe can be selectively targeted to the ER. 
o Show the probe can react with hydrogen peroxide in the ER  
o Develop a simple and robust method of use of the sensor in cellulo. 
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7.0 Materials and Methods 
All general chemicals sourced from Sigma-Aldrich unless stated otherwise. 
Antibodies 
Antibody Animal of Origin  
Anti-FLAG-tag Mouse Sigma-Aldrich 
Anti-GAPDH Mouse Abcam 
Anti-Mouse-FITC Rabbit Sigma-Aldrich 
Anti-PDI Rabbit Abcam 
Anti-Rabbit-Texas Red Mouse Abcam 
Anti-SNAP-P Rabbit Pierce Antibodies 
Anti-SNAP-tag Rabbit New England Biolabs 
Anti-Tubulin Mouse Santa Cruz 
Biotechnology 
IR Dye 800 Secondary Rabbit Li-Cor 
IR Dye 800 Secondary Mouse Li-Cor 
IR Dye 680 Secondary Rabbit Li-Cor 
IR Dye 680 Secondary Mouse Li-Cor 
 
Expression and purification of SNAP-tag 
A pET 28a His-tagged SNAP-tag construct was transformed into BL21 DE3 E. coli 
cells. Colonies were grown on LB agar containing kanamycin at a concentration 
of 20 µg/mL overnight at 37⁰C. 
A colony was picked and used to inoculate 5 mL Luria Broth (LB)  containing 
kanamycin at a concentration of 10 µg/mL. This culture was incubated at 37⁰C 
overnight, shaking at 180 rpm. The 5 mL culture was used to inoculate 500 mL 
LB also containing kanamycin, which was left to grow until the OD600 reached 
between 0.5 and 1. At this point the culture was induced using 0.5 mM isopropyl-
β-D-thiogalactopyranoside (IPTG, Bioline), returned to incubation at 37⁰C and 
shaken at 180 rpm for 3 h. 
Cells were then pelleted by centrifugation at 5000 x g for 20 min at 10⁰C before 
resuspending in 20 mL ice-cold lysis buffer (50 mM Tris-HCl, pH 8.0 containing 
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200 mM NaCl, 0.5% Triton X-100, 100 µg/mL lysosyme, 10 µg/mL DNAse) 
containing one complete EDTA free protease inhibitor tablet (Roche). Cells were 
lysed by freeze-thawing in liquid nitrogen and a 37⁰C water bath twice. The 
solution was rocked for 20 min at room temperature then centrifuged for 30 min 
at 5000 x g. The supernatant was mixed with Ni-NTA agarose resin (Qiagen) 
which had been equilibrated in 50 mM Tris-HCl pH8.0 buffer containing 500 mM 
NaCl and 20 mM imidazole. The suspension of supernatant and Ni-NTA agarose 
was rocked at room temperature for 30 min then centrifuged at 4000 × g for 5 
min. The resin was resolubilised with 10 mL equilibration buffer and left to rock 
at room temperature for 5 min. This suspension was centrifuged at 4000 × g for 5 
min and the process repeated. Elution buffer (5 mL) containing 50 mM Tris-HCl 
pH8.0, 500 mM NaCl, 0.5 mM EDTA and 500 mM imidazole was then added to the 
resin, the solution rocked at room temperature for 5 min. The resin solution was 
poured into a disposable chromatography column (Bio-Rad) and the eluate 
collected. The resin was washed with a further 5 column volumes of dH2O and 1 
mL factions collected. Presence of SNAP was confirmed by running 20 µL of each 
fraction on a reducing 12.5% SDS-PAGE and visualising the proteins with Colloidal 
Coomassie (10% w/v ammonium sulfate, 0.1% w/v Coomassie G-250, 5% ortho-
phosphoric acid, 20% v/v methanol). 
The fractions containing SNAP-tag were then pooled and purified further via a 
GE healthcare Mono-Q anion exchange column on an ÄKTA purifier system. The 
binding buffer contained 50 mM Tris-HCl pH7.5, 50 mM NaCl and 1 mM DTT. The 
protein was eluted using a gradient with buffer containing 50 mM Tris-HCl pH7.5, 
1M NaCl and 1 mM DTT. The protein was desalted using a PD-10 column (GE 
healthcare) according to manufacturer’s instructions. The concentration was 
determined by measuring the absorbance of the solution at 280 nm on a Cary 
300-bio UV-visible spectrophotometer and using the extinction coefficient of 
SNAP-tag. 
SDS-PAGE and Western Blotting 
Samples for SDS-PAGE analysis were resuspended in SDS sample buffer (25 mM 
Tris-HCl pH 6.8, 25% glycerol, 7.5% w/v SDS and 0.004% w/v bromophenol blue). 
Samples were boiled in the presence or absence of 50 mM DTT for 2 min prior to 
loading on the gel. Gels used were either 10% or 12.5% SDS-PAGE gels 
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Gels were then either stained with colloidal Coomassie or transferred onto a 
nitrocellulose membrane. Membranes were blocked for 1 h with 8% skimmed 
milk powder in TBST buffer (10 mM Tris-HCl pH8.0, 150 mM NaCl, 0.05% Tween-
20). Membranes were incubated with primary antibodies in TBST containing 3% 
skimmed milk powder for 1 h at dilutions between 1 in 500 and 1 in 10000. Blots 
were washed 3 × with TBST for 5 min before incubation with fluorescently-
labelled secondary antibodies at a 1 in 10000 dilution for 1 h in TBST. Blots were 
washed 2 × with TBST with a H2O rinse in between washes. Blots were stored in 
the dark in H2O for 10 min before being scanned with an Odyssey Sa quantitative 
fluorescence imaging system.  
Tissue Culture 
Experiments used an HT1080 human fibrosarcoma cell line. Cells were passaged 
in a sterile hood according to normal tissue culture practice and incubated at 
37°C with 5% CO2. Cells were grown in Dulbecco’s modified eagle medium 
(DMEM, Gibco) supplemented with 10% foetal calf serum (Gibco), 1% v/v L-
glutamine (200 mM stock, Gibco) and 1% v/v penicillin/streptomycin (5000 
units/mL penicillin, 5000 µg/mL streptomycin stock, Gibco). Cells were washed 
with Dulbecco’s Phosphate Buffered Saline (PBS, Gibco) and passaged with 0.05% 
Trypsin-EDTA (Gibco). 
For the creation of the stable cell line HT SNAP ER the SNAP plasmid containing 
a KDEL sequence and ER targeting sequence was linearised using 20 µg DNA, 5µL 
restriction enzyme 10 x buffer H (Promega), 20 units restriction endonuclease 
SSP (Roche)  and made up to 50 µL with H2O and incubated at 37⁰C for 2 h. TE 
buffer (250 µL, 10 mM Tris-HCl pH7.5 and 1 mM EDTA) and 300 µL 
phenol/chloroform/isoamylalcohol 25:24:1 were added, the solution vortexed 
and centrifuged for 2 min at 16162 × g. The upper phase was removed, 300 µL 
chloroform added and the solution vortexed and centrifuged at 16162 × g for 5 
min. The upper phase was then transferred to a new eppendorf tube and 
precipitation induced by the addition of an excess of ethanol. The solution was 
then centrifuged at 16162 × g for 10 min. The supernatant was disposed of and 
the pellet washed with 1 mL 70% ethanol. This was centrifuged for 5 min at 
16162 × g. The supernatant was removed again and the pellet left to air dry 
before being resuspended in 10 µL H2O. 
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For transfection 0.5 mL DMEM and 10 µL polyethyleneimine (PEI) were added to 
each to two 15 mL falcon tubes. Linearised DNA solution (4 µL) was then added 
to one of the tubes. These were vortexed and left at room temperature for 10 
min. A further 3.5 mL of DMEM were then added to each tube and each solution 
was added to a 6cm dish with good cell coverage. The pCI vector was used which 
carries neomycin resistance. G418 was used as the selection agent at a 
concentration of 800 µg/mL. 
The stable cell line, HT SNAP Cyto was created by M. Pringle (University of 
Glasgow) and carries Hygromycin B (Roche) resistance (250 µg/mL). 
Confocal Microscopy 
Immunofluorescence Staining of HT SNAP ER cells 
Coverslips were dipped in ethanol then left to air dry in a sterile hood. 
Coverslips were placed in the wells of a 6-well dish and 50 µL of poly-D-lysine 
HBr pipetted on top of each coverslip. After 5 min poly-D lysine HBr was 
removed and HT1080, HT SNAP ER cells in medium were seeded. Cells seeded 
onto coverslips were left overnight. The next morning cover slips were washed 
with PBS × 2 and fixed with -20⁰C methanol for 10 min. The methanol was 
removed and cells washed twice with PBS. A solution of 0.2% bovine serum 
albumin (BSA, Sigma Aldrich) in PBS was then left on the coverslips for 30 min. 
The primary antibody solutions were then left on the coverslips for 1 h at a 
dilution of 1 in 200 in 0.2% BSA in PBS. Antibodies used were anti-FLAG (Sigma-
Aldrich) and anti-PDI (Abcam). The coverslips were then washed with PBS twice 
and the secondary antibody solutions were placed on the coverslips for 1 h, 
again in 0.2% BSA in PBS. The secondary antibody for anti-FLAG was anti-mouse-
FITC (Sigma-Aldrich) and for anti-PDI, anti-rabbit-Texas red (Abcam). The 
coverslips were then washed with PBS and H2O. The coverslips were adhered 
onto slides using a solution of 25 mg/mL1,4-diazabicyclo[2.2.2]octane (DABCO) 
in Mowiol 4.88. A Zeiss LSM confocal microscope was used to collect images of 
fixed cells. 
Treatment of HT SNAP ER and Cyto with BG-NBD-X and Fluorescence 
Coverslips were dipped in ethanol then left to air dry in a sterile hood. 
Coverslips were placed in the wells of a 6-well dish and 50 µL of poly-D-lysine 
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HBr pipetted on top of each coverslip. After 5 min poly-D lysine HBr was 
removed and HT1080, HT SNAP ER and HT SNAP Cyto cells in medium were 
seeded. G418 and Hygromycin B were added accordingly. The following day cells 
were washed with PBS and either medium or medium with 5 µM BG-NBD-X added 
to the wells. After 30 min incubation cells were washed with PBS twice and fixed 
for 10 min with -20°C methanol. Coverslips were removed from wells and 
washed with PBS then H2O and adhered to slides using 7 µL 25 mg/mL DABCO in 
Mowiol 4.88. Images of cells were taken using a Zeiss LSM confocal microscope. 
Fluorescein Maleimide Binding Assay 
Hemocyanin from Megathura crenulata (Keyhole limpet, KLH) (1 µg, 0.4 µL KLH 
3.0 mg-7.0 mg in PBS, Sigma-Aldrich) either untreated or treated with hapten, 
was mixed with 10 µL 5 mM fluorescein maleimide in DMSO and 19.6 µL 
denaturing buffer (6M urea, 200 mM Tris-HCl pH 8.0, 0.5% SDS), and rocked at 
room temperature for 30 min in the dark. The reaction was stopped by 
precipitating the mixture with 150 µL of -20°C acetone. The solution was stored 
at -20°C for 1 h then centrifuged for 10 min at 16162 × g. Supernatant was 
removed and samples resuspended in 5 × SDS sample buffer with 50 mM DTT. 
After boiling, samples were run on a 6% polyacrylamide gel with no stacking gel 
for 3 h. The gel was fixed in 5% acetic acid with 10% methanol and scanned using 
a GE healthcare Typhoon FLA 9500. 
HPLC Purification of Peptides 
Peptides were purified by HPLC on a GE healthcare ÄKTAmicro system. An ACE 5 
C4-300 column was used. Flow rate was run at 0.2 mL/min. Gradient was 0-90% 
MeCN with 0.1% TFA in H2O over a volume of 2 mL. 
Sample Preparation of Purified SNAP Samples for MALDI-TOF 
A stock of SNAP-B was prepared by adding 222 µL of a 1 mg/mL solution of BGB 
in buffer (100 mM Tris-HCl pH7.5) to 120 µL of a 351 µmol solution of SNAP in 
buffer (50 mM Tris-HCl pH7.5 with 150 mM NaCl). The solution was kept at 37°C 
for 30 min. Excess unbound BGB was removed by buffer exchange using Bio-Rad 
Micro Bio-Spin chromatography columns resulting in a stock of SNAP-B in 100 mM 
Tris-HCl pH 7.5 buffer at a concentration of 123 µmol. 
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For each sample 2 µL of SNAP-B was added to an eppendorf tube containing 7 µL 
of buffer (100 mM Tris-HCl pH7.5) and 1 µL of H2O2 at the desired concentration. 
After allowing samples to react for a particular time period reaction was stopped 
by the addition of 50 µL -20°C acetone. Samples were kept at -20°C for 1 h to 
precipitate protein. Samples were then centrifuged at 16162 x g for 10 min and 
resuspended in trypsin solution (10 ng/µL in 100 mM Tris-HCl pH 7.5). Samples 
were kept overnight at 37°C then the next day 10 µL acetonitrile containing 0.4% 
formic acid added. Samples were kept at room temperature for 30 min before 
analysis.  
Sample Preparation of HT SNAP Samples for MALDI-TOF 
HT SNAP cells were seeded into 10 cm dishes. The following day, cells at 
confluency of 70-90% cells were washed with PBS then DMEM containing 5 µM 
BGB added and cells placed back in incubator for 30 min. Cells were washed 
with PBS to remove unbound probe then medium containing H2O2 or other 
treatment was added to cells. Cells were then placed back in the incubator for 
the desired time. Medium was then removed and cells washed with PBS, then 
fresh PBS containing 25 mM iodoacetamide left on for 5 min to block free thiols. 
Cells were then lysed in 200 µL lysis buffer (50 mM Tris-HCl pH 8.0, 1% Triton X-
100 and 150 mM NaCl). Lysates were left on ice for 10 min then centrifuged at 
14167 x g for 5 min.  
Supernatants were added to 20 µL anti-FLAG M2 affinity gel (Sigma-Aldrich) 
which had been equilibrated using TBS buffer (50 mM Tris-HCl pH 7.5, 150 mM 
NaCl) according to manufacturer’s instructions. SNAP expressed in mammalian 
cells has a FLAG tag incorporated to allow immunoaffinity purification. Total 
volume was made up to 1 mL with lysis buffer (50 mM Tris-HCl pH 7.5, 200 mM 
NaCl, 0.5% Triton X-100). Samples were immunoisolated for 2 h at 4°C on a roller 
shaker. Samples were centrifuged at 8000 x g for 30 seconds and supernatant 
removed. Affinity gels were washed three times with 400 µL TBS buffer and 
resuspended in 10 µL 8 M urea in 50 mM Tris-HCl pH8.0. Samples were incubated 
at 60 °C for 45 min then diluted with 70 µL 100 mM Tris-HCl pH 7.5 containing 
100 ng trypsin. Samples were stored overnight at 37°C. Supernatants were 
transferred into fresh Eppendorf tubes and peptides purified using C18 ZipTips 
(Millipore). Use of ZipTips differed from manufacturer’s instructions as wetting 
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solution was isopropanol: H2O: TFA 1:1:0.1, equilibrating solution was H2O: TFA 
1:0.1 as recommended and elution solution was isopropanol: TFA 1:0.1. 
MALDI-TOF 
Samples were analysed using either a Bruker Ultraflex MALDI-TOF/TOF or a 
Shimadzu AXIMA Performance MALDI-TOF/TOF. A Bruker MTP 384 ground steel 
target plate was used. Matrices used were either 5 mg/mL α-cyano-
4hydroxycinnamic acid (CHCA) in 50% acetonitrile and 0.1% trifluoroacetic acid 
(TFA) or 5 mg/mL 2,5-dihyroxybenzoic acid (DHB) with 2.5 mg/mL CHCA in 50% 
acetonitrile and 0.1% TFA. Sample solution (0.5 µL) was mixed with matrix 
solution (0.5 µL), spotted on the target and allowed to air dry completely before 
analysis. 
In Vitro Translation 
Peptide NYTCKDEL (AnaSpec) was solubilised in H2O at a concentration of 25 mM. 
Peptide NYTC (Cambridge peptides) was solubilised in 10% acetonitrile in dH2O 
at a concentration of 25 mM. In each reaction tube was added 16.5 µL rabbit 
reticulocyte lysate, 0.4 µL KCl, 0.5 µL methionine free amino acid mix, 1 µL 
influenza virus hemagglutinin RNA and 1 µL 35S methionine. If included, peptides 
were added to a final concentration of 5 mM and 1 µL of dog pancreas 
microsomes were used. Samples were incubated for 60 min at 30 °C then 
centrifuged at 16162 × g for 5 min. Supernatants were removed and samples 
prepared for SDS-PAGE. After electrophoresis, gels were fixed for 30 min at 
room temperature in 10% acetic acid and 10% methanol. Gels were then dried 
for 1 h at 80°C using a Hoefer Scientific DryGel. Phosphor plates were prepared 
by illumination on a lightbox for 10 min prior to exposure overnight to the dried 
gel. Phosphor plates were analysed using a phosphorimager (Fujifilm FLA-7000). 
ELISA 
SNAP, SNAP-B and SNAP-P were bound to 96-well plates at a concentration of 10 
µg/mL in 100 µL of 50 mM sodium carbonate buffer pH 9.6. Plates were 
incubated overnight at 4°C. Wells were then washed with 1% w/v BSA (bovine 
serum albumin, Melford), 0.5 Tween20 in PBS. Non-specific binding was blocked 
by incubation for 1 h at 37°C with 200 µL per well of 1% w/v BSA in PBS. A 1:500 
dilution anti-SNAP-P (100 µL, Pierce) in 1% w/v BSA in PBS was added to each 
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well and plates incubated for 1 h at 37°C. Wells were then washed twice with 
200 µL 1% w/v BSA, 0.5 Tween20 in PBS. 100 µL of 1:10000 Goat anti-Rabbit HRP 
conjugate was added to each well and incubated for 1 h at 37°C. Wells were 
then washed twice with 200 µL 1% w/v BSA, 0.5 Tween20 in PBS. One O-
phenylenediamine dihydrochloride tablet (10 mg) was dissolved in 25 mL 50 mM 
phosphate-citrate buffer pH5.0 with 10 µL 30% H2O2. 100 µL of substrate was 
added to each well and incubated for 20 min at room temperature. The reaction 
was stopped by the addition of 25 µL of 3 M HCl to each well. Absorbance was 
read at 490 nm using a BMG Labtech Pherastar FS plate reader. 
Use of Peptides in HT1080 Cells 
Confluent HT1080 cells in 6 cm dishes were first washed with PBS then treated 
with either 1 mM Ac-NYTCKDEL (AnaSpec) or Ac-NYTC (Cambridge Peptides) in 
medium, or medium only for the control. Cells were incubated with peptides for 
1 h. After incubation medium was removed and cells were washed with PBS. 100 
µL of cold 10% trichloroacetic acid (TCA) was added to each dish to precipitate 
proteins. The lysates were centrifuged for 10 min at 14167 x g at 4°C. 
Supernatants were purified using C18 ZipTips (Millipore) according to 
manufacturer’s instructions. Samples were analysed by MALDI-TOF using a matrix 
with CHCA (5 mg/mL in 50% acetonitrile, 0.1% TFA). 
Antibody Purification 
A stock of SNAP-P was first prepared by mixing 600 µL of 351 µM purified SNAP, 
360 µL 100 mM Tris-HCl pH 7.5 and 40 µL of 10 mg/mL benzylguanine-phenol 
(BGP) in DMF and incubating the solution at 37 °C for 30 min. Excess BGP was 
removed and SNAP-P buffer exchanged into 0.1 M NaHCO3 pH 8.3 with 0.5 M 
NaCL using a PD10 column (GE healthcare) according to manufacturer’s 
instructions. The fraction collected from the PD10 column was concentrated to a 
volume of 1.5 mL using a Sartorius Vivaspin 20 centrifugal concentrator. 
Cyanogen bromide (CNBr) activated Sepharose (0.3 g, Amersham) was suspended 
in 2 mL 1 mM HCl and placed on a glass sinter attached to a conical flask with a 
side arm. This was placed under vacuum and the Sepharose washed with 200 ml 
1 mM HCl. The concentrated SNAP-P and the prepared CNBr-Sepharose were 
mixed and left on a rocker at 4 °C overnight. Prior to mixing with the Sepharose, 
the absorbance at 280 nm of the SNAP-P stock was measured. 
55 
 
The next day supernatant was removed from the Sepharose and the absorbance 
at 280 nm measured. The drop in absorbance indicated coupling of the protein 
to the Sepharose had occurred. The SNAP-P Sepharose washed with 5 × gel 
volume of coupling buffer (0.1 M NaHCO3 pH 8.3, 0.5 M NaCl). Tris-HCl pH8.0 
(0.1 M) was added to the gel and it was left to stand for 2 h to block any 
remaining unreacted groups. The gel was washed 3 × with alternating pH 
buffers.  
1. 0.1 M NaOAc/acetic acid, 0.5 M NaCl, pH 4.0 
2. 0.1 M Tris-HCl, 0.5 M NaCl, PH 8.0 
The gel was packed into a disposable chromatography column (Bio-Rad) and 
flushed with PBS (Gibco). Crude antibody serum (1 mL) was placed on the gel 
bed and the flow-through reapplied three times before washing with seven times 
column volumes of PBS (Gibco). The antibody was eluted with 10 mL 0.1 M 
glycine.HCl pH 2.8. Fractions (1 mL) were collected into eppendorf tubes 
containing 70 µL 1 M Tris-HCl to raise the pH. The absorbance of the fractions at 
280 nm was measured to assess which ones contained antibody. The purification 
was assessed by using the eluate in an ELISA experiment to gauge the affinity of 
the sera to SNAP, SNAP-B and SNAP-P.  
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8.0 Chemistry Experimental 
All reactions under an inert atmosphere were carried out using flame dried 
glassware. Solutions were added via syringe. Acetonitrile, diethyl ether, 
tetrahydrofuran, dichloromethane, and toluene were dried where necessary 
using a solvent drying system, PuresolvTM, in which solvent is pushed from its 
storage container under low nitrogen pressure through two stainless steel 
columns containing activated alumina and copper. Triethylamine was dried via 
distillation with calcium hydride. Reagents were obtained from commercial 
suppliers and used without further purification. 1H, 13C NMR spectra were 
obtained on a Bruker DPX/400 spectrometer operating at 400 and 100MHz 
respectively or on a Bruker AVIII spectrometer operating at 500, and 126 MHz 
respectively.  All coupling constants are measured in Hz. DEPT was used to 
assign the signals in the 13C NMR spectra as C, CH, CH2 or CH3. Mass spectra (MS) 
were recorded on a Jeol JMS700 (MStation) spectrometer except ESI+, ESI– and 
certain CI+ analyses, which were recorded on a Thermofisher LTQ Orbitrap XL. 
Infra-red (IR) spectra were obtained on a Shimadzu FTIR-8400S spectrometer 
using attenuated total reflectance (ATR) so that the IR spectrum of the 
compound (solid or liquid) could be directly detected (thin layer) without any 
sample preparation. Fluorescence spectra were collected on a Shimadzu RF-
5301PC spectrofluorophotometer. MALDI-TOF MS spectra were collected out on a 
Shimadzu AXIMA Performance MALDI-TOF/TOF mass spectrometer. High 
performance liquid chromatogpraphy (HPLC) was carried out on a GE healthcare 
ÄKTAmicro chromatography system. 
4-(Aminobenzyl)methanol (34) 
 
Methyl 4-cyanobenzoate 33 (3.00 g, 18.6 mmol, 1.0 eq) was dissolved in 
anhydrous THF (100 mL) and cooled to 0 °C. To the stirred solution, lithium 
aluminium hydride (1.90 g, 50.0 mmol, 2.7 eq) was added slowly, leading to a 
change of colour to from yellow to blue/dark green and formation of a slurry, 
out of which hydrogen gas evolved. The reaction mixture was heated to reflux 
for 12h, then cooled to 0 °C and H2O (50 mL) was added slowly to quench the 
reaction. The mixture was treated with aqueous NaOH (10%, 50 mL), and then 
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extracted into DCM (5 × 40 mL). The combined organic layers were washed twice 
with brine, dried over magnesium sulfate and evaporated to dryness in vacuo 
yielding amine 34 as a cream solid (1.67 g, 12.2 mmol, 66%). H (CDCl3, 400 
MHz): 7.31 (2H, d, J = 8.1 Hz, H2 and H6), 7.26 (2H, d, J = 8.1 Hz, H3 and H5), 
4.6 (2H,s, OCH2), 3.82 (2H, s, NCH2), 1.98 (1H, br s). C (CDCl3, 100 MHz): 142.28 
(C), 139.84 (C), 127.27 (CH), 127.23 (CH), 64.79, (CH2), 46.09 (CH2).  
Agrees with literature [93]. 
N-[4’-(Hydroxymethyl)benzyl]2,2,2-trifluoro-acetamide (35) 
 
To a solution of amine 34 (693.0 mg, 5.10 mmol, 1.0 eq) and triethylamine (0.8 
mL, 6.60 mmol, 1.3 eq) in anhydrous MeOH (10 mL), ethyl trifluoroacetate (0.7 
mL, 5.1 mmol, 1.0 eq) was added dropwise. The reaction mixture was stirred for 
45 min, diluted with EtOAc (150 mL) and H2O (150 mL). The combined organic 
layers washed with brine and dried over Na2SO4. After removal of solvent in 
vacuo, column chromatography (0-20% EtOAc in cyclohexane) yielded amide 35 
(0.70 g, 3.0 mmol, 59 %). Rf[SiO2, EtOAc: cyclohexane (1:1)]:0.26. H (CDCl3, 400 
MHz): 7.36 (2H, d, J = 8.1 Hz, H3’ and H5’), 7.27 (2H, d, J = 8.1 Hz, H2’ and 
H6’),6.70 (1H, br s, NH), 4.68 (2H, s, OCH2), 4.51 (2H, d, J = 5.9 Hz, NCH2), 1.84 
(1H, br s). C (CDCl3, 100 MHz): 141.04 (C), 135.21 (C), 128.18 (CH), 127.57 (CH), 
117.00 (C), 114.71 (C), 64.80 (CH2), 43.64 (CH2).  
Agrees with literature [93].  
1-(2’-Amino-9H-purin-6’-yl)-1-methylpyrrolidinium chloride (37) 
 
6-Chloro-guanine 36 (5.0 g, 29.4 mmol, 1.0 eq) was dissolved in 100 mL 
anhydrous DMF at 40°C. After cooling to room temperature, 1-methyl-pyrrolidine 
(7.0 mL, 65.8 mmol, 2.2 eq) was added and the reaction mixture stirred 
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overnight at rt. Acetone (10 mL) was added to complete precipitation and the 
solid was filtered, washed with Et2O (50 mL) and dried yielding chloride 37 as a 
beige solid (3.54 g, 13.8 mmol, 47%). H (d6-DMSO, 500 MHz): 13.38 (1H, br s, 
13.38, NH), 8.35 (1H, s, H8’), 7.12 (2H, br s, NH2), 4.62-4.58 (2H, m, H2/H5), 
3.98-3.95 (2H, m, H2/H5), 3.65 (3H, s, Me), 2.27-2.21 (2H, m, H3/H4), 2.06-2.01 
(H3/H4). C (d6-DMSO, 100 MHz): 159.52 (C), 159.03 (C), 152.12 (C), 143.42 
(CH), 116.50 (C), 64.52 (CH2), 52.04 (Me), 21.92 (CH2). 
Agrees with literature [93]. 
O6-(4-Aminomethyl-benzyl)guanine (39) 
 
Amide 35 (473 mg, 2.00 mmol, 1.0 eq) was dissolved in anhydrous DMF under 
argon and sodium hydride (0.24 g, 6.10 mmol, 3.0 eq) was added forming a blue 
solution. 4-Dimethylaminopyridine (25.0 mg, 0.20 mmol, 0.1 eq) was added to 
the mixture then chloride 37 (0.50 g, 2.00 mmol, 1.0 eq) and the solution 
warmed to 40 °C and stirred under argon for 3h. A few drops of H2O were added 
to quench any excess sodium hydride and solvent removed in vacuo. Column 
chromatography (MeOH 0-10% in DCM) yielded amine 39 at 75% purity (341.6 mg, 
0.958 mmol, 48%). Rf[SiO2, MeOH-DCM (1:5)]: 0.07. Not purified further to 
prevent loss of material. Selected data from crude: H (DMSO, 400 MHz): 7.82 
(1H, s, H6), 7.39 (4H, m, Ar), 6.27 (2H, s, NH2, guanine), 5.45 (2H, s, CH2O), 
3.71 (2H, s, CH2NH2).  
Agrees with literature [93].  
 
 
 
 
 
59 
 
N-(4-[(2’-Amino-9H-purin-6’-yl)oxymethyl]benzyl)-6’’-[(7’’’-nitro-
2’’’,1’’’,3’’’-benzoxadiazol-4’’’-yl)amino]hexanamide (BG-NBD-X) (41) 
 
Triethylamine (7 µL, 0.048 mmol, 3.0 eq.) was added to a solution of O6-(4-
aminomethyl)benzylguanine 39 (75% pure, 11.3 mg, 0.031 mmol, 2.0 eq.) in 
anhydrous DMF (0.1 mL). NBD-X-succinimidyl ester (6.1 mg, 0.0165 mmol, 1.0 
eq.) was added and the mixture stirred at room temperature under argon for 24 
h. Solvent was removed in vacuo. Column chromatography (0-20% MeOH in DCM) 
yielded BG-NBD-X 41 as an orange solid (6.5 mg, 0.012 mmol, 74%). H (MeOD, 
400 MHz): 8.42 (1 H, d, J = 8.8 Hz, H-6’’’), 7.78 (1H, br s, H-8), 7.48 (2 H, d, J = 
8.2 Hz, H-3’ and H-5’), 7.30 (2H d, J = 8.2 Hz, H-2’ and H-6’), 6.19 (1 H, d, J = 
8.8 Hz, H-5’’’), 5.50 (2H, s, CH2O), 4.35 (2H, s, PhCH2NH), 3.45 (2H, br s, H-6), 
2.26 (2H, t, J = 7.2 Hz, H-2), 1.76-1.66 (4H, m, H-4 and H-5), 1.47-1.41 (2H, m, 
H-3). LRMS (EI+): m/z 569 ([M+Na]+ 8%), 481 (instrument background 100%). HRMS 
(ESI+): m/z 569.1964. C25H26N10O5 requires [M+Na]+ 569.1980. 
2,3-Dihydro-2-(3’-hydroxyphenyl)-1H-isoindole-1,3-dione (43) 
 
3-Aminophenol 42 (15.00 g, 137 mmol, 1.0 eq) was mixed with phthalic 
anhydride (20.29 g, 137 mmol, 1.0 eq) and heated to 150 ◦C to form a melt. This 
was left for 48 h before acidification with 10% HCl (200 mL) and extraction into 
EtOAc (3 × 250 mL). The organic layers were combined, dried over MgSO4 and 
concentrated in vacuo to yield phthalimide 43 as a lilac solid (25.99 g, 109 
mmol, 79%). Mp: 219-220 °C. νmax (ATR): 3327 (OH), 1699 (C=O), 1609 (Ar) cm
-1. 
H (CDCl3, 400 MHz): 7.96 (2H, dd, J = 3.1, 5.5 Hz, H5 and H6), 7.80 (2H, dd, J = 
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3.1, 5.5 Hz, H4 and H7), 7.37 (1H, t, J = 8.1 Hz, H5’), 7.04, (1H, ddd, J = 0.8, 
1.9, 8.0 Hz, H4’), 6.96 (1H, t, J = 2.2 Hz, H2’), 6.88 (1H, ddd, J = 0.8, 2.5, 8.2 
Hz, H6’). C (CDCl3, 100 MHz): 167.22 (C), 156.03 (C), 134.49 (CH), 131.70 (C), 
130.10 (CH), 123.84 (CH), 120.99 (C) 118.90 (CH), 115.34 (CH), 113.78 (CH). 
LRMS (CI+): m/z 240 [(M+H)+, 100%]. HRMS (CI+): m/z [M+H]+ 240.0659. C14H10O3N 
requires 240.0661. 
4-(2’,3’-Dihydro-1’,3’-dioxo-1H-isoindol-2’-yl)-2-hydroxybenzaldehyde (44) 
 
Magnesium chloride (2.97 g, 31.0 mmol, 1.5 eq), triethylamine (11 mL, 79.0 
mmol, 3.8 eq) and paraformaldehyde (4.18 g, 139 mmols, 6.7 eq) were added to 
a stirring solution of phthalimide 43 (4.95 g, 20.7 mmol, 1.0 eq.) in MeCN (100 
mL). The reaction was heated to reflux and stirred overnight under argon. The 
reaction mixture was acidifed with 10% HCl (50 mL), extracted into DCM (3 × 100 
mL), dried over MgSO4 and concentrated in vacuo. Column chromatography (0-
10% EtOAc in DCM) yielded aldehyde 44 as needles (2.82 g, 10.6 mmol, 51%). 
Rf[SiO2, EtOAc-DCM (1:20)]: 0.89. Mp: 197-198 °C. νmax (ATR): 3051 (OH), 2872 
(CHO), 1735 (C=O), 1628 (Ar) cm-1. H (CDCl3, 400 MHz): 11.16 (1H, s, H1), 9.94 
(1H, s, OH), 7.98 (2H, J = 3.1, 5.5 Hz, H5’ and H6’), 7.83, (2H, dd, J = 3.0, 5.5 
Hz, H4’ and H7’), 7.69 (1H, dd, J = 1.0, 7.6 Hz, H5), 7.20 (2H, m, H6 and H3). C 
(CDCl3, 100 MHz): 195.81 (CH), 166.42 (C), 162.02 (C), 139.31 (C), 138.84 (CH), 
134.19, (CH), 131.48 (C), 124.09 (CH), 119.56 (C), 117.31 (CH), 115.00 (CH). 
LRMS (CI+): m/z 268 [(M+H)+, 100%]. HRMS (CI+): m/z [M+H]+ 268.0611. C15H10O4N 
requires 268.0610. 
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4-(2’,3’-Dihydro-1’,3’-dioxo-1H-isoindol-2’-yl)-2-(prop-2’’-en-1’’-
yloxy)benzaldehyde (45) 
 
Potassium carbonate (5.91 g, 42.8 mmol, 1.1 eq.) and allyl bromide (3.70 mL, 
42.8 mmol, 1.1 eq.) were added to a stirring solution of aldehyde 44(10.4 g, 
38.9 mmol, 1.0 eq.) in MeCN (250 mL). The solution was heated to reflux and 
left overnight. The reaction was quenched into H2O (100 mL) and extracted into 
DCM (3 × 100 mL). The organic layers were dried over MgSO4 and concentrated in 
vacuo to yield allyl ether 45 as a white amorphous solid (11.4 g, 37.1 mmol, 
95%). Mp: 158-160°C. νmax (ATR): 1724 (C=O), 1688 (C=C) cm
-1. H (CDCl3, 400 
MHz): 10.54 (1H, s, CHO), 8.00-7.98 (3H, m, H6, H5’ and H6’), 7.83 (2H, dd, J = 
3.0, 5.4 Hz, H4’ and H7’), 7.23 (1H, ddd, J = 0.6, 1.8, 8.4 Hz, H5), 7.19 (1H, d, J 
= 1.8 Hz, H3), 6.15-6.05 (1H, m, H2’’), 5.48 (1H, dd, J = 1.5, 17.5 Hz, H3’’), 
5.37, (1H, dd, J = 1.5, 10.6 Hz, H3’’), 4.71 (2H, dt, J = 1.5, 5.3 Hz, CH2). C 
(CDCl3, 100 MHz): 188.77 (CH), 166.63 (C), 161.05 (C), 138.32 (C), 134.82 (CH), 
131.94 (CH), 131.45 (C), 129.00 (CH), 123.98 (CH), 118.57 (CH2), 118.27 (CH), 
110.67 (CH), 69.54 (CH2). LRMS (EI
+): m/z 307 [(M)•+, 55%] 267 [(M - C3H5)
 •+, 
100%]. HRMS (EI+): m/z [M]•+ 307.0844. C18O4NH13 requires 307.0845. 
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6-(2’,3’-Dihydro-1’,3’-dioxo-1H-isoindol-2’-yl)-1-benzofuran-2-carbaldehyde 
(46) 
 
Methyl morpholine N-oxide (5.97 g, 51.0 mmol, 2.8 eq.) and osmium tetroxide 
(2.5% in propanol, 6.2 mL, 0.6 mmol, 0.03 eq.) were added to a stirring solution 
of allyl ether 45 in THF (70 mL). The solution was stirred at room temperature 
overnight under argon. Solvent was then removed in vacuo and the residue 
produced dissolved in EtOAc (100 mL) and H2O (100 mL). The aqueous layer was 
washed with further EtOAc (100 mL) and the organic layers were combined and 
dried over magnesium sulphate and concentrated in vacuo. The residue 
produced was dissolved in MeOH (40 mL) and H2O (20 mL), sodium 
metaperiodate (8.56 g, 40.0 mmols, 2.2 eq.) added and the mixture stirred at 
room temperature overnight. The solvent was removed in vacuo and the residue 
produced was dissolved in EtOAc (100 mL) and H2O (100 mL). The organic layers 
were combined, washed with H2O, dried over MgSO4 and concentrated in vacuo, 
yielding a beige solid. The beige solid was dissolved in acetic acid (100 mL) and 
heated to reflux overnight. Solvent was removed in vacuo and column 
chromatography (0-10% EtOAc in DCM) yielded benzofuran 46 as an amorphous 
solid (2.58 g, 8.86 mmol, 89%). Rf[SiO2, EtOAc-DCM(1:20)]: 0.87. Mp: 274 – 276 
°C. νmax (ATR): 1719 (C=O), 1705 (C=O), 1676 (alkene C) cm
-1. H (CDCl3, 400 
MHz): 9.91 (1H, s, CHO), 8.00 (2H, dd, J = 3.1, 5.4 Hz, H5’ and H6’), 7.88 (1H, d, 
J = 8.4 Hz, H4), 7.84 (2H, dd, J = 3.1, 5.4 Hz, H4’ and H7’), 7.78 (1H, s, H5), 
7.61 (1H, d, J = 0.7 Hz, H7), 7.50 (1H, dd, J = 1.65, 8.50 Hz, H5) . C (CDCl3, 100 
MHz): 179.63 (CH), 166.99 (C), 155.92 (C), 153.84 (C), 134.71 (CH), 132.39 (C), 
131.58 (C), 126.20 (C), 123.99 (CH), 123.88 (CH), 122.85 (CH), 116.93 (CH), 
111.20 (CH). LRMS (CI+): m/z 292 [(M+H)+, 80%], 268 [C15H9NO4 + H)
+, 100%]. 
HRMS (CI+): m/z [M+H]+ 292.0607. C17H10O4N requires 292.0610. 
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3-Azidoprop-1-ylamine (48) 
 
Sodium azide (13.9 g, 214 mmol, 2.8 eq) was added to a stirring solution of 3-
chloroprop-1-yl-aminium chloride 47 (10.0 g, 77.0 mmol, 1.0 eq) in H2O (150 mL) 
and heated to 80 °C overnight. The mixture was cooled to  ̶ 10 °C and potassium 
hydroxide added until the pH reached 14. The mixture was extracted to Et2O (3 
× 150 mL). The organic layers were combined, dried over MgSO4 and 
concentrated in vacuo to yield amine 48 as a colourless oil (6.65 g, 66.4 mmol, 
86%). νmax (ATR): 2938 (CH), 2090 (N3) cm
-1. H (CDCl3, 400 MHz): 3.38 (2H, t, J = 
6.8 Hz, NCH2), 2.80 (2H, t, J = 6.8 Hz, N3CH2), 1.73 (2H, quintet, J = 6.8 Hz, 
CH2CH2CH2). C (CDCl3, 100 MHz): 49.04 (CH2), 39.18 (CH2), 32.25 (CH2). LRMS 
(CI+): m/z 101 [(M+H)+, 72%], 75 [(C3H10N2 + H)
+, 100%]. HRMS (CI+): m/z [M+H]+ 
101.0827. C3H9N4 requires 101.0825. 
3-Isothiocyanatoprop-1-ylamine (49) 
 
1,1’-Thiocarbonyldiimadazole (5.35 g, 30.0 mmol, 1.5 eq) was added slowly to a 
stirring solution of amine 48 (2.00 g, 20.0 mmol, 1 eq) and potassium carbonate 
(5.80 g, 42.0 mmol, 2.1 eq) in DCM (25 mL) and H2O (25 mL). The mixture was 
stirred under argon for 90 min then quenched into H2O (50 mL) and extracted to 
DCM (3 × 50 mL). The combined organic layers were washed with 20% HCl (100 
mL), dried over MgSO4 and concentrated in vacuo to yield isothiocyanate 49 
(1.84 g, 12.9 mmol, 65%), which was not purified due to instability. Selected 
data from crude. H (CDCl3, 400 MHz): 3.66 (2H, t, J = 6.3 Hz, SCNCH2), 3.49 (2H, 
t, J = 6.3 Hz, N3CH2), 1.94 (2H, quintet, J = 6.4 Hz, CH2CH2CH2). 
3-(3’-Azidopropyl)-2-sulfanylideneimidazolidin-4-one (50) 
 
Glycine methyl ester hydrochloride (1.81 g, 14.5 mmol, 1.1 eq) was added to a 
stirring solution of isothiocyanate 49 (1.84 g, 12.9 mmol, 1.0 eq) and 
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triethylamine (2.0 mL, 14.5 mmol, 1.1 eq) in EtOAc (20 mL). The reaction was 
heated to reflux and stirred overnight. The mixture was then cooled, H2O (20 
mL) added to quench and extracted to DCM (3 × 20 mL). The combined organic 
layers were dried over MgSO4 and concentrated in vacuo to yield thiohydantoin 
50 as a red solid (2.13 g, 11.4 mmol, 88%). Mp: 73 - 75 °C. νmax (ATR): 2092 (N3), 
1717 (C=O) cm-1. H (CDCl3, 400 MHz): 7.05 (1H, s, NH), 4.09, (2H, s, 2 × H5), 
3.93 (2H, t, J = 6.9 Hz, NCH2), 3.40 (2H, t, J = 6.7 Hz, N3CH2), 1.98 (2H, quintet, 
J = 6.7 Hz, CH2CH2CH2). C (CDCl3, 100 MHz): 184.80 (C), 171.54 (C), 49.05 (CH2), 
48.46 (CH2), 38.87 (CH2), 27.07 (CH2). LRMS (CI
+): m/z 200 [(M+H)+, 100%]. HRMS 
(CI+): m/z [M+H]+ 200.0606. C6H9N5OS requires 200.0609. 
2-(4’-Bromobenzyloxy)tetrahydrofuran (52) 
 
A solution of 4-bromobenzyl alcohol 51 (13.0 g, 69.5 mmol, 1.0 eq), 2,3-
dihydrofuran (6.3 mL, 84 mmol, 1.2 eq) and para-toluene sulfonic acid 
monohydrate (20.0 mg, 0.11 mmol, 0.0016 eq) in DCM (50 mL) was stirred at 
room temperature for 90 min.  The reaction mixture was then washed with H2O 
(2 × 100 mL) and saturated aqueous NaHCO3 (100 mL). Organics were dried over 
MgSO4 and concentrated in vacuo to yield THF ether 52 as a yellow oil (17.2 g, 
66.9 mmol, 96%). H (CDCl3, 400 MHz): 7.45 (2H, d, J = 8.3 Hz, H3’ and H5’), 
7.20 (2H, d, J = 8.3 Hz, H2’ and H6’), 5.19 (1H, dd, J = 3.7 and 2.6 Hz, H2), 4.65 
(1H, d, J = 12.4 Hz, ArCHAHB), 4.42 (1H, d, J = 12.4 Hz, ArCHAHB), 3.95-3.84 (2H, 
m, 2 × H5), 2.07-1.80 (4H, m, 2 × H3 and 2 × H4). C (CDCl3, 100 MHz): 137.44 
(C), 131.41 (CH), 129.43 (CH), 121.29 (C), 103.17 (CH), 67.97 (CH2), 67.08 (CH2), 
32.34 (CH2), 23.44 (CH2).  
Data agree with literature [112]. 
 
 
65 
 
2-[4’-(4’’,4’’,5’’,5’’-Tetramethyl-1’’,3’’,2’’-dioxaborolan-2’’-yl)benzyloxy] 
tetrahydrofuran (53) 
 
A solution of THF ether 52 (12.00 g, 46.7 mmol, 1.0 eq) in anhydrous THF (130 
mL) was cooled to –78 oC and degassed with argon for 15 min.  Under argon, 
nBuLi (1.68 M in hexanes, 31.7 mL, 56.0 mmol, 1.2 eq) was added dropwise over 
three hours and the mixture allowed to stir for 15 min.  2-Isopropoxy-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (11.4 mL, 56.0 mmol, 1.2 eq) was added 
dropwise and the resulting solution allowed to stir for 2h.  The reaction was 
quenched with H2O (100 mL) and the product extracted with DCM (3 × 100 mL). 
Combined organics were washed with brine (100 mL), dried over MgSO4 and 
concentrated in vacuo to give a yellow oil.  Impurities were removed by 
Kugelrohr distillation to yield boronate ester 53 as a residual yellow oil, which 
solidified on standing (11.9 g, 39.1 mmol, 84%). H (CDCl3, 400 MHz): 7.78 (2H, d, 
J = 7.7 Hz, H-3’ and H-5’), 7.34 (2H, d, J = 7.7 Hz, H-2’ and H-6’), 5.20 (1H, dd, 
J = 4.2 and 1.2 Hz, H-2), 4.72 (1H, d, J = 12.4 Hz, ArCHAHB), 4.50 (1H, d, J = 12.4 
Hz, ArCHAHB), 3.97-3.86 (2H, m, 2  H-5), 2.09-1.83 (4H, m, 2  H-3 and 2  H-
4), 1.34 (12H, s, 4  CH3). C (CDCl3, 100 MHz): 141.60 (C), 134.86 (CH), 126.99 
(CH), 103.09 (CH), 83.73 (C), 68.60 (CH2), 67.02 (CH2), 32.33 (CH2), 24.84 (CH3), 
23.44 (CH2).  
Data agree with literature [112]. 
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[4-(4’,4’,5’,5’-Tetramethyl-1’,3’,2’-dioxaborolan-2’-yl)phenyl]methanol (54) 
 
Aluminium trichloride (40 mg, 0.30 mmol, 0.1 eq) was added to a stirring 
solution of boronate ester 53 (1.00 g, 3.29 mmol, 1 eq) in anhydrous EtOH (10 
mL) under argon.  The mixture was stirred overnight at room temperature and 
then concentrated under reduced pressure.  The residue was dissolved in Et2O 
(40 mL) and filtered. The filtrate was concentrated under reduced pressure and 
redissolved in EtOH (10 mL) under argon.  Aluminium chloride (30.0 mg, 0.22 
mmol, 0.07 eq) was added and the solution was stirred overnight at room 
temperature.  The residue was concentrated in vacuo, dissolved in Et2O (40 mL) 
and filtered.  The filtrate was concentrated in vacuo to yield benzylic alcohol 54 
as an oil (517 mg, 2.21 mmol, 67%).  H (CDCl3, 400 MHz): 7.79 (2H, d, J = 7.7 
Hz, H-3’ and H-5’), 7.39 (2H, d, J = 7.7 Hz, H-2’ and H-6’), 4.49 (2H, s, CH2), 
1.34 (12H, s, 4  CH3). C (CDCl3, 100 MHz): 144.07 (C), 134.99 (CH), 126.06 
(CH), 83.82 (C), 65.05 (CH2), 24.83 (CH3).  
Data agree with literature [112]. 
Benzyl N-(4-iodophenyl)carbamate (56) 
 
A mixture of benzyl alcohol 55 (0.2 mL, 1.9 mmol, 1.0 eq) and anhydrous 
pyridine (0.16 mL, 2.0 mmol, 1.1 eq) was slowly added to a stirring solution of 
phosgene (20% in toluene, 5.1 mL, 9.7 mmol, 5.1 eq) in anhydrous THF (10 mL) 
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under argon. The mixture was stirred for 3 h at room temperature. The white 
precipitate formed was filtered off and washed with further anhydrous THF (10 
mL). The filtrate was concentrated in vacuo. The residue produced was 
redissolved in anhydrous THF (10 mL) and 4-iodoaniline (0.42 g, 1.9 mmol, 1.0 
eq) was added. The mixture was stirred for a further 24 h under argon. THF was 
then removed in vacuo and the residue dissolved in EtOAc (20 mL) and washed 
with H2O (20 mL). The aqueous layer was extracted with further EtOAc (20 mL). 
Combined organic layers were washed with brine and dried over MgSO4 before 
concentration in vacuo to yield carbamate 56 as a beige solid (681 mg, 1.92 
mmol, 100%). Mp: 124 °C. νmax (ATR): 1703 (C=O), 1532 (Ar), 1233 (CO). H 
(CDCl3, 400 MHz): 7.59 (2H, d, J = 8.9 Hz, H5 and H3), 7.40-7.33 (5H, m, 5 × 
ArH), 7.17 (2H, d, J = 8.8 Hz, H2 and H6), 6.62 (1H, s, NH), 5.19 (2H, s, CH2). C  
(CDCl3, 100 MHz): 153.04 (C), 138.98 (CH), 137.62 (C), 135.82 (C), 128.68 (CH), 
128.49 (CH), 128.38 (CH), 120.54 (CH), 86.41 (C), 67.26 (CH2). LRMS (CI
+): m/z 
354 [(M+H)+, 100%]. HRMS (CI+): m/z [M+H]+ 353.9998. C14O2 H12NI requires 
353.9991. 
N-[4’- (2’’-Amino-9H-purin-6’’-oxymethyl)benzyl]pent-4-ynamide (57)  
 
EDCI.HCl (38.0 mg, 0.20 mmol, 1.1 eq), HOBt.H2O (27 mg, 0.2 mmol, 1.1 eq) and 
4-pentynoic acid (20 mg, 0.20 mmol, 1.1 eq) were added to a stirring solution of 
amine 39 (75% pure, 64.8 mg, 0.18 mmol, 1 eq) in anhydrous DMF (5 mL). The 
reaction was stirred under argon at room temperature overnight then quenched 
with H2O (5 mL) and extracted into DCM (3 × 20 mL). The organic extracts were 
washed with brine (10 mL) and dried over MgSO4 before concentration in vacuo. 
The residue was washed with EtOAc (50 mL) to remove excess HOBt.H2O to yield 
alkyne 57 (49.0 mg, 0.14 mmol, 78%). Mp: 151 °C. νmax (ATR): 1775 (C≡C), 1700 
(C=O), 1271 (CN), 607 (alkyne CH). H (MeOD, 400 MHz): 8.40, (1H, t, J = 5.6, 
H6’’), 7.45 (2H, d, J = 8.1, H2’ and H6’), 7.28 (2H, d, J = 8.1, H3’ and H5’), 6.28 
(2H, s, NH2), 5.45 (2H, s, OCH2), 4.28 (2H, d, J = 5.9, NHCH2), 2.79 (1H, t, J = 
2.6, H1), 2.36 (4H, m, 2 × CH2). C (MeOD, 100 MHz): 173.95 (C), 161.69 (C), 
139.91 (C), 136.92 (C), 129.64 (CH), 128.68 (CH), 126.27 (CH), 125.91 (C), 
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118.69 (CH), 112.10 (C), 83.57 (C), 70.38 (C), 68.68 (CH2), 43.88 (CH2), 36.05 
(CH2), 15.75 (CH2). LRMS (FAB/NOBA): m/z 351 [(M+H)
+, 15%]. HRMS 
(FAB/NOBA): m/z [M+H]+ 351.1569. C18H18N6O2 requires 351.1564. 
2-(2’-[1’’-(3’’’-Azidopropyl)-2’’-oxo-5’’-sulfanylideneimidazolidin-4’’-
ylidene]methyl-1’-benzofuran-6’-yl)-2,3-dihydro-1H-isoindole-1,3-dione (58) 
 
Aldehyde 46 (1.92 g, 6.59 mmol, 1.1 eq) was dissolved in EtOH (30 mL). 
Piperidine (1.3 mL, 13.2 mmol, 2.2 eq) and thiohydantoin 50 (1.20 g, 6.02 
mmol, 1.0 eq) were added and the solution heated to reflux overnight. The 
reaction was then quenched with H2O (20 mL) and extracted to EtOAc (3 × 30 
mL). The combined organic layers were washed with brine (30 mL), dried over 
MgSO4 before concentration in vacuo to give crude azide 8. Column 
chromatography (0-5% EtOAc in DCM) yielded azide 58 as a yellow solid (1.02 g, 
2.20 mmol, 36%). Rf[SiO2, EtOAc-DCM(1:20)]: 0.70. Mp: 209 °C. νmax (ATR): 2926 
(CH), 2101 (N3), 1727 (C=O) cm
-1. H (CDCl3, 400 MHz): 9.49 (1H, s, NH), 8.01 
(2H, dd, J = 3.1 Hz, 5.4, H5 and H6), 7.84 (2H, dd, J = 3.0, 5.4 Hz, H4 and H7), 
7.71 (2H, m, H4’ and H7’), 7.43 (1H, dd, J = 1.5, 8.4 Hz, H5’), 7.06 (1H, s, H3’), 
6.61 (1H, s, methylidene), 4.04 (2H, t, J = 6.9 Hz, NCH2), 3.42 (2H, t, J = 6.6 Hz, 
N3CH2), 2.03 (2H, quintet, J = 7.0 Hz, CH2CH2CH2). C (CDCl3, 100 MHz): 176.72 
(C), 167.19 (C), 163.27 (C), 154.38 (C), 152.83 (C), 134.69 (CH), 131.65 (C), 
130.29 (C), 127.65 (C), 126.28 (C), 124.01 (CH), 122.69 (CH), 121.99 (CH), 
111.93 (CH), 109.96 (CH), 99.20 (CH), 49.00 (CH2), 38.96 (CH2), 27.29 (CH2). 
LRMS (CI+): m/z 473 [(M+H)+, 15%], 441 (100%). HRMS (CI+) m/z: [M+H]+ 473.1024. 
C23H21O4N6S requires 473.1027. 
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5-[(6’’-Amino-1’’-benzofuran-2’’-yl)methylidene]-3-(3’-azidopropyl)-2-
sulfanylideneimidazolidin-4-one (59) 
 
58 (20.0 mg, 0.04 mmol, 1 eq) was dissolved in MeOH (0.5 mL) and hydrazine 
hydrate added (3 µL, 0.06 mmol, 1.5 eq). The mixture was stirred at room 
temperature for 3 h. Solvent was removed in vacuo to yield amine 59 as a red 
solid (13.5 mg, 0.04 mmol, 97%). Selected data from crude. H (CDCl3, 400 MHz): 
7.36 (1H, d, J = 8.4 Hz, H4’’), 6.93 (1H, s, H7’’), 6.80 (1H, s, H3’’), 6.66 (1H, 
dd, J = 2.0, 8.4 Hz, H5’’), 6.56 (1H, s, H2’’), 4.03 (2H, t, J = 6.9 Hz, NCH2), 3.41 
(2H, t, J = 6.7 Hz, N3CH2), 2.03 (2H, quintet, J = 6.9 Hz, CH2CH2CH2). 
Degradation occured before further characterisation could be carried out. 
3-[4’-(4”,4”,5”,5”-Tetramethyl-1”,3”,2”-dioxabrolan-2”-
yl)phenyl]propanoic acid (70) 
 
Pinacol (120 mg, 1.03 mmol, 1 eq.) was added to a solution of 4-(2-
carboxyethyl)benzeneboronic acid 69 in CHCl3 (10 mL). The mixture was stirred 
at room temperature of 30 min and solvent removed in vacuo yielding boronate 
ester 70 as a white solid (280 mg, 1.03 mmol, 100%). δH (400 MHz. CDCl3): 7.75 
(2H, d, J = 8.1 Hz, H-3’ and H-5’), 7.23 (2H, d, J = 8.1 Hz, H-2’ and H-6’), 2.98, 
t, J = 7.7 Hz, ArCH2), 2.68 (2H, t, J = 8.1 Hz, CH2COOH), 1.34 (12H, s, 4 × Me). C 
(CDCl3, 100 MHz): 177.61 (C), 143.47 (C), 135.11 (CH), 127.71 (CH), 83.74 (C), 
35.17 (CH2), 24.86 (Me). 
Data agree with literature [113]. 
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2’’’,5’’’-Dioxopyrrolidin-1’’’-yl 3-[4’-(4”,4”,5”,5”-tetramethyl-1”,3”,2”-
dioxaborolan-2”-yl)phenyl]propanoate (71) 
 
A mixture of N,N-dicyclohexylcarbodiimide (208 mg, 1.01 mmol, 1.4 eq.) in 
anhydrous DMF (12 mL) was added to a flask containing boronate ester 70 (200 
mg, 0.720 mmol, 1.0 eq.) and N-hydroxysuccinimide (99.0 mg, 860 µmol, 1.2 
eq.) which had been dried by azeotrope with toluene. The reaction mixture was 
stirred at room temperature overnight under argon the added to deionized H2O 
(10 mL) and extracted into Et2O (3 × 20 mL). The combined organic layers were 
washed with H2O and brine and dried over MgSO4, before concentration in vacuo. 
Column chromatography (0-30% hexane in EtOAc) yielded succinimidyl ester 71 
as a white solid (163 mg, 0.51 mmol, 70%). Rf[SiO2, hexane:EtOAc(3:10)]: 0.62. 
Mp: 137 ºC. νmax (ATR): 1738 (C=O), 1072 (C-O). H (CDCl3, 400 MHz): 7.76 (2H, d, 
J =  8.1 Hz, H-3’ and H-5’), 7.24 (2H, d, J = 8.1 Hz, H-2’ and H-6’), 3.07 (2H, t, J 
= 8.0 Hz, COCH2), 2.92 (2H, t, J = 8.0 Hz, ArCH2), 2.82 (4H, s, 2 × CH2), 1.33 
(12H, s, 4 × Me). C (CDCl3, 100 MHz): 169.06 (C), 167.84 (C), 142.33 (C), 135.24 
(CH), 127.66 (CH), 83.75 (C), 32.45 (CH2), 30.63 (CH2), 25.59 (CH2), 24.87 (Me). 
LRMS (ESI+): m/z 396 [(M+Na [11B])+, 100%]. HRMS (ESI+) m/z: 395.1614 and 
396.1590. C19H24O6N
10B requires [M+Na]+ 395.1625 and C19H24O6N
11B requires 
[M+Na]+ 396.1625. 
N-[4’’’-(2’’’’-Amino-9H-purin-6’’’’-yloxymethyl)benzyl]-3-[4’-(tetramethyl-
1’’’,3’’’,2’’’-dioxaborolan-2’’’-yl)phenyl]propanamide (BGB) (61) 
 
Triethylamine (0.04 mL, 0.27 mmol, 3.0 eq.) was added to a solution of O6-(4-
aminomethyl)benzylguanine 39 (75% pure, 32.0mg, 0.09 mmol, 1.0 eq.) in 
71 
 
anhydrous DMF (0.5 mL). Boronate ester 71 (50.0 mg, 0.10 mmol, 1.1 eq) was 
added and the reaction mixture stirred at room temperature under argon for 24 
h. Solvent was removed in vacuo and the mixture purified by HPLC (12 mL/min, 
20% - 50% MeCN in 0.1% formic acid in H2O over 45 min, using a Phenomenex 
Gemini NX  C18 110A 250 x 4.60 mm, BGB retention time: 27 min) yielding BGB 
61 as a white solid (10.4 mg, 0.019 mmol, 21%). Mp: 66 ºC. νmax (ATR): 1620 
(C=O), 1581 (NH) cm-1. H (MeOD, 400 MHz): 7.85 (1H, s, H-8’’’’), 7.68 (2H, d, J 
= 8.1 Hz, H-3’’’ and H-5’’’), 7.39 (2H, d, J = 8.1 Hz, H-3’’ and H-5’’), 7.23 (2H, 
d, J = 8.1 Hz, H-2’’’ and H-6’’’), 6.98 (2H, d, J = 8.1 Hz, H-2’’ and H-6’’), 5.50 
(2H, s, CH2O), 4.31 (2H, s, NHCH2), 2.97 (2H, t, J = 7.4 Hz, NHCOCH2CH2), 2.57 
(2H, t, J = 7.3 Hz, NHCOCH2CH2), 1.33 (12H, s, 4 × Me). C (MeOD, 100 MHz): 
173.55 (C), 160.00 (C), 144.10 (C), 138.48 (C), 135.15 (C), 134.60 (CH), 128.22 
(CH), 127.71 (CH), 127.42 (CH), 127.11 (CH), 83.64 (C), 67.34 (CH2), 42.22 (CH2), 
37.13 (CH2), 31.48 (CH2), 23.78 (Me). LRMS (ESI
+): m/z 551 [(M+Na [11B])+, 100%]. 
HRMS (ESI+): m/z 550.2559 and 551.2539. C28H33O4N6
10B requires [M+Na]+ 
550.2549 and C28H33O4N6
11B requires [M+Na]+ 551.2549. 
3-(4’-Acetoxyphenyl)propanoic acid (73) 
 
Sodium hydroxide (0.920 g, 22.9 mmol, 3.8 eq.) was added to a suspension of 3-
(4’-hydroxyphenyl)propanoic acid 72 (1.00 g, 6.02 mmol, 1.0 eq.) in deionised 
H2O (10 mL) at 0°C. Acetic anhydride (2.10 mL, 22.3 mmol, 3.7 eq.) was added 
and the mixture allowed to warm to room temperature and stirred for 48 h. 1M 
HCl (5 mL) was added and the organics extracted into EtOAc (3 x 15 mL). The 
organic layers were combined, washed with H2O and brine, dried over MgSO4 and 
concentrated in vacuo to yield acetate 73 as a white solid (1.14 g, 5.43 mmol, 
90%). H (CDCl3, 400 MHz): 7.25 (2H, d, J = 8.7 Hz, H-2’ and H-6’), 7.05 (2H, d, J 
= 8.6 Hz, H-3’ and H-5’), 2.80 (2H, t, J = 7.8 Hz, ArCH2), 2.71 (2H, t, J = 7.8 Hz, 
CH2COOH), 2.32 (3H, s, Me). C (CDCl3, 100 MHz): 178.86 (C), 169.67 (C), 149.18 
(C), 137.74 (C), 129.28 (CH), 121.62 (CH), 35.50 (CH2), 29.94 (CH2), 21.13 (Me). 
Data agree with literature [114]. 
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2”,5”-Dioxopyrrolidin-1”-yl 3-(4’-acetoxyphenyl)propanoate (74) 
 
N-Ethyl-N’-(3-dimethylaminoprop-1-yl)carbodiimide (1.38 g, 7.20 mmol, 1.5 eq.) 
was added to a solution of acetate 73 (1.00 g, 4.80 mmol, 1.0 eq.) and N-
hydroxysuccinimide (0.94 g, 8.16  mol, 1.7 eq.) in anhydrous DMF (15 mL). The 
reaction mixture was stirred at room temperature under argon for 48 h. H2O (15 
mL) was added and the mixture extracted to DCM (3 x 30 mL). The combined 
organic layers were washed with H2O and brine and dried over MgSO4. Column 
chromatography (0-20% MeOH in DCM) yielded succinimidyl ester 74 as a white 
solid (1.40 g, 4.60 mmol, 96%). Rf[SiO2, methanol-dichloromethane (1:10)]:0.68. 
Mp: 94 ºC. νmax (ATR): 1734 (C=O), 1200 (CN) cm
-1. H (CDCl3, 400 MHz): 7.23 (2H, 
d, J = 8.6 Hz, H-2’ and H-6’), 7.01 (2H, d, J = 8.6 Hz, H-3’ and H-5’), 3.03 (2H, t, 
J = 8.0 Hz, ArCH2CH2), 2.89 (2H, t, J = 7.9 Hz, ArCH2CH2), 2.75 (4H, s, 2 × 
succinimidyl CH2), 2.25 (3H, s, Me). C (CDCl3, 100 MHz): 169.52 (C), 169.36 (C), 
167.92 (C), 149.39 (C), 136.76 (C), 129.33 (CH), 121.75 (CH), 32.46 (CH2), 29.76 
(CH2), 25.54 (CH2), 21.04 (CH3). LRMS (EI
+): m/z 305 ([M•+] 70%), 263 ([M•+ - 
CH2CO
•] 100%), 107 [HOC6H5CH2
+]. HRMS (EI+): m/z 305.0903. C15H15O6N requires 
[M•+] 305.0899. 
N-[4’’-(2’’’-amino-9H-purin-6’’’-yloxymethyl)benzyl]-3-(4’-
hydroxyphenyl)propanamide (BGP) (68) 
 
Triethylamine (50 µL, 360 µmol, 3.0 eq.) was added to a solution of O6-(4-
aminomethyl)benzylguanine 39 (43.0 mg, 120 µmol, 1.0 eq.) in anhydrous DMF 
(0.6 mL). Succinimidyl ester 74 (40.0 mg, 0.13 mmol, 1.0 eq) was added to the 
reaction mixture stirred at room temperature under argon for 24 h. Solvent was 
removed in vacuo and the crude gum produced was dissolved in anhydrous MeOH 
(1.0 mL). K2CO3 (33.0 mg, 240 µmol, 2.0 eq.) was added to the solution and it 
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was stirred at room temperature for 2 h under argon. The mixture was 
concentrated in vacuo and purified by HPLC (12 mL/min 20% - 50% MeCN in 0.1% 
formic acid in H2O over 45 min, using a Phenomenex Gemini NX C18 110A 250 x 
4.60 mm, BGP retention time: 5 min) yielding BGP 68 as a white solid (4.00 mg, 
9.56 µmol, 8%). H (MeOD, 00 MHz): 7.68 (1H, s, H-8’’’), 7.45 (2H, d, J = 8.1 Hz, 
H-3’’ H-5’’), 7.14 (2H, d, J = 8.1 Hz, H-2’’ and H-6’’), 6.91 (2H, d, J = 8.5 Hz, H-
2’ and H-6’), 6.61 (2H, d, J = 8.5 Hz, H-3’ and H-5’), 5.51 (2H, s, CH2O), 4.32 
(2H, s, H Hz, NHCH2), 2.79 (2H, t, J = 7.6 Hz, NHCOCH2CH2), 2.46 (2H, t, J = 7.6 
Hz, NHCOCH2CH2). LRMS (ESI
+): m/z 441 ([M + Na]+ 100%). HRMS (ESI+): m/z 
441.1639. C22H22N6O3 requires [M + Na]
+ 441.1646. 
2-(3’-bromobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (80) 
 
Pinacol (165 mg, 1.40 mmol, 1.0 eq) was added to a solution of 3-bromobenzyl 
boronic acid 79 (0.30 g, 1.40 mmol, 1.0 eq) in EtOAc (5 mL). The reaction was 
stirred for 30 min at room temperature then solvent was removed in vacuo. 
Crude material was recrystallised from EtOH yielding boronate ester 80 as a 
white solid (416 mg, 1.40 mmol, 100%). Mp: 84 °C. νmax (ATR): 607 (C-Br), 1356 
(C-H) cm-1. δH (400 MHz, CDCl3): 7.82 (1H, s, H-2), 7.74 (1H, d, J = 7.4 Hz, H-4), 
7.52-7.48 (1H, m, H-6), 7.36 (1H, t, J = 7.5 Hz, H-5), 4.50 (2H, s, CH2), 1.35 
(12H, s, 4 × Me). δC (100 MHz, CDCl3): 137.15 (C), 135.22 (CH), 134.83 (CH), 
131.96 (CH), 128.28 (CH), 83.99 (C), 33.49 (CH2), 24.89 (CH3). LRMS (ESI
+): m/z 
318 [M+Na(79Br, 10B)]+, 319 [M+Na(79Br, 11B)]+, 320 [M+Na(81Br, 10B)]+, 321 
[M+Na(81Br, 11B)]+. HRMS (ESI+): m/z 318.0517, 319.0470, 320.0499 and 321.0451. 
C13H18NaO2
10B79Br requires [M+Na]+ 318.0512. C13H18NaO2
11B79Br requires [M+Na]+ 
319.0476. C13H18NaO2
10B81Br requires [M+Na]+ 320.0492. C13H18NaO2
11B81Br 
requires [M+Na]+ 321.0456. 
Data agrees with literature [115]. 
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Pep-B (77) 
 
Ac-NTYCKDEL (0.005 g, 5.00 µmol, 1.0 eq, AnaSpec) and boronate ester 80 (15.0 
mg, 0.05 mmol, 10 eq) were dissolved in a mixture of phosphate buffered saline 
(0.5 mL) and acetonitrile (1.0 mL). The reaction was stirred overnight at room 
temperature then purified by HPLC (0.2 mL/min 0-90% MeCN with 0.1% TFA in 
dH2O over a volume of 2 mL, ACE 5 C4-300 column). Binding was confirmed by 
MALDI-TOF with DHB matrix. [M+H]+ 1279.78. 
3-(Bromomethyl)phenol (82) 
 
Triphenylphosphine (1.06 g, 4.03 mmol, 2.5 eq) and carbon tetrabromide (1.34 
g, 4.03 mmol, 2.5 eq) were dissolved in anhydrous THF (6 mL).  3-
(hydroxymethyl)phenol 80 (0.20 g, 1.61 mmol, 1.0 eq) was added and the 
reaction was stirred overnight at room temperature under argon. The reaction 
was quenched with H2O (4 mL) and extracted to DCM (3 × 10 mL). Organic layers 
were combined, washed with brine, dried over MgSO4 and concentrated in 
vacuo. Column chromatography (0-10% EtOAc in DCM) yielded benzyl bromide 81 
as a white solid (149 mg, 0.80 mmol, 50%). Rf[SiO2, EtOAc-DCM (1:10)]:0.75. Mp: 
61-62 °C. νmax (ATR): 694 (C-Br), 3246 (O-H) cm
-1. δH (400 MHz, CDCl3): 7.19 (1H, 
t, J = 8.0 Hz, H-3), 6.95 (1H, d, J = 7.6 Hz, H-4), 6.86 (1H, t, J = 2 Hz, H-2), 6.76 
(1H, ddd, J = 8.4 Hz, 2.8 Hz, 0.8 Hz, H-6), 5.19 (1H, br s, OH), 4.41, (2H, s, 
CH2). δC (100 MHz, CDCl3): 155.54 (C), 139.48 (C), 130.15 (CH), 121.61 (CH), 
116.01 (CH), 115.65 (CH), 33.27 (CH2). LRMS (ESI
-): m/z 185 ([M-H (79Br)]- 100%), 
187 [M-H (81Br)]-. HRMS (ESI-): m/z 184.9604 and 186.9584. C7H6O
79Br requires 
[M-H]- 184.9608 and C7H6O
81Br requires [M-H]- 186.9588.  
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Data agrees with literature [116]. 
Pep-P (83) 
 
Ac-NTYCKDEL (0.005 g, 5.00 µmol, 1.0 eq) and benzyl bromide 81 (0.009 g, 0.05 
mmol, 10 eq) were dissolved in a mixture of phosphate buffered saline (0.5 mL) 
and acetonitrile (1.0 mL). The reaction was stirred overnight at room 
temperature then purified by HPLC (0.2 mL/min 0-90% MeCN with 0.1% TFA in 
dH2O over a volume of 2 mL, ACE 5 C4-300 column).  Binding was confirmed by 
MALDI-TOF with DHB matrix. [M+H]+ 1133.76. 
N-[4’-hydroxymethyl(benzyl)]-3-(4’-acetoxyphenyl)propanamide (84) 
 
Triethylamine (1.8 mL, 12.9 mmol, 3.0 eq) was added to a solution of 4-
(hydroxymethyl)benzylamine 34 (590 mg, 4.30 mmol, 1.0 eq) in anhydrous DMF 
(14 mL). Succinimidyl ester 74 (1.44 g, 4.73 mmol, 1.1 eq) was added and the 
reaction mixture was stirred overnight under argon then quenched with H2O (10 
mL) and extracted into EtOAc (3 × 40 mL). Organic layers were combined, 
washed with brine (40 mL), dried over MgSO4 and concentrated in vacuo. The 
crude mixture was purified by column chromatography (0-10% MeOH in DCM) 
then recrystallised from EtOAc and hexane yielding amide 83 as a cream solid 
(0.760 g, 2.32 mmol, 54%). Rf[SiO2, MeOH-DCM (1:10)]:0.48. Mp: 126 °C. νmax 
(ATR): 1628 (amide CO), 1758 (ester CO) cm-1. δH (400 MHz, CDCl3): 7.29 (2H, d, 
J = 8.4 Hz, H-2’’ an H-6’’), 7.18 (2H, d, J = 8.8 Hz, H-2’ and H-6’), 7.14 (2H, d, J 
= 8.4 Hz, H-3’’ and H-5’’), 6.97 (2H, d, J = 8.8 Hz, H-3’ and H-5’), 5.60 (1 H, br 
t, NH), 4.67 (2H, d, J = 6.0 Hz, HOCH2Ar) 4.39 (2H, d, J = 6.0 Hz, ArCH2NH), 2.97 
(2H, t, J = 7.6 Hz, ArCH2CH2), 2.48 (2H, t, J = 7.6 Hz, ArCH2CH2), 2.29 (3H, s, 
Me), 1.75 (1H, t, J = 6.0 Hz, OH). δC (100 MHz, CDCl3): 171.80 (C), 169.69 (C), 
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149.09 (C), 140.22 (C), 138.31 (C), 137.50 (C), 129.39 (CH), 127.96 (CH), 127.35 
(CH), 121.56 (CH), 64.99 (CH2), 43.33 (CH2), 38.38 (CH2), 31.02 (CH2), 21.15 
(CH3). LRMS (ESI
+): m/z 350 ([M+Na]+ 100%). HRMS (ESI+): m/z 350.1362.  
C19H21NO4 requires [M+Na]
+ 350.1363. 
N-[4’-4’’-(hydroxymethyl)benzyl]-3-(4’’-4’-hydroxyphenyl)propanamide (85) 
 
Potassium carbonate (2.10 g, 15.2 mmol, 2.0 eq) was added to a solution of 
amide 83 (2.49 g, 7.61 mmol, 1.0 eq) in anhydrous MeOH (25 mL). The reaction 
was stirred at room temperature for 2.5 h then filtered and solvent removed in 
vacuo. The crude material was flushed through a column (10% MeOH in DCM) to 
remove residual inorganics yielding phenol 84 as white needles (2.16 g, 7.57 
mmol, 99%). Rf[SiO2, EtOAc-DCM (1:5)]:0.03. Mp: 139 °C. νmax (ATR): 1649 
(amide CO) cm-1. δH (400 MHz, MeOD): 7.25 (2H, d, J = 8.1 Hz, H-2’’ and H-6’’), 
7.06 (2H, d, J = 8.1 Hz,H-3’’ and H-5’’), 7.00 (2H, d, J = 8.5 Hz, H-2’ and H-6’), 
6.67 (2H, d, J = 8.5 Hz, H-3’ and H-5‘), 4.56 (2H, s, HOCH2Ar), 4.29 (2H, s, 
ArCH2NH), 2.83 (2H, t, J = 7.4 Hz, ArCH2CH2), 2.47 (2H, t, J = 7.4 Hz,ArCH2CH2). 
δC (100 MHz, MeOD): 175.25 (C), 156.82 (C), 141.53 (C), 138.91 (C), 132.84 (C), 
130.49 (CH), 128.49 (CH), 128.18 (CH), 116.27 (CH), 65.01 (CH2), 43.77 (CH2), 
39.30 (CH2), 32.14 (CH2). LRMS (ESI
-): m/z 284 ([M-H]- 100%). HRMS (ESI-): m/z  
284.1280. C17H18NO3 requires [M-H]
- 284.1292.  
N-[4’-4’’-(bromomethyl)benzyl]-3-(4’’-hydroxyphenyl)propanamide (78) 
 
Triphenylphosphine (4.59 g, 17.5 mmol, 2.5 eq) and carbon tetrabromide (5.80 
g, 17.5 mmol, 2.5 eq) were dissolved in anhydrous tetrahydrofuran (25 mL).  
Phenol 84 (2.00 g, 7.00 mmol, 1.0 eq) was added and the reaction was stirred 
overnight at room temperature under argon. The reaction was quenched with 
H2O (20 mL) and extracted into EtOAc (3 × 40 mL). Organic layers were 
combined, washed with brine, dried over MgSO4 and concentrated in vacuo. 
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Crude material was purified by column chromatography (0-50% EtOAc in DCM) 
then recrystallised from DCM yielding benzyl bromide 78 as white needles (312 
mg, 0.89 mmol, 13%). Rf[SiO2, ethyl acetate-dichloromethane (1:5)]:0.55. Mp: 
148 °C. νmax (ATR): 610 (C-Br), 1626 (amide CO) cm
-1. δH (400 MHz, MeOD): 7.31 
(2H, d, J = 8.2 Hz, H-2’’ and H-5’’), 7.04 (2H, d, J = 8.2 Hz, H-3’’ and H-5’’), 
7.01 (2H, d, J = 8.6 Hz, H-2’ and H-6’), 6.69 (2H, J = 8.6 Hz , H-3’ and H-5’), 
4.53 (2H, s, BrCH2Ar), 4.29 (2H, s, ,ArCH2NH), 2.84 (2H, t, J = 7.4 Hz, ArCH2CH2), 
2.49 (2H, t, J = 7.4 Hz, ArCH2CH2). δC (100 MHz, MeOD): 175.37 (C), 156.89 (C), 
140.06 (C), 138.52 (C), 132.69 (C), 130.51 (CH), 130.28 (CH), 128.74 (CH), 
116.25 (CH), 43.67 (CH2), 39.18 (CH2), 33.81 (CH2), 32.09 (CH2). LRMS (ESI
+): m/z 
370 ([M+Na(79Br)]+ 65%), 372 ([M+Na(81Br)]+ 65%), 325 ([X+Na]+ 100%). HRMS 
(ESI+): m/z 370.0406 and 372.0387. C17H18NNaO2
79Br requires [M+Na]+ 370.0413 
and C17H18NNaO2
81Br requires [M+Na]+ 372.0393. 
KLH conjugated N-[4’-(bromomethyl)benzyl]-3-(4’’-
hydroxyphenyl)propanamide (79) 
 
Hemocyanin from Megathura crenulata (keyhole limpet) (2.0 mL of a 5.0 mg/mL 
solution in phosphate buffered saline, 2.5 × 10-8 mmol, 1.0 eq) was stirred with 
benzyl bromide 78 (10.0 mg, 0.028 mmol, 1000.0 eq) in phosphate buffered 
saline (1.0 mL) and DMSO (3.0 mL) for 24 h at room temperature. Reaction 
mixture was buffer exchanged into 50 mM ammonium bicarbonate using a GE 
healthcare PD10 desalting column according to manufacturer’s instructions. 
Solution was freeze-dried producing the KLH-hapten conjugate as a fluffy white 
solid. Binding was confirmed by reaction with fluorescein maleimide and 
fluorescence scan of protein on an SDS-PAGE gel.  
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9.0 Results I  
9.1 Introduction 
It has been shown that hydrogen peroxide plays an enormously important role in 
cells, and what was once thought of as just a toxic and damaging by-product is 
now considered a far more dynamic compound. In recent years hydrogen 
peroxide’s role as a signalling molecule and vital part of homeostasis has started 
to become more understood. As a signalling molecule, hydrogen peroxide is 
known to play a role in many events including tyrosine phosphorylation, 
proliferation and differentiation and cell stress [1].  
In the ER it has been found that hydrogen peroxide plays a vital role in the 
formation of disulfide bonds. When PDI catalyses the formation of a new 
disulfide bond in a substrate protein, the catalytic disulfide of PDI is reduced 
and therefore must be reoxidised to maintain its enzymatic role. Originally it 
was believed that glutathione was responsible for oxidising PDI, however it was 
discovered that in cells this role is performed by Ero1, a flavoprotein [26]. The 
result of the recycling of PDI is a reduced disulfide in Ero1. The disulfide in Ero1 
is reoxidised by the parallel reduction of oxygen, producing hydrogen peroxide 
[27]. 
The PDI-Ero1 relay results in one molecule of hydrogen peroxide for every 
disulfide formed in a newly formed protein. Although Ero1 activity is tightly 
controlled by regulatory disulfides, there also exist within the ER mechanisms 
for removing hydrogen peroxide. One such example is PrxIV which is localized to 
the ER and contains a peroxidatic cysteine (Cys124) capable of reacting with 
hydrogen peroxide to form sulfenic acid and a molecule of water. The resolving 
cysteine (Cys245) in PrxIV then forms a disulfide with the peroxidatic cysteine 
[4]. Other proteins which are involved in removal of hydrogen peroxide in the ER 
are GPx7 and GPx8. 
It is this balance of hydrogen peroxide production and removal that we wanted 
to investigate. Under what conditions does it change from a signalling molecule 
to a destructive force, particularly with regards to the ER. 
The key aim of the project was to develop an effective, ratiometric and user-
friendly method of measuring hydrogen peroxide in the ER in order to be able to 
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study the intricate balance with regards to protein folding and disulfide 
formation. We decided that the best method to tackle this would be the use of a 
synthetic probe that could be targeted specifically to the ER, which would react 
with hydrogen peroxide and which would display a measurable change as this 
reaction occurred. 
During the design of the probe several factors had to be considered. From the 
previous literature we concluded there were two main options for ER targeting. 
One was to use a peptide targeting system, and the other to use the SNAP-tag 
system.  
SNAP-tag is the G160W mutant of human AGT. It specifically reacts with O6-(4-
aminomethyl-benzyl)guanine derivatives and has been shown to be a useful tool 
for conjugating synthetic probes to various cellular locales [93]. SNAP-tag can be 
expressed in mammalian cells with targeting and retention sequences for the ER 
and has previously been shown to do so [101]. The advantages of SNAP-tag 
include that it can be expressed in any cellular locale, which would mean the 
probe structure would not have to be altered if we later wished to compare and 
contrast hydrogen peroxide levels, for example between the cytosol and the ER. 
There is good literature precedent for synthetic probes conjugated to O6-(4-
aminomethyl)benzylguanine  being able to cross not only the cell membrane but 
also the ER membrane. 
A peptide targeting system would involve conjugating the synthetic probe to a 
peptide scaffold. This scaffold would likely include the ER retention sequence, 
KDEL [117] and an NYTC glycosylation site which once glycosylated prevents the 
peptide from diffusing back out of the ER. The main advantage the peptide 
system has is that it does not require any transfection, unlike for SNAP-tag which 
must be transfected either transiently or by the creation of a stable cell line, 
which can be a slow process. A probe conjugated to a peptide system could 
therefore be used in any cell line and the levels of hydrogen peroxide could be 
compared between cell lines. 
Cell permeability cannot be predicted; however it can be prepared for. 
Generally the larger a compound is the less likely it will be cell permeable. It 
was also considered that the probe has to cross both the cell membrane and the 
ER membrane. It was decided that adding a bulky peptide onto the probe would 
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be too high risk and since previously, fluorophores had been conjugated to the 
SNAP-tag substrate, O6-(4-aminomethyl-benzyl)guanine, and been shown to be 
capable of reaching the ER, the SNAP-tag system was chosen as the most likely 
to be successful. 
We chose to incorporate a fluorophore into the probe to provide a method of 
measuring the change as the probe reacts with hydrogen peroxide. The 
advantage of a fluorophore is that live cell experiments can be performed. With 
all other methods, cells must first be lysed before analysis. 
The fluorophore we chose was based on Fura-Red™ (Fig. 18). Fura-Red™ is a 
commercially available calcium sensor [118]. One of the major advantages of 
Fura-Red™ is that it absorbs in the visible region, meaning the wavelength of 
irradiation used will not be harmful to the cells being examined. 
 
Figure 18 - Fura-Red™, a commercially available calcium sensor. 
Inspiration was taken from the calcium sensor 28 when designing 
the fluorophore of BG-Fura-B. 
Fura-Red™ has a large Stokes shift of 200 nm and the excitation and emission are 
red-shifted so there is little interference from any cellular autofluorescence 
(Fig.19). It is the only truly ratiometric calcium sensor excited in the visible 
spectrum that is commercially available. This is because it is fluorescent both 
when free and when binding calcium and the large Stokes shift in the absorption 
allows excitation at different frequencies for the two forms and fluorescence to 
be detected at a single frequency [119]. 
 Figure 
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Fura-Red™ undoubtedly has the most ideal prop
calcium sensors
as designing a completely novel fluorophore is a challenging task and the rules 
on how to do so form an interesting debate in current literature 
It has been well documented in the literature that boronic acids are 
chemical moiety that selectively react with hydrogen peroxide over other 
reactive oxygen species and have been shown to be highly successful when 
incorporated in probes 
19. For ease of synthesis and stability the boronic acid was designed in the 
pinacol ester form, which does not affect the reactivity 
peroxide once in use. The phenyl ring on which the boronic acid is situated is 
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19 – The absorption and emission spectra of Fura
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Figure 21 - Probe conjugation to SNAP-tag. BG-Fura-B 29 binds to 
SNAP-tag with the release of guanine forming SNAP-Fura-B 30. 
After hydrogen peroxide reacts, the boronate ester is converted 
into a phenol 31. A quinone methide and carbon dioxide are lost 
producing the final amine, SNAP-Fura-A 32. 
BG-Fura-B was designed to perform live cell imaging experiments. To prepare for 
these studies, mammalian cell lines were stably transfected to express SNAP-tag 
localised to the ER. This construct included the ER retention sequence KDEL. 
Once stably expressed this cell line could be treated with BG-Fura-B which 
would bind irreversibly to SNAP-tag. Any excess probe could then be washed out. 
The aim was to then image cells. In the first experiments, cells would be treated 
with hydrogen peroxide to assess the efficiency of the probe and in later 
experiments, other stressors such as dithiothrietol (DTT) would be used [123]. 
DTT is a powerful reducing agent and it has been shown that upon the addition 
of DTT to cells, disulfide formation in the ER is prevented. DTT acts as a 
substrate for Ero1, which catalyses the formation of disulfide bonds in PDI [124]. 
The result of the stimulation of Ero1 by DTT is the in situ production of hydrogen 
peroxide as Ero1 reoxidises by reaction with oxygen. 
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resin to bind to the His-tag of the protein. The most intense band present in the 
cell lysate was partially purified with some weak background bands being visible. 
It was decided a second purification step would be undertaken to remove these 
bands. Ion exchange chromatography was chosen as the second purification step. 
Lane 3 shows the protein sample after ion-exchange. The background bands seen 
in the sample after the Ni-NTA agarose affinity were deemed to be reduced to a 
sufficient level. The final step involved de-salting of the protein to remove the 
high salt in from the ion-exchange elution buffer, shown in lane 4. 
9.2.2 Creation of HT SNAP Cell Lines 
SNAP-tag was expressed and purified in E.coli to prepare for in vitro testing with 
BG-Fura-B. In addition, mammalian cell lines expressing SNAP were created for 
the in cellulo testing. 
The mammalian fibroblastic cell line, HT1080 was chosen to be transfected as it 
had been extensively used within the group previously to study disulfide 
formation in newly synthesised proteins. The plasmid, which encoded FLAG-
tagged SNAP-tag with ER targeting and retention sequences, was linearised and 
transfected into cells using PEI as the transfection reagent. The pCI mammalian 
expression vector was used and carries neomycin resistance. After transfection 
and selection with neomycin, colonies that grew were isolated and expanded. A 
killing curve was carried out to determine the most suitable concentration of 
G418 to remove untransfected cells. This was found to be 800 µg/mL. Cells from 
individual isolated clonal cell lines were lysed and lysates tested for SNAP-tag 
expression using Western blot probed with anti-FLAG-tag and anti-tubulin as a 
control (Fig. 23). 
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9.2.4 O6-(4-Aminomethyl)benzylguanine Synthesis 
After preparing purified SNAP-tag for in vitro experiments and mammalian cells 
expressing SNAP-tag in the ER and the cytosol, the next task was to synthesise 
the O6-(4-aminomethyl)benzylguanine substrate of SNAP-tag. This synthesis had 
already been published by Keppler et al. (Fig. 26) [93].  
 
Figure 26 – The synthesis and yields of O6-(4-
Aminomethyl)benzylguanine 39 designed by Keppler et al. 
Keppler et al. first performed a reduction on methyl 4-cyanobenzoate 33 using 
lithium aluminium hydride which produced 4-(aminobenzyl)methanol 34 in a 
moderate yield. The amine was then protected with ethyl trifluoroacetate in a 
high yield. With regards to the guanine functionality of the molecule, 2-amino-6-
chloropurine 36 was first reacted with N-methylpyrrolidine in a moderate yield 
in order to create a better leaving group for the coupling with the protected 4-
(aminobenzyl)methanol 35. The coupling of the two halves 35 and 37 was then 
performed with potassium tert-butoxide acting as the base producing amide 38 
in a high yield. The final step was then deprotection of the amine with 
potassium carbonate yielding O6-(4-aminomethyl)benzylguanine 39, also in a 
high yield. 
When planning our own synthesis of O6-(4-aminomethyl)benzylguanine we aimed 
to follow the procedure of Keppler et al., apart from the lithium aluminium 
reduction of methyl 4-cyanobenzoate 33 for which we decided to forgo the 
addition of sulphuric acid. When this step was first attempted we also changed 
the solvent to THF which gave better solubility. This gave a yield of 66% for 
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amine 34, an improvement on the published method and required no 
purification (Fig. 27). For the protection of the amine 34 with ethyl 
trifluoroacetate to yield amide 35, we followed the method of Keppler at al; 
however the yield was reduced, though still moderate at 59%. Again no 
purification was required. To create the N-methylpyrrolidine leaving group on 2-
amino-6-chloropurine 36 we also followed the published method and this also 
gave a lower yield of 47%. No purification was required for this step. The 
reaction relies on the product cleanly precipitating from the reaction mixture. It 
was possible that the product did not precipitate in its entirety, even when it 
was left for an extended period of time. To force the precipitation further may 
have resulted in any unreacted starting material precipitating. With regards to 
the guanine containing products, column chromatography is often best avoided 
as solubility is very low in all the common solvents used in chromatography. 
 
Figure 27 - Our altered synthesis of O6-(4-
Aminomethyl)benzylguanine 39. 
The next step was to perform the coupling of the two halves 35 and 37 of the 
target, 39. Keppler et al performed this step with potassium tert-butoxide in 
DMF and purified the product by column chromatography. We found when we 
attempted this step that often a mixture of compounds was produced but most 
of the starting materials remained. It was not possible to locate more than trace 
amounts of the desired reaction product. The utmost care was taken to ensure 
the reaction was completely dry; however we could not produce a yield 
anywhere close to the published data of 88%. We decided to look at other ways 
of performing this reaction and attempted the step with sodium hydride as the 
base and catalytic 4-dimethylaminopyridine. From the crude 1H NMR spectrum it 
could be seen that starting materials did remain, however there clearly was 
desired product as well. Column chromatography proved difficult due to a 
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combination of poor solubility, high polarity and very similar polarities of the 
desired product 39 and guanine starting material 37. It was also found that the 
compound deprotected on the column, which was not a significant issue as it 
negated having to perform another step in the synthesis. Unfortunately a 
considerable amount of the product did not elute from the column. We also 
found that on some occasions what did elute still contained some of the guanine 
starting material. On those occasions we decided to use the O6-(4-
aminomethyl)benzylguanine 39 without purifying it as if we attempted another 
purification it would result in the loss of even more material and we anticipated 
that addition of the masked fluorophore later in the sequence should alter the 
polarity sufficiently that separation would not be an issue. On the occasions that 
the purification was successful the yield was low, though an improvement on 
what we had achieved when using the method of Keppler et al. 
9.2.5 BG-NBD-X 
We decided to test the functionality of the purified SNAP-tag and the HT SNAP 
mammalian cell lines before attempting the synthesis of the fluorescent probe, 
BG-Fura-B. The main test of functionality would be to ensure the SNAP 
substrate, O6-(4-aminomethyl)benzylguanine, could successfully react with 
SNAP-tag both in vitro and in cellulo. To do this we required a method that 
would be able to show the binding of the small molecule substrate to the 
protein. 
It was decided that the simplest method to study the binding of O6-(4-
aminomethyl-benzyl)guanine to SNAP-tag would be to conjugate a fluorophore, 
commercially available if possible, to O6-(4-aminomethyl)benzylguanine and to 
visualise the binding by fluorescence scanning of an SDS-PAGE gel to confirm the 
in vitro binding and by confocal microscopy for the in cellulo binding. 
We first decided on the fluorophore to use. 6-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)amino)hexanoic acid (NBD-X) (Fig. 28) is a commercially available fluorophore 
with an absorption maximum of 466 nm and an emission maximum of 539 nm. 
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Figure 28 - The structure of NBD-X. NBD-X 40 was the fluorophore 
chosen to conjugate to O6-(4-aminomethyl)benzylguanine to test 
the functionality of SNAP-tag. 
NBD-X was found to be available as the succinimidyl ester, which is amine 
reactive and so would be easily conjugated to O6-(4-aminomethyl)benzylguanine. 
The maximum absorption of 466 nm was also particularly suitable for use as the 
available confocal microscope contained a laser of 488 nm, meaning the 
fluorescence recorded from the probe should be strong (Fig. 29). 
 
Figure 29 - Absorption (blue) and emission (red) spectra of NBD-X. 
The synthesis of benzylguanine-NBD-X (BG-NBD-X) 41 involved the coupling of 
O6-(4-aminomethyl-benzyl)guanine 39 to the succinimidyl ester of NBD-X. This 
proceeded in a moderate yield and did not require any purification (Fig. 30). 
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Figure 30 - The synthesis of BG-NBD-X 41. O6-(4-
Aminomethyl)benzylguanine 39 was coupled to the succinimidyl 
activated NBD-X via an amide bond. 
With the test fluorophore, BG-NBD-X in hand, we progressed to testing of SNAP-
tag functionality. SNAP-tag which had been expressed in E.coli and purified was 
mixed with a 100 times excess of BG-NBD-X and incubated at 37 °C for 30 min to 
allow binding to occur. The reaction was stopped by precipitating all the protein 
in solution with -20 °C acetone. The protein pellet produced was washed with 
further acetone to remove any excess unbound BG-NBD-X. The pellet was 
resuspended in SDS-PAGE sample buffer with DTT and subsequently run on a 
12.5% SDS-PAGE gel. The gel was scanned by a GE healthcare Typhoon 
fluorescence scanner then stained with colloidal Coomassie (Fig. 31). 
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The images collected from the confocal microscope show fluorescence produced 
by SNAP-NBD-X. The fluorophore was excited with the 488 nm laser that is 
traditionally used for fluorescein but works with NBD-X as it has a similar 
absorbance. For the cells that had not been treated with BG-NBD-X (Fig. 33.A 
and C) there is no fluorescence compared to the cells that had been treated 
with BG-NBD-X (Fig. 33.B and D). In Fig.33.B the fluorescence is strong and 
appears to be throughout the whole cell, the expected result for the HT SNAP 
Cyto cell line. In Fig.33.D, the fluorescence shows perinuclear staining that is 
typical of ER expression. We previously confirmed the ER localisation of SNAP-
tag in the cell line in the immunofluorescence experiment which showed that 
SNAP-tag colocalised with PDI (Fig. 25). Fig. 33 confirms that BG-NBD-X is 
capable of diffusing though the cell membrane and the ER membrane and 
conjugating to SNAP-tag in live cells when expressed in either the ER or the 
cytosol.  
9.2.6 BG-Fura-B 
With a stock of purified SNAP-tag for in vitro experiments, cell lines expressing 
SNAP-tag in both the cytosol and ER and having confirmed the functionality of 
both the purified SNAP-tag and the SNAP-tag in mammalian cells using a SNAP-
tag substrate BG-NBD-X, the next step was to synthesise the hydrogen peroxide 
reactive probe. 
The synthesis was first designed by separating the target molecule into the 
various functional components in a rational manner. These included the 
fluorophore core of the molecule, the boronate ester for hydrogen peroxide 
reactivity and the benzylguanine moiety for SNAP-tag reactivity (Fig. 20). 
The synthesis of BG-Fura-B began with the dehydrative protection of the amine 
42 with phthalic anhydride (Fig. 34). The planned method using phthalic 
anhydride in DMF was not successful; however, it was reasoned that the reaction 
may be possible as a melt. The melting point of phthalic anhydride is 131-132 °C 
[125] and the melting point of 3-aminophenol is 123-124 °C [126]. As the melting 
points are relatively close to each other it is possible to melt both compounds 
and consequently drive water off the reaction. This was found to be a successful 
method and produced phthalimide 43 in a clean and high yielding manner (Fig. 
33). With the amine protected, the next step was to formylate the phenyl ring. 
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The original plan had been to utilise the Vilsmeier-Haack reaction; however, 
again this step was found to be unsuccessful [127]. There are other methods for 
formylation, one being the use of magnesium chloride and paraformaldehyde 
[128]. Magnesium chloride coordinates through the oxygen of the phenol to form 
a phenoxymagnesium chloride salt or possibly diphenoxymagnesium and acts to 
direct the formylation in the ortho position only [129]. This method was used 
and gave aldehyde 44 in a moderate yield. Following the formylation the original 
plan had involved deprotonating the phenol of 44 and performing a nucleophilic 
substitution on 2-bromo-1,1-diethoxyethane in preparation for the cyclisation 
[130]. It was found that the nucleophilic substitution only proceeded with very 
low yield. Alternatives were studied and a nucleophilic substitution with allyl 
bromide was instead chosen as it was found to be a much better reaction and 
produced allyl ether 45 with a yield of 95%. This did essentially mean an extra 
step was required as the vinyl group of compound 45 then had to be oxidised to 
the aldehyde prior to the cyclisation. The Lemieux-Johnson oxidation can be 
used for this purpose and involves the dihydroxylation of a carbon-carbon double 
bond using sodium periodate-osmium tetroxide, followed by cleavage of the 
carbon-carbon single bond; however it creates a lot of side-products and can 
result in a low yield [131]. A similar procedure which first dihydroxylated using 
catalytic osmium tetroxide and N-methylmorpholine N-oxide and subsequently 
oxidatively cleaved by sodium periodate was used instead [132]. This reaction 
was then combined with the cyclisation in acid to give benzofuran 46 and in an 
overall high yield of 89%. 
99 
 
 
Figure 34 - The synthesis of BG-Fura-B. 
The thiohydantoin ring, which makes up the other section of the fluorescent 
core of the probe was then synthesised (Fig. 35). This synthesis began with the 
formation of the azide, functionality which was to later perform the Click 
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chemistry as the final step in the synthesis (Fig. 34). Azidealkylamine 48 was 
formed using sodium azide and 3-chloroprop-1-yl-aminium chloride 47 in a high 
yield. This was then reacted with 1,1’-thiocarbonyldiimidazole to form the 
somewhat unstable isothiocyanate 49 in a moderate yield. This compound was 
not purified due to its instability. Finally, a cyclisation using the methyl ester of 
glycine produced the thiohydantoin 50 in a high yield.  
 
Figure 35 - The synthesis of the thiohydantoin ring. 
At this point other components of BG-Fura-B were prepared. The boronic ester 
moiety 54 was prepared according to literature procedures (Fig. 36) [112]. 4-
Bromobenzyl alcohol 51 was first protected with 2,3-dihydrofuran to give the 
tetrahydrofuranyl ether 52 in excellent yield. This was followed by the use of n-
butyl lithium in a halogen-lithium exchange reaction followed by borylation to 
give boronate ester 53 in a high yield. Deprotection using aluminium chloride 
converted the acetal 53 into benzyl alcohol 54 in a moderate yield. 
 
Figure 36 - The synthesis of the boronic acid moiety of BG-Fura-B. 
It was decided that a test reaction would be used to check the efficacy of the 
reaction which would be required to form the carbamate bond (Fig. 37). Benzyl 
alcohol 55 and 4-iodoaniline were chosen as the substrates. Benzyl alcohol was 
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first reacted with pyridine and phosgene to form the intermediate benzyl 
chloroformate. Attack on the carbonyl by the nitrogen atom of 4-iodoaniline 
yielded carbamate 56 in a quantitative yield. This was promising for the 
formation of the carbamate for BG-Fura-B as it was important that we did not 
suffer big losses in yield near the end of the synthesis. It is also possible to form 
the carbamate by starting with the aniline and going via an intermediate 
isocyanate. 
 
Figure 37 - The synthesis of the carbamate test compound. 
The final part of the probe to be incorporated was the SNAP-tag reactivity. A 
carbodiimide coupling was to be used to create the amide bond via which the 
alkyne would be incorporated (Fig. 38). The azide-alkyne Huisgen cycloaddition 
which would bring all parts of BG-Fura-B together, is a 1,3-dipolar cycloaddition 
and an example of Click chemistry. To be classed as Click chemistry, a reaction 
must fulfil a number of criteria including high yield, able to work with a wide 
range of substrates, stereospecific, able to work with benign solvents and 
require little in the way of purification. The azide-alkyne cycloaddition does 
fulfil a number of these requirements, but only if copper is included as a 
catalyst or a strained alkyne is used [133] [90] . Traditionally the azide-alkyne 
cycloaddition is a thermal reaction requiring high temperatures and produces 
mixtures of regioisomers, thus preventing it from being classed as a Click 
reaction. The copper catalysed version however, can be conducted in water, at 
room temperature and produces only the 1,4-disubstituted regioisomer. This 
reaction is then particularly suited to the final step of the synthesis, as at this 
stage gentle conditions and a high yield of the correct product are extremely 
desirable. 
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The previously synthesised O6-(4-aminomethyl)benzylguanine 39 was modified 
with an alkyne in preparation for the Click chemistry step (Fig. 38). The 
carbodiimide coupling reagent, EDCI was chosen to form the amide bond 
between the alkyne and O6-(4-aminomethyl)benzylguanine 39. EDCI was used in 
conjunction with 1-hydroxybenzotriazole to form the alkyne 57 in a high yield, 
ready for the Click reaction. 
 
Figure 38 - The synthesis of the alkyne conjugated O6-(4-
aminomethyl-benzyl)guanine. 
With the carbamate reaction successfully tested and the hydrogen peroxide 
reactive boronate ester 54 and the click-ready SNAP-tag substrate 57 prepared, 
the synthesis of the BG-Fura-B core was continued (Fig. 34). The thiohydantoin 
and the aldehyde benzofuran underwent a Knoevenagel condensation which 
involved the nucleophilic addition of the thiohydantoin to the carbonyl, followed 
by a dehydration to produce the double bond [134]. This produced azide 58 in a 
low 36% yield. A large proportion of the product was thought to be lost during 
column chromatography. The product was highly fluorescent, but failed to 
produce distinct bands on the silica column. Various solvent systems and 
stationary phases were investigated; however no improvement was found.  
Nevertheless the synthesis was continued. The next step was deprotection of 
azide 58 by removal of the phthalimide group using hydrazine to give amine 59 
[135]. There was some evidence that the reaction was successful, however after 
attempts at column chromatography to purify this, very little was recovered. It 
was also noticed that the compound degraded very quickly, even when stored at 
-20 °C in the dark. What material we had was used to investigate whether a 
particular degradation product was being produced, however there was no one 
compound but many different species, which were impossible to distinguish from 
each other. The fluorescence of the material produced was recorded, however 
full characterisation data was unfortunately never collected due to the 
degradation (Fig. 39). 
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Figure 39 - Absorption and fluorescence spectra of amine 59. 
The absorption and fluorescence spectra are as expected and show the core of 
BG-Fura-B would have had the desired fluorescent properties, particularly the 
large band gap of almost 200 nm. This would have helped towards the goal of a 
ratiometric probe for hydrogen peroxide. The instability, however, proved fatal 
to the project as there was no obvious solution or structural change which could 
be applied. Another option was to completely redesign the fluorophore but it 
would have been unlikely that the fluorescent properties required for a 
ratiometric probe could have been achieved. This coupled to the fact that such a 
synthesis requires a great deal of time confirmed the decision that the project 
would take a lower-risk change of direction. 
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9.3 Conclusions 
9.3.1 SNAP-tag Expression and Purification 
The SNAP-tag expression and purification was successful with a high yield of 
protein. When the protein was first expressed an intense band was seen in the 
SDS-PAGE of the supernatant after cell lysis. This showed that the protein was 
soluble and not retained in the cell pellet so minimal protein was lost during the 
lysis procedure. As the SNAP-tag expression vector contained a His-tag this 
allowed for a simple and effective first step in the purification. This removed 
most of the other E.coli proteins however a few remained. These were then 
removed in the ion exchange purification. This led to a pure and high yielding 
stock of protein. The yield produced was 50.5 mg of protein per litre of culture. 
9.3.2 HT SNAP Cell Lines 
HT SNAP ER and HT SNAP Cyto were stably transfected using the pCI expression 
vector. Both cell lines showed positive colonies. The expression of HT SNAP Cyto 
was notably higher than that of HT SNAP ER, as can be seen in the western blot 
(Fig. 24). In mammalian cells the volume of the cytoplasm is believed to be 
around 70% of the whole cell, with the ER taking up a much smaller volume. The 
larger band seen in the western blot could simply be due to the fact that there is 
more of the cytosol in each cell. It is also possible that SNAP-tag is less stable in 
the ER or is simply expressed at a lower level. The band seen for the HT SNAP 
Cyto cell line also runs lower than that of the HT SNAP ER cell line. This is due to 
the fact that it does not contain the ER targeting and retention sequences and so 
is a slightly smaller protein. 
Both cell lines were transfected successfully and were maintained under 
selection at all times in culture. However it was found, particularly with regards 
to the HT SNAP ER cell line that on a number of occasions, expression reduced 
and was lost fairly quickly after bringing cells into culture, often at a passage 
number below 20. The consequence was that cells were regularly frozen at low 
passage number in order to maintain sufficient stocks to enable new cells to be 
brought into culture as and when required.  
The cell lines were stably transfected as this offers a number of advantages over 
transient transfection. In transient transfection it can be difficult to achieve a 
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high level of gene expression, the conditions for transfection must be optimized, 
the transfection must be performed for every experiment and gene expression 
can vary between each experiment depending on transfection efficiency. Since 
SNAP-tag was the only protein to be expressed, the time invested in creating 
stably transfected cell lines was deemed to be acceptable and, therefore, 
repeated transient transfections would offer no advantage.  
Stably transfected cell lines do occasionally lose their expression. This is thought 
to happen in cases where the protein being expressed has some kind of 
detrimental effect on the overall health of the cell. In such fast growing cell 
lines as are used in cell biology, mutations as cells divide are not uncommon 
and, therefore, any cells which mutate so that they do not express SNAP-tag but 
do retain the selection resistance will have a selective advantage over those 
which still express the protein. This can lead to a population of cells in which all 
have selection resistance but most do not express the desired protein anymore 
and so appear to have lost expression when the lysates are analysed by western 
blot. 
It is not possible to know whether this is the case for SNAP-tag so we can only 
assume, but a recommendation for the future may be to stably transfect SNAP-
tag as an inducible cell line. The tetracycline repressor protein (TetR) taken 
from the E.coli tetracycline resistance operon can be used to generate tight 
control over expression in mammalian cell systems. In the most commonly used 
system TetR blocks transcription by binding to the Tet-operator in the promoter 
region unless tetracycline is added in which case transcription occurs [136]. This 
would help reduce any loss of expression since the cells would spend far less 
time actually expressing any protein which may be inhibiting or damaging to 
them. 
9.3.3 BG Synthesis 
The synthesis by Keppler et al. [5] was used as a basis; however, minor 
adjustments were made, namely the altered lithium aluminium hydride 
reduction which yielded amine 34 in an improved yield compared to the 
published method. The other alteration made was to the conjugation of the two 
halves 35 and 37 of the universal BG precursor 39. Sodium hydride and catalytic 
DMAP was used instead of potassium carbonate. This reduced the number of 
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steps as O6-(4-aminomethyl-benzyl)guanine 39 was produced directly, since the 
intermediate deprotected under the reaction conditions. The yields for all the 
steps other than that of the reduction were lower than those published, however 
enough of the universal BG precursor 39 was made for the uses required. 
9.3.4 BG-NBD-X 
BG-NBD-X was successfully synthesised and did not require any purification. BG-
NBD-X showed that SNAP-tag was functional when expressed and purified in 
E.coli and in HT SNAP lysates through the use of a fluorescent scan of the 
protein after being run on a 12.5% SDS-PAGE gel. With regards to this method 
the probe was very effective.  
When BG-NBD-X was added to HT SNAP cells, which were then fixed and 
visualised by confocal microscopy, the fluorescence recorded was indicative of 
the probe being able to diffuse into the cells and bind to SNAP-tag whether in 
the ER or cytosol; however, there were issues with the fluorophore itself. NBD-X 
bleaches very quickly, even with the addition of Mowiol 4-88, an anti-fade 
compound used in immunofluorescence. NBD-X is known to be environmentally 
sensitive [137] and so though it allowed the aims of the experiment to be 
achieved it perhaps does not have the best attributes for confocal microscopy. 
9.3.5 BG-Fura-B  
The design of BG-Fura-B (Fig. 19) encompassed all the moieties necessary. The 
SNAP-tag substrate and boronate ester both had good literature precedence and 
Fura-red is used as a commercially available sensor. It would not, therefore, 
have been possible for us to foresee the stability issues that we encountered. 
The fluorescence which was recorded suggests that the probe would have had at 
least the desired fluorescent properties. 
Since the fluorescent properties had to be very specific to be successful as a 
ratiometric probe, synthesis of a newly designed or different fluorophore was 
not altogether appealing. The aim of the project was to make a probe which can 
get into mammalian cells and to use this to look at hydrogen peroxide levels 
inside cells when they are placed under various stresses. The aim of the project 
did not include synthesis of a novel fluorophore or advanced method 
development for synthesis.  
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The main learning outcomes were that SNAP-tag was a very effective system and 
would be ideal for a probe to be targeted to the ER but perhaps the fluorescent 
system designed was not the most appropriate. It was decided that the next part 
of the project would keep the use of SNAP-tag but simplify the probe. This 
would allow the most important aim of the project, to perform experiments in 
mammalian cells, to occur sooner. 
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10.0 Results II 
10.1 Introduction 
Due to the lack of success with regards to BG-Fura-B it was decided to reassess 
the probe design. In theory BG-Fura-B was the perfect probe as it had the 
desired fluorescent properties, successful targeting method and hydrogen 
peroxide reactivity. However, in practice this did not work out. Due to the 
complexity of the structure of BG-Fura-B, a lot of time was invested in the 
synthesis and in attempting to create solutions for the synthetic problems. After 
concluding the lack of stability of BG-Fura-B was too great a hurdle to overcome 
it was decided that the next step in the project must include a lower risk 
solution for chemical synthesis. 
It was clear that SNAP-tag was the best method for targeting a synthetic probe 
to the ER. The synthesis and use of BG-NBD-X confirmed that the method was 
successful both in vitro and in mammalian cells. It was, therefore, concluded 
that the next probe design would incorporate the benzylguanine structure. From 
the numerous uses previously published it was also concluded that a boronate 
ester would also have to be included in the structure [138]. The boronate being 
the only biologically validated group that irreversibly reacts with hydrogen 
peroxide in a selective manner. The boronate ester rather than the boronic acid 
was chosen as it makes the compound easier to handle in the synthetic setting 
[73]. 
The final decision involved changing the method of detection and analysis. 
Fluorescence microscopy was previously chosen as it has the advantage of the 
power to analyse events taking place in live cells. However, since the attempt to 
incorporate the desired fluorescent properties into a probe had been 
unsuccessful a different approach was chosen. MitoB previously synthesised in 
the Hartley group is a successful probe to measure hydrogen peroxide in the 
mitochondria [115]. Importantly, this provides an accurate and ratiometric 
assessment since the analysis is carried out by mass spectrometry. This led to 
the conclusion that a new probe design would allow for analysis also by mass 
spectrometry.  
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The final probe (BGB, Fig. 40) therefore incorporates the benzylguanine moiety 
for SNAP-tag reactivity, an aryl-boronic acid caged as the pinacol ester and a 
short linker holding the two functionalities together. 
 
Figure 40 - Design of the probe BGB. After the benzylguanine 
substrate, BGB 61, reacts with cysteine in the active site of SNAP-
tag, forming SNAP-B 62 and releasing guanine. When SNAP-B reacts 
with a molecule of H2O2, the boronate ester is converted into a 
phenol and SNAP-P 63 is produced. 
After designing BGB the method of detecting reactivity was considered. After 
BGB enters the cell and comes into contact with SNAP-tag the irreversible 
reaction between the benzylguanine moiety and the cysteine in the active site 
will occur, releasing guanine and covalently binding the probe to the protein, 
resulting in the SNAP-B conjugate. The experimental plan then involved stressing 
the cells to cause an increase in hydrogen peroxide. The next step would involve 
recovery of the SNAP-tag conjugated probe to measure the ratio of SNAP-B 
(unreacted) to SNAP-P (reacted). It is possible to recover a specific protein from 
a cell lysate using immunoisolation. This is a process which allows the isolation 
of a particular protein from a mixture of many thousands of proteins, such as 
would exist in a cell lysate mixture, by the use of an antibody which recognises 
the desired protein and which is conjugated to a solid support such as agarose 
beads. SNAP-tag was expressed in cells with a FLAG-tag to allow easy detection 
and to act as a handle for the immunoisolation.  FLAG-tag has the sequence 
DYKDDDDK and is an example of epitope tagging. 
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There exists a range of different types of mass spectrometry, each suited to a 
particular type of analyte molecule. Electrospray ionisation, for example, is 
particularly suited to the analysis of polar molecules [139]. When choosing the 
type of mass spectrometry for analysis of BGB samples the important point for 
consideration was that the probe would be conjugated to a protein. MALDI-TOF 
is generally the mass spectrometry method of choice for biochemical molecules 
including proteins, peptides and glycopeptides. MALDI-TOF uses a gentle 
ionisation process which creates singly charged ions and is usually coupled to a 
time of flight analyser. This means the interpretation of spectra is simpler than 
for mass spectrometry methods which create multiply charged ions and also 
allows any modifications to stay intact during the procedure [140]. Consequently 
it was decided to analyse the SNAP-B to SNAP-P ratio by MALDI-TOF. 
The SNAP-tag probe conjugate was digested into its component peptides by 
trypsin prior to analysis. MALDI-TOF is capable of analysing whole proteins, 
however the greater the mass being analysed the broader the peaks produced in 
the spectrum. By instead studying the peptides, the mass peaks produced are 
more accurate and therefore unambiguous. An in silico digest can be used to 
calculate theoretical peptides masses (Table.1).  
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Mass  Peptide sequence 
6437.1763 
GTSAADAVEVPAPAAVLGGP EPLMQATAWLNAYFHQPEAI 
EEFPVPALHHPVFQQESFTR  
2791.4442 LCIPQVLLALFLSMLTGPGE GSASMDK 
2390.2714 FGEVISYQQLAALAGNPAAT AAVK 
1687.9312 TALSGNPVPILIPCHR 
1636.8540 VVSSSGAVGGYEGGLAVK 
1555.7784 LELSGCEQGLHEIK 
1513.8372 LGKPGLGPAGIGADYK 
1247.6279 EWLLAHEGHR 
931.5095 TTLDSPLGK 
673.4031 QVLWK 
625.2320 DCEMK 
607.2205 DDDDK 
 
Table 1 - Masses and sequences of peptides derived from SNAP-tag. 
The masses were calculated using an in silico digest with trypsin. 
The active site peptide (highlighted) has a mass of 1688. 
A standard enzyme used for creation of peptides for MALDI is trypsin which 
cleaves at the carboxyl side of arginine and lysine residues. Trypsin was 
consequently chosen as the starting point for the digestion. The calculated mass 
for the active site peptide is [M+H]+ 1688. The active site peptide from 
unreacted SNAP-B has a mass of [M+H]+  2066 with the boron in the boronate 
ester form, however, since the boronate ester is in an equilibrium with the 
boronic acid in aqueous solutions, it is far more likely to be in the boronic acid 
form and have a mass of [M+H]+ 1984. The mass of the active site peptide from 
the product of reaction with hydrogen peroxide, SNAP-P is [M+H]+ 1955 (Fig. 41). 
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10.2 Results 
10.2.1 Syntheses of BGB and BGP 
The structures of the designed molecular probes are shown in Fig. 41. BGB, is 
the boronate probe and BGP, is a reagent that would produce the phenol 
product SNAP-P directly from unmodified SNAP-tag. BGP is necessary for use in 
control experiments. The structures were based on the derivatised O6-(4-
aminomethyl)benzylguanine.  
 
Figure 42 – The structures of BGB 61 and BGP 68. The probes were 
based on the derivatised O6-(4-aminomethyl)benzylguanine. 
With the universal SNAP-tag substrate precursor 39 previously synthesised, the 
task of producing BGB and BGP was a relatively simple one. This had of course, 
been the focal point of the design process of the probe. The design of the 
fluorescent probe BG-Fura-B, had been in theory the perfect probe, however, 
unforeseen synthetic difficulties prevented its realisation. With the simplified 
structure of BGB it meant the concept of a mass spectrometry probe for the ER 
could be tested quickly and so provide some proof of concept. Once this 
reassurance had been gained, then if required the structure could be tweaked 
and more synthesis carried out. 
The syntheses of BGB and BGP are shown in Fig. 43. 
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Figure 43 - The syntheses of the probes BGB and BGP. The 
syntheses  incorporated the SNAP-tag substrate and H2O2 reactive 
boronate ester for BGB with the corresponding phenol for BGP. 
The synthesis of BGB began with a protection of 4-(2-
carboxyethyl)benzeneboronic acid 69 with pinacol yielding pinacol ester 70 in a 
quantitative yield. The pinacol ester is used for synthetic ease as the polarity of 
the boronic acid can lead to issues in purification and the formation of stable 
trimers via the acid [73]. The pinacol ester is in equilibrium with the boronic 
acid in aqueous solutions so is likely to be hydrolysed when used at high dilution 
in a biological system. This was followed by activation of the carboxylic acid via 
a carbodiimide coupling with N-hydroxysuccinimide in a high yield. Succinimidyl 
esters are reactive towards amine groups [141] and so succinimidyl ester 71 was 
chosen because it was expected to react with O6-(4-aminomethyl)benzylguanine 
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39 without the use of a coupling agent that would give side products that may 
be difficult to remove. 
BGB 61 was produced by coupling the activated succinimidyl ester with the 
SNAP-tag substrate 39 with triethylamine as the base. There was a low yield for 
this reaction. The coupling itself was fairly efficient but loss of material 
occurred in the purification steps. O6-(4-aminomethyl)benzylguanine is insoluble 
in most solvents and once formed, BGB also maintained this level of insolubility. 
Unfortunately this rendered the purification by column chromatography a fairly 
tricky process where a lot of material was lost on the silica of the column. 
Nevertheless enough material was produced for the required purposes. Since the 
aim of the process was just to produce enough material for biological testing, it 
was not deemed worthwhile to spend further synthetic time in improving this 
process. 
The synthesis of the corresponding phenol, BGP 68, also began with a 
protection. 3-(4-Hydroxyphenyl)propanoic acid 72 was protected as the acetate 
73 with acetic anhydride in a high yield. Again the carboxylic acid was activated 
as a succinimidyl ester 74 for amide bond formation using N-hydroxysuccinimide 
and a carbodiimide coupling, also in a high yield. In a mirroring of the BGB 
synthesis, the coupling to O6-(4-aminomethyl)benzylguanine 39 also proved 
troublesome for the same reasons. The coupling of the two halves of the 
molecule was followed by the deprotection of the phenolic hydroxyl group 
without purifying the intermediate. The yield of BGP 68 over these two steps 
was low due to the difficulty of working with such compounds, but enough was 
produced for biological testing purposes. 
10.2.2 Confirmation of Probe Binding and Visualisation in MALDI-TOF Mass 
Spectra 
With both BGB and BGP in hand from a relatively short and effective synthesis, 
the first step was to achieve the proof of concept which was lacking for BG-Fura-
B.  
HT SNAP ER cells where treated with DMEM with or without 5 µM BGB for 30 min. 
After 30 min cells were washed to remove any excess unbound probe. Cells were 
then lysed and prepared for SDS-PAGE as usual. Samples were run on a 15% gel 
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conformation for reaction with the  O6-(4-aminomethyl)benzylguanine 
derivative. If this was the case then the cysteine would still be available for 
alkylation with iodoacetamide after the addition of BGP. 
Tandem mass spectrometry, performed out of house also confirmed the 
sequence of the peptides and the mass of the modification of the peak at 1955. 
A stock of SNAP-tag conjugated to BGB (SNAP-B) had been prepared and this was 
digested with trypsin in order to confirm that the mass peak for the active site 
peptide derived from SNAP-B could also be visualised by MALDI-TOF. The use of 
mass spectrometric analysis was based on the fact that the intensities of the 
starting material and product peaks could be compared to measure the 
reactivity of the probe and hence hydrogen peroxide levels. The probe had been 
synthesised as the boronate ester, however, in the dilute aqueous conditions 
used for biological experimentation this was expected to be hydrolysed and for 
the unreacted probe to be in the boronic acid form. The expected mass for the 
SNAP-B peptide was therefore 1984 (2066 for the boronic ester).  
Any boron containing peak in the mass spectrum was easy to identify as boron 
produces a very distinct splitting pattern due to the presence of the 10B and 11B 
isotopes (Fig. 47). 
 
Figure 47 – The calculated mass and splitting pattern of the peak 
representing the active site peptide from SNAP-B. The peak was 
calculated using SNAP-B in the boronic acid form as this is expected 
to be dominant in highly aqueous conditions. 
Unfortunately a peak at 1984 was not observed. On some occasions a small peak 
that did display the characteristic splitting pattern was observed at 2066, 
suggesting some of the SNAP-B derived peptide was still in the ester form. With 
 the aqueous conditions used it was known that most of the probe would be in 
the acid form and it became evident that this for
Other peaks were also occasionally observed in the spectra that contained the 
boron splitting pattern but were not at expected masses
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seen by the splitting pattern. This was not a mass at which anything should have 
contained boron and had not been calculated from the 
presence of h
being formed. This was disappointing as the planned method had been to 
compare intensities of the unreacted boronic acid peak to the reacted phenol 
peak. The facts that the boronic acid did not 
containing adducts were present meant that this simple method of analysis 
would not be possible.
Other ways of processing the data were considered in order to overcome the 
issue. The phenol peak at 1955 successfully flew in th
produce any problematic adducts. It was decided that an internal standard could 
be used as a method to measure against so the increase in the intensity of the 
peak at 1955 as the
derived peptide was chosen as the internal standard. This peptide had a mass of 
48 – A peak with mass 2357 displaying the characteristic 
 a peak was recorded with mass 2357 which seemed to contain boron as 
igh mass boron containing peaks suggested that adducts may be 
attern.
 
 probe reacted could be determined
 
120 
m did not fly by MALDI
 (Fig. 
fly and other high mass boron 
e MALDI
48). 
 
in silico 
-TOF and did not 
. Another SNAP
-TOF. 
digest. The 
-tag 
 1247 and consistently showed good intensity in all spectra. Tandem mass 
spectrometry performed out
derived peptide
SNAP-tag conjugated 
Since the amount of probe in the boronic acid form could not be calc
was circumvented
been completely saturated with hydrogen peroxide. This meant all probe in the 
saturated samples was in the phenol form which could be measured in the 
MALDI-TOF spectra (Equation 1).
Equation 
SNAP
internal standard and saturated sample to account for the inability 
to measure the boronic acid using MALDI
In Equation 1 the 
of the fraction of SNAP
boronic acid. This had not been the original plan; however
development of the BGB system 
10.2.3 In V
After deciding to use the internal standard and saturated sample system as a 
means of overcoming the fact that studying SNAP
not possible
recombinant protein.
As mentioned a stock of SNAP
test the new system. SNAP
peroxide for varying times at room temperature. For the satura
to calculate the total amount probe, SNAP
. Even with
 
1 –
-B to SNAP
method of 
itro Results 
, the next step was to test this system 
-
 the use of the internal standard the total amount of 
probe present in each sample
by the inclusion of samples i
 The equation devised to calculate the reaction of 
-P. This incorporated the 
-B that had reacted
 
 
-B was mixed with varying concentrations of hydrogen 
of-house confirmed that this was in 
 
calculation is shown that allowed 
to continue to advance.
-B had previously been prepared and was used to 
121 
-TOF mass spectrometry.
 without direct measurement of the 
-B was mixed with 10 mM hydrogen 
 still 
n each experiment which had 
use of a SNAP
 
-B directly by MALDI
fact a SNAP
needed to be known. 
-tag derived 
the determination
, it 
using the purified 
ted samples used 
-tag 
ulated, this 
 
allowed the 
-TOF was 
 
 
 peroxide. The reactions between SNAP
by adding a five times volume of cold acetone to each reaction
precipitated the prot
hour before 
resuspended in trypsin solution and incubated overnight at 37 ºC before analysis 
by MALDI
the reaction of SNAP
Fig. 49 shows an experiment displaying the effects of a range of hydrogen 
peroxide concentrations on the phenol
SNAP-P). 
Figure 
SNAP
peroxide for 30 min at 37°C in 100 mM Tris
stopped by the addition of 
calculated using t
completely saturated with hydrogen peroxide to determine total 
amount of probe.
they 
-TOF and the peak intensities produce
49 - SNAP
-B was mixed with different concentrations of hydrogen 
ein. The samples
were centrifuged and supernatants removed. Samples were 
-B to SNAP
-B concentration range 
he internal standard and by including samples 
 
-P. 
-20°C acetone. The y axis values were 
122 
-B and hydrogen peroxide were stopped 
 were stored at 
d, used in Equation 1 to measure 
 (SNAP-P)
-20 ºC for a further one 
 to total probe ratio
experiment
-HCl. Reactions were 
. Recombinant
, which 
 (SNAP-B + 
 
 
123 
 
In Fig. 49 the results from the concentration range studied show that Equation 1 
can be used as a method of calculating the reaction of SNAP-B with hydrogen 
peroxide. SNAP-B was mixed with the varying concentrations of hydrogen 
peroxide for 30 minutes. Interestingly the graph does not go through zero. This 
suggests that after 30 minutes in buffer the probe is around 10% oxidised. 
Saturation is reached at around 250 µM hydrogen peroxide and sensitivity is 
achieved even in the low micromolar concentrations. 
The reaction of SNAP-B to hydrogen peroxide with fixed concentrations over 
time was also studied (Fig. 50). 
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The in vitro time courses (Fig. 50) show reactivity at low micromolar 
concentrations with increasing reactivity at the higher concentrations. The error 
bars are smaller at 100 µM and 200 µM than for the 50 µM timecourse but the 
change in the SNAP-B to SNAP-P ratio can still be measured. The first time point 
was recorded at four minutes at which point the probe has already been oxidised 
to varying extents. Both the time courses and concentration range showed SNAP-
B in vitro reacted with hydrogen peroxide and the reaction could be measured 
without direct detection of SNAP-B in the MALDI-TOF mass spectra. 
In the experiments hydrogen peroxide was in a vast excess over SNAP-B. This 
means pseudo first order kinetics are expected where the value of k when the 
molarity is 200 µM is four times that of the value of k when the molarity is 50 
µM. The rate of reaction clearly increases when the hydrogen peroxide 
concentration increases; however, pseudo first order kinetics are not apparent 
from Fig. 50. This is possibly due to some variability as a consequence of the 
choice of analysis technique. 
10.2.4 In Cellulo Experimental Method Development 
The preliminary experiments showed that the probe was capable of binding to 
SNAP-tag in vitro and in cellulo. The mass spectrometry experiments confirmed 
that the trypsin digestion was successful and produced the expected peaks, 
including the active site peptide. The use of SNAP-P in mass spectrometry 
experiments showed that the phenol product of the probe after hydrogen 
peroxide reaction was visible by MALDI-TOF and the development of Equation 1 
allowed for the fact that SNAP-B could not be directly measured from the mass 
spectra. These experiments were carried out on recombinant protein only so the 
next requirement was a method for use of the probe in cells to prove that the 
previous method development was applicable in cellulo (Fig. 51). 
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products are available for use with this tag and include the anti-FLAG affinity gel 
which was utilised in this procedure. 
After isolation the SNAP-B and SNAP-P mixture was then denatured using 8M 
urea, to remove the protein from the agarose beads of the affinity gel and to 
unfold the protein so the trypsin digest was more effective and subsequently 
diluted with buffer to a 1M solution in preparation for the trypsin digestion. 
Trypsin was then incubated with the protein overnight to produce the peptides. 
At this point samples of the peptides were mixed with 10 mM hydrogen peroxide 
and stored on the bench for 30 minutes to completely oxidise the probe and 
make the saturation samples. 
The use of SNAP-tag ensured that BGB was maintained in either the ER or the 
cytosol and washing steps were included in the procedure to ensure that any 
BGB not bound to SNAP-tag was removed from the cells. Cells were treated with 
hydrogen peroxide after the washing steps to ensure that the reaction that 
occurred between the probe and hydrogen peroxide was only experienced by 
probe which had bound to SNAP-tag and was, therefore, in the ER. 
Immunoisolating SNAP-tag after lysis and studying the probe bound to the 
immunoisolated SNAP-tag ensured that only the levels of hydrogen peroxide in 
the ER were studied. 
The peptides were purified and concentrated using a chromatography step. This 
was required since the presence of urea has a negative effect on the quality of 
the mass spectrum produced and the peptides had been diluted in order to 
reduce the urea concentration sufficiently for the trypsin to work, which could 
also cause a reduction in spectrum quality. There was however an advantage to 
including the denaturation step as the denatured protein was more susceptible 
to trypsin digestion. The combination of these steps was found to produce a 
higher quality spectrum and greater peak intensities. With the analysis method 
used, the greater the peak intensities, the lower the variability in the results as 
essentially a better signal to noise ratio was produced. At this point the samples 
were ready for analysis by MALDI-TOF. 
10.2.5 In Cellulo Results 
Fig. 51 and Fig. 52 show the results of treatment of HT SNAP ER and HT SNAP 
Cyto with hydrogen peroxide. Cells were seeded into 10 cm dishes and once 70 
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to 90% confluent, treated with 5 µM BGB in medium for 30 min to allow 
complete binding and saturation of SNAP-tag with BGB. Cells were then washed 
to remove any excess probe. Medium or medium containing either 500 µM or 1 
mM hydrogen peroxide was then added to the dishes. Cells were washed and 
lysed at 0 min, 20 min, 40 min and 60 min. All time points were carried out in 
triplicate. Immunoisolation was used to purify the SNAP-tag from the lysates by 
the FLAG-tag which the protein was expressed with. Samples were denatured 
once immunoisolated and trypsin digested. Saturated samples were prepared by 
treating peptides with 10 mM hydrogen peroxide for 30 min at 37 ºC, also in 
triplicate, prior to the analysis. Peptides were purified and concentrated before 
analysis by MALDI-TOF with CHCA used as the matrix compound. Results were 
calculated using Equation 1. 
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In Fig. 52 the results from the treatment of HT SNAP ER cells are seen. The top 
graph displays the results measured when no hydrogen peroxide was added to 
the medium. The graph displays no increase in the ratio of phenol to total probe 
over the 60 min of the experiment. It was expected that an increase would occur 
as though there was no exogenous hydrogen peroxide added; there is 
endogenous hydrogen peroxide in the ER which SNAP-B is capable of reacting 
with. This result suggests that the analysis method as a whole is not sensitive 
enough to detect endogenous levels of hydrogen peroxide. Some of the error 
bars are larger than optimal which also prevents sensitive reaction 
measurements. The experiments displayed in the graphs middle and bottom of 
Fig. 51 show the results when cells were treated with 500 µM and 1 mM hydrogen 
peroxide respectively. Both of these experiments showed increases in the phenol 
to total probe ratio over the course of 60 min. It is intriguing that the graphs do 
not go further than around 50% phenol to total probe. The graph showing the 
results from treatment with 1 mM hydrogen peroxide plateaus by 60 min. There 
is evidence [44] that hydrogen peroxide cannot move freely around cells and is 
controlled by aquaporins. It is not possible to know how much of the hydrogen 
peroxide added to the cells reaches the ER, but it is likely that it is only a 
fraction. 1 mM hydrogen peroxide is a very high concentration and certainly by 
60 min cell death occurred due to its toxicity.  
With regards to the expected pseudo first order kinetics, the graph showing the 
results from cells treated with 1 mM hydrogen peroxide increases at a faster rate 
than that of the graph showing results from cells treated with 500 µM hydrogen 
peroxide. It is possible that the pseudo first order kinetics are occurring but are 
obscured by variability. What can be concluded is that BGB can react with 
exogenously added hydrogen peroxide in the ER. 
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In Fig. 53 the equivalent experiments were carried out on HT SNAP Cyto cells as 
were carried out on HT SNAP ER cells in Fig. 51. As with the HT SNAP ER 
experiment there was no significant increase over time in the SNAP-P level when 
the cells were incubated with medium only for 60 min. In the cytosol it is also 
expected that the probe would come into contact with hydrogen peroxide so 
again this is likely to be due to the lack of sensitivity of the method. Increases in 
the level of SNAP-P are seen in both the 500 µM and 1 mM hydrogen peroxide 
samples. The level of increase is greater than that of the HT SNAP ER samples. 
This is perhaps due to the fact that more of the hydrogen peroxide reaches the 
SNAP-B conjugate as it only has to cross the cell membrane rather than both the 
cell and ER membranes. Again some of the error bars are fairly large, possibly an 
indication that MALDI-TOF as a quantification technique is not ideal. As with Fig. 
51 there is no clear representation of pseudo first order kinetics however it is 
likely that MALDI-TOF may be the source of the lack of representation rather 
than anything on a molecular level. 
10.2.6 Trapping the Boronic Acid 
It was considered that the issues with variability and lack of sensitivity in the 
results in Figs. 52 and 53 could be at least in part due to the fact that a direct 
measurement of starting material to product could not be taken as the boronic 
acid did not fly by MALDI-TOF. It was hypothesised that if this problem could be 
overcome and all the boronic acid could be trapped in one measurable form then 
variability in the final data would be reduced. 
Boronic acids often come in the form of pinacol esters as it makes them easier to 
handle, but this also illustrates an important type of reactivity. Boronic acids are 
capable of forming reversible covalent complexes with a range of compounds 
including sugars, hydroxamic acids and amino acids, which allow bidentate 
binding. They have even been exploited as detectors of sugar transport in cells 
[143].  
It was known that the pinacol ester form of SNAP-B flew by MALDI-TOF but that 
the majority of the probe was not in this form. If, for example, a large excess of 
pinacol could be added to the sample as it was crystallised on the MALDI plate 
then perhaps this would trap all the boronic acid as the boronate ester when the 
water evaporated and crystals formed. In theory this would work, however 
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MALDI-TOF is a very sensitive process and the addition of large amounts of any 
compound is likely to have a detrimental effect on the quality of the spectrum. 
However, there would be a danger that if you lowered the pinacol concentration 
sufficiently to negate any disadvantages then the concentration would not be 
high enough to trap all the boronic acid present. 
There are a range of different matrix compounds that can be used when 
performing MALDI-TOF. The most suitable one depends on the analyte being 
studied and often trial and error is used to find the best one. CHCA is perhaps 
the best all round choice as it provides good sensitivity for peptides, proteins 
and glycans, however, there are a wide range of others possibilities. 
2,5-Dihydroxybenzoic acid is also known as one of the most efficient matrices 
and has been shown to be able to act as both the matrix and derivatising agent 
for boronic acid containing peptides [144]. When the analyte is co-crystallised 
with the matrix, the matrix is in such a huge excess that as the water evaporates 
all boronic acids are trapped in an on-plate esterification procedure. It was 
proposed that this would trap any SNAP-B derived boronic acid (Fig. 54). 
 
Figure 54 – SNAP-B trapped with DHB. The SNAP-B derived peptide 
in the boronic acid form 66 has a mass of 1984. Once derivatised 
with DHB 75 which also acts as the matrix compound, the expected 
mass is 2102. 
Once the SNAP-B derived peptide had been derivatised with DHB the expected 
mass would be 2102. This is also a sufficient distance from the phenol mass at 
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The graphs produced show the reaction of SNAP-B with 200 µM, 400 µM and 600 
µM hydrogen peroxide over 15 min. The results are comparable to the in vitro 
results produced using the previous method of including saturated samples and 
Equation 1, however, the background is noticeably higher. This is due to the fact 
that the peak at 2102 representing SNAP-B did not fly as well as the SNAP-P peak 
at 1955. This meant that the peak at 2102 was always far lower in intensity than 
1955 and so when these values were used it lead to a high value for the zero 
timepoint and prevented the results from displaying pseudo first order kinetics. 
It was hoped that the real impact would be seen from experiments carried out in 
the HT SNAP cells however when these were attempted the peak at 2102 was 
either not seen at all or barely above baseline. This is likely to be due to the 
combination of the fact that the peak at 2102, representing SNAP-B, did not fly 
well and a concentration effect as the concentration of peptides produced from 
cellular SNAP-tag is far lower than that produced from an in vitro digestion of 
purified material. This unfortunately prevented further use of this method. 
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10.3 Conclusions 
10.3.1 Syntheses and Conjugations 
The syntheses of both BGB and BGP were by and large successful. The lower 
yielding reactions were due to the difficulty of working with the fairly insoluble 
O6-(4-aminomethyl)benzylguanine, the insolubility of which did not improve once 
conjugated to the boronate and phenol moieties. Purifications were attempted 
using column chromatography however higher yields may be achieved using an 
HPLC system. Even with the low yields resulting from the purification of the final 
compounds, enough material was produced for biological testing, the aim of the 
syntheses. 
Initial testing was successful with the probes conjugating efficiently to both 
purified SNAP-tag and protein in HT SNAP cells. Comprehensive labelling was 
evident from the western blot showing SNAP-tag running slower through the gel 
after labelling (Fig. 44). 
10.3.2 In Vitro Experiments 
The initial MALDI-TOF experiments showed that the peptide derived from SNAP-P 
could be detected and this was confirmed to be the correct peptide by a number 
of different experiments. Unfortunately the peptide derived from SNAP-B could 
not be detected but a solution was found with the use of the internal standard 
and inclusion of hydrogen peroxide saturated samples in every experiment. The 
in vitro experiments which showed the reaction of SNAP-B over concentration 
and time courses showed that this method was capable of demonstrating the 
reactivity of SNAP-B down to low micromolar concentrations of hydrogen 
peroxide. It is assumed that the lack of pseudo first order kinetics displayed in 
the results is due to variability caused by the use of MALDI-TOF as an analysis 
technique. 
10.3.3 In Cellulo Experiments 
The experiments then carried out in cells did show reactivity towards exogenous 
hydrogen peroxide but there were a number of issues encountered. The error 
bars produced were in some cases large and this prevented lower concentrations 
of hydrogen peroxide, which would be more akin to those produced 
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endogenously, from being studied. There is evidence that hydrogen peroxide 
cannot diffuse freely though cells and so when it is added as a solution in the 
medium there is no way of determining how much reaches the inner 
compartments, particularly the ER. The method developed for use with BGB was 
not particularly simple and so with the number of steps involved, the chance of 
variability was increased. The variability and the lack of pseudo first order 
kinetics observed were likely to be due to the use of MALDI-TOF. Though as a 
technique it is capable of detecting analytes in the femtomolar range, for 
quantification the concentration must be far higher.  
When doing the analysis of SNAP-tag derived from cells the concentration of 
SNAP-tag depends on a number of things. The expression of the protein inside 
the cells must be high. As discussed in Chapter I, it was found that the HT SNAP 
cell line had an issue with losing expression, often at low passage number. This 
meant that on a number of occasions the protein levels were less than optimal 
and so the final peptide concentration that was analysed would also be less than 
optimal. The expression level of the HT SNAP ER cell line was also far lower than 
that of the HT SNAP Cyto cell line (Results I, Fig. 24). The peptide intensity is 
also dependent on both the immunoisolation procedure and the trypsin digest. 
10.3.4 Changing the Matrix 
The use of DHB as the matrix compound, in theory, would have allowed the 
direct comparison of starting material to product. It was hoped that this would 
provide greater sensitivity. The in vitro results were comparable to those 
calculated using CHCA and Equation 1; however there was no major 
improvement. When DHB was used with material produced from the HT SNAP 
cell lines it became evident that the peak representing SNAP-B was not 
differentiated enough from the baseline to provide useful information. 
It has been shown that BGB can be localised to the desired cell compartment 
and reacts with hydrogen peroxide in the desired manner, but the analysis of the 
probe was the limiting factor in the overall success of the method. It is 
potentially possible to use MALDI-TOF for quantification, but many factors can 
influence its ability to provide the sensitivity required for measurements of 
endogenous factors within cells. The aim was to develop an effective and user-
friendly method and though the method has shown some success, in particular 
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with the short and effective synthesis which allowed the biological experiments 
to be tackled very quickly, the process of using the probe in cells was not wholly 
user-friendly. With BG-Fura-B the synthesis had been the issue and with BGB this 
was overcome, but the difficulties with the method had been troublesome. This 
was a consideration which was taken into account for the next development in 
the project. 
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11.0 Results III 
11.1 Introduction 
The main lesson learned from the synthesis of BG-Fura-B was that the focus 
should be on the biological utility of the probe rather than the complexity of 
synthesis. This was applied in the synthesis and design of BGB. BGB was fairly 
successful as a design and this allowed method development in cells to occur. 
The method developed did show the reaction of BGB in cells, but not at the 
sensitivity required and it was time consuming to quantify SNAP-B and SNAP-P by 
mass spectrometry. This led to a reconsideration of the possible analysis 
techniques. The chemistry of BGB was effective and so the aim was still to 
incorporate this into the next phase of the project. 
For the greatest chance of success it was decided that a double pronged 
approach would be used. One of the downfalls of the analysis method of BGB 
experiments was that it required many steps and each experiment required 
these steps done over a period of three days. It was reasoned that if this process 
could be simplified then the method would be more effective.  
SNAP-tag targeting, though effective, did affect the process as there were issues 
with loss of expression in cells. The use of SNAP-tag also required 
immunoisolation and trypsin digestion, both of which added length to the time 
required for an experiment to be carried out. An alternative method of targeting 
a synthetic peptide to a cellular locale would be to use a targeting peptide. 
Peptides have been used before to target to the ER [145] and this technology 
was chosen to be developed for use with a boronate based probe.  
A previous example of peptide targeting to the ER used the peptide Ac-NYTC 
[108]. This peptide is not a targeting sequence to the ER as such, but it contains 
a site that is glycosylated by enzymes in the ER, and once glycosylated the 
peptide is trapped within the ER lumen. Originally, the peptide was used as a 
means of measuring the redox state in the ER by measurement of the ratio of 
reduced glutathione to glutathione disulfide. The peptide diffused in to the ER 
then underwent N-linked glycosylation at the Asn-Y-Thr sequence (Fig. 58). This 
prevented the peptide from diffusing back out of the ER since the hydrophilic 
nature of the oligosaccharide prevented it from crossing the ER membrane [146] 
 and so a local concentration built up in the organelle. The terminal cysteine 
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recognition of the four amino acid sequence [149]. It was felt that this would 
provide an extra measure of keeping the peptide in the ER. The glycosylated 
peptide may not be able to diffuse back through the ER membrane, but that 
does not prevent it from being packaged into a transport vesicle and traversing 
the secretory pathway. 
Hwang et al. utilised a cysteine residue to react with glutathione and 
glutathione disulfide in the ER. This cysteine was not necessary for the use of 
the peptide as a method of boronate probe targeting so it was decided that it 
could be used as a reactive group to conjugate the boronate to the peptide. 
Various chemical groups are reactive to cysteine residues including maleimides 
and alkyl halides. The design of the probe therefore incorporated a benzylic 
bromide in the arylboronate, required for hydrogen peroxide reactivity. The 
benzylic bromide was placed in the meta position to the boronate (Fig. 59). The 
positioning avoids any potential fragmentation when the electron-withdrawing 
boronate is converted into an electron-donating hydroxyl group by hydrogen 
peroxide. 
 
Figure 59 – The formation and design of Pep-B. The peptide 76 
which incorporates the site for N-linked glycosylation, ER retention 
sequence and probe binding site reacts with the boronate via the 
maleimide moiety to form Pep-B 77. 
Once formed, the theory was that Pep-B would be added to cells where it would 
diffuse into the ER. There it would become glycosylated and the combination of 
the hydrophilic nature of the oligosaccharide preventing diffusion back across 
 the membrane and the KDEL receptor retrieving any that reached the secretory 
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and so it was hoped that the method would go on to be used by others in a wider 
setting. It was considered that not all labs have access to MALDI-TOF or the 
training to use it but all labs have access to and use western blotting 
successfully. It was reasoned that if a Western blotting method could be used for 
experiments involving the probe BGB, then the issues stemming from the use of 
MALDI-TOF would be resolved and the method would have the ability to reach a 
much wider audience.  
In order to use Western blotting an antibody would be required to recognise 
either SNAP-B or SNAP-P. An antibody which recognised either SNAP-B or SNAP-P 
would also be useable in ELISA and in-cell Western systems as well, providing 
further options. It was decided that an antibody to recognise SNAP-P, the phenol 
product, would be a more attractive choice as it was known that SNAP-B was not 
always fully in the boronic acid form. 
In order to raise an antibody against a small molecule a hapten is required. This 
is a compound which is non-immunogenic itself, but must be attached to a 
carrier protein and once in this adduct form can elicit an immune response 
[150]. Most antibodies produced for bioscience purposes are raised against 
proteins but there are previous examples of antibodies specific for protein 
modifications by small molecules. There are, for example, commercially 
available antibodies to recognise phosphorylation of proteins. The first 
phosphor-antibody was produced in 1981 by the conjugation of p-azobenzyl 
phosphonate to keyhole limpet hemocyanin (KLH) [151]. Rabbits were immunised 
with the small molecule-KLH adduct and an immune response elicited. The 
antibody produced was capable of recognising proteins containing 
phosphotyrosine.  
The design of the hapten was of utmost importance as antibody production is 
both slow and expensive as months and repeated immunisation are required for 
the animal to produce the antibodies. The animals are bled at various timepoints 
throughout the process to check the sera for an immune response and are 
terminated and bled at the end of the process.  
The hapten must be conjugated to a carrier protein; however, it was not 
possible to use SNAP-P as the hapten-protein conjugate as antibodies would 
likely be produced that recognised SNAP-tag rather than the chemical 
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modification. It was, therefore, decided that the hapten analogue of BGP would 
be conjugated to KLH. The hapten could not be BGP itself as BGP contained the 
derivatised O6-(4-aminomethyl)benzylguanine which reacted with the active site 
of SNAP-tag and which would have no reactivity towards KLH. It was decided 
that the same method of conjugation would be used as for Pep-B (Fig. 60) with a 
benzylic bromide group providing cysteine reactivity. The design of the hapten is 
shown in Fig. 61. 
 
Figure 61 – The design of the hapten 78 used to create the anti-
SNAP-P antibody. The hapten contains a benzylic bromide for 
cysteine reactivity, with the rest of the molecule being the same as 
the modification to SNAP-tag produced when BGP 68 reacts to form 
SNAP-P 63. 
The design of the hapten incorporated the benzylic bromide to give reactivity 
towards cysteine residues. KLH is an extremely large multi subunit protein with 
a size of approximately 390 KDa. It therefore has a large number of available 
cysteine residues and many haptens will bind to the one protein structure, 
increasing the immune response. It is the most widely used protein for antibody 
generation. Since KLH comes from a gastropod, it is phylogenetically distinct 
enough that when used in mammalian systems the chances of producing non-
specific antibodies is reduced. It can be notoriously difficult to work with, 
however, as the large size means aggregation and precipitation is fairly common 
[152]. Once conjugated to KLH the hapten modification exactly mirrors the 
modification of BGP on SNAP-tag, therefore, giving the best chance of good 
antibody recognition (Fig. 62). 
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Figure 62 – Hapten structure similarity to SNAP-P. The hapten 78 
binds to KLH via a nucleophilic substitution of the thiol onto the 
hapten structure with the loss of HBr. The conjugate 79 mirrors the 
modification of SNAP-tag by BGP, SNAP-P 63. 
Once the hapten KLH conjugate is formed and binding is confirmed, the 
procedure involves injection into two rabbits for the production of a polyclonal 
antibody for a 70 day protocol. Once crude sera are collected they can be tested 
for reactivity by Western blot or ELISA. 
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11.2 Results 
11.2.1 Syntheses of Pep-B and Pep-P 
Of the two alternative methods discussed, the first to be investigated was the 
peptide probe, Pep-B. The first step was the synthesis of benzylic bromides 80 
and 81 which were conjugated to the peptide Ac-NYTCKDEL to form the 
boronate probe Pep-B and the phenol product Pep-P (Fig. 63). 
 
Figure 63 – The syntheses of Pep-B 77 and Pep-P 82. Pep-B was 
synthesised as the boronate ester as with BGB and both probes 
were conjugated to the cysteine residue of the peptide via a 
nucleophilic substitution reaction. 
The syntheses of Pep-B and Pep-P were both simple and effective. For Pep-B the 
first step was to protect 3-(bromobenzyl)boronic acid as the boronate ester 
boronate ester 80, which was achieved in quantitative yield. The benzylic 
bromide 80 was then stirred in Tris-HCl pH 7.5 buffer with the peptide to form 
Pep-B 77. With regards to Pep-P the first reaction was to brominate 3-
(hydroxymethyl)phenol via an Appel reaction, which yielded benzyl bromide 81 
in a moderate yield [153]. The coupling to the peptide to form Pep-P 82 was 
performed in the same manner as for Pep-B. 
11.2.2 Purification and Detection of Pep-B and Pep-P 
After the couplings had taken place the reaction mixtures were prepared for 
HPLC to separate unreacted benzylic bromide 80 or 81 and peptide from the 
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final products, Pep-B and Pep-P. The chromatograms of the peptide alone, Pep-B 
and Pep-P are shown in Fig. 63. The different peaks in the chromatograms were 
assessed by MALDI-TOF to determine which ones contained the probes. DHB was 
used as the matrix to trap the boronic acid as the aqueous conditions of the 
peptide conjugation and purification meant that the pinacol ester was likely to 
have been removed (Fig. 65). 
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was analysed by MALDI-TOF. No peaks were seen which did not appear in the 
control. It was hypothesised that this could have been due to a number of 
different reasons. Pep-P may not have been capable of crossing the cell 
membrane or ER membrane, glycosylation may not have occurred which would 
have prevented isolation from the lysate by ConA or if Pep-P was reaching the ER 
and becoming glycosylated then perhaps the concentration doing so was so small 
that after the isolation procedure it was not detectable by mass spectrometric 
methods. 
11.2.5 Control Experiment  
In order to determine what the exact issue with the system was a number of 
steps were taken. The peptide Ac-NYTC was ordered from an external company 
as this peptide had been shown to be capable of reaching the ER and of 
becoming glycosylated from the work of Hwang et al [108]. The idea was that 
this would be used as a control to test out the theories for the lack of detection 
of Pep-P. 
An experiment was devised that would incorporate Ac-NYTC as a control and 
that would show if the peptide Ac-NYTCKDEL was capable of crossing the ER 
membrane. An in vitro translation system was used which consisted of dog 
pancreas microsomes, rabbit reticulocyte lysate and an appropriate mRNA and in 
which protein translation, co-translational insertion and glycosylation occurred 
[154]. It has been shown that upon the addition of peptides containing the 
glyosylation site, Asn-X-Ser/Thr, the glycosylation of the translated protein is 
inhibited as the peptide is glycosylated instead [155]. 
It was decided that an in vitro translation system which incorporated 35S 
methionine amongst the amino acids would be used as the addition of Ac-NYTC 
or Ac-NYTCKDEL should prevent glycosylation of the translated protein if the 
peptides are capable of crossing the ER membrane of the microsomes. The use 
of 35S methionine in the amino acid mixture meant the experiment could be 
analysed by phosphorimaging if the translated protein was run on an SDS-PAGE 
gel. Glycosylation of a protein produces a noticeable shift in mobility. The mRNA 
chosen coded for influenza virus hemagglutinin (HA). 
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one band which is fairly weak but at the level of the signal peptide 
cleaved material. Again no glycosylation has occurred. In lane 7 the 
translation was treated with 0.5 mM Ac-NYTCKDEL. There is a 
stronger band at the level of the signal peptide cleaved material 
and a weaker band above as for the samples treated with AC-NYTC. 
The in vitro translation suggested that Ac-NYTCKDEL was in fact capable of 
crossing the ER membrane. The lack of glycosylated HA appearing in the gel 
suggests this. The control Ac-NYTC which has previously been shown to be 
capable of reaching the ER of cells and becoming glycosylated showed the same 
bands in the gel as for the translations treated with Ac-NYTCKDEL. The 
experiment does not prove that AC-NYTCKDEL was capable of crossing the cell 
membrane and it was in vitro rather than in cells but it was a positive result in 
suggesting that Ac-NYTCKDEL was capable of behaving as hypothesized. 
11.2.6 Treatment of Cells with High Concentration of Peptide 
The in vitro translation suggested that Ac-NYTCKDEL would be capable of 
crossing the ER membrane and of being glycosylated. One of the other possible 
reasons for lack of success when cells were treated with Pep-P was that the final 
concentration of peptide being analysed by MALDI-TOF was too low for 
detection. It was decided that cells would be treated with a higher 
concentration of peptide and that the process of recovering the peptide would 
be simplified in order to increase the chance of detection. HT1080 cells were 
treated with 1 mM Ac-NYTCKDEL for 1 hour before cells were washed and a cold 
solution of 10% trichloroacetic acid (TCA) added to cells. The acid acted to 
precipitate all proteins but left the peptides in solution. The solutions were 
centrifuged to remove all precipitated protein and any peptides in the 
supernatants concentrated and purified by the use of C18 ZipTips. Cells were 
treated with either Ac-NYTC or Ac-NYTCKDEL. Control samples which were not 
treated were also included. By not including the ConA sepharose isolation and 
EndoH digest to remove oligosaccharides, any evidence of glycosylation 
occurring was visible in the analysis (Fig. 69). 
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of Ac-NYTC, from a 1 mM concentration in the 4 mL of medium used, entered 
the cells and 3 nM would have been glycosylated. Considering this and the fact 
that any peptides would have been further diluted by the addition of 10% TCA, it 
may have meant that the final amount of peptide deposited on the MALDI-TOF 
plate for analysis may not have been enough for detection. 
The preliminary experiments with Pep-B showed the reactivity of the probe was 
reliable but once in cellulo the practicality of such a system was not so 
efficient. This further propagated the idea for a different method of analysis.  
11.2.7 Synthesis of Hapten for Anti-SNAP-P 
The design of the hapten incorporated a benzylic bromide for reactivity towards 
cysteine residues on KLH, the carrier protein chosen to be used in the antibody 
production, and the rest of the molecule which mirrored the structure of BGP 
once conjugated to SNAP-tag (Fig. 70). 
 
Figure 70 – The synthesis of the hapten. The hapten was conjugated to 
KLH, the carrier protein, to induce an antibody response in rabbits for 
the generation of a polyclonal anti-SNAP-P antibody. The key 
intermediate 78 included a benzylic bromide for reactivity towards 
cysteine residues on KLH and the para-xylyl group linked through a 
nitrogen atom to 4-(4-hydroxyphenylpropanamide), which mirrors the 
structure of BGP after conjugation to SNAP-tag. 
159 
 
The synthesis of the hapten began with the coupling of the previously 
synthesised succinimidyl ester 74 with the also previously synthesised amine 34 
to form amide 84. This reaction proceeded in a moderate yield. The acetate was 
then deprotected using potassium carbonate in a high yield. The final small 
molecule reaction was an Appel reaction to prepare the alkyl bromide of the 
hapten 78 [153]. The hapten was then used with KLH to prepare the conjugate 
79 ready for inoculation. 
11.2.8 Hapten-KLH Conjugation 
After synthesising the hapten molecule, the subsequent step was to couple it to 
KLH. KLH was bought as a solution in PBS. KLH fairly easily precipitates out of 
solution due to its large size and it is not possible to get it back into solution 
once this has happened. The hapten was not soluble in aqueous solution so 
finding a solvent system in which both the hapten and KLH remained in solution 
involved some trial and error. The most suitable system involved dissolving the 
hapten in DMSO and then adding this to the solution of KLH in a dropwise manner 
so that not more than 50% of the final solution was DMSO. The solution was left 
to stir for 24 hours before analysis was carried out to determine whether the 
binding of the hapten to KLH was successful.  
It was decided that the most successful way of determining whether the 
conjugation had occurred was to assay for free cysteine residues on KLH. If the 
hapten had conjugated then the number of available cysteine residues would 
have decreased. Fluorescein maleimide was chosen for the assay. Fluorescein 
maleimide reacts with any available cysteine residue and can be analysed by its 
fluorescence. KLH and KLH-hapten were reacted with fluorescein maleimide and 
run on a gel as well as KLH-hapten alone and the gel analysed on a fluorescence 
imager (Fig. 71). 
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hypothesis was that when the sera were passed over SNAP-P immobilized on 
sepharose any antibodies which recognised the phenol group would bind and 
those which recognised the boronate or boronic acid would pass over. SNAP-P 
was chosen for binding rather than SNAP-B as it was known that SNAP-B would be 
in a mixture of forms. Binding of SNAP-P to the sepharose was confirmed by 
checking the absorbance reading of the SNAP-P solution before and after the 
binding reaction. There was a reduction in absorbance which confirmed the 
binding was successful. Antibody sera (1 mL) were passed through the SNAP-P 
modified sepharose which had been packed into a column. The sepharose was 
washed and fractions collected. The fractions were tested for SNAP-B and SNAP-
P affinity in an ELISA experiment (Fig. 75). The fractions collected were used as 
the primary antibodies and goat anti-rabbit HRP conjugate used as the 
secondary. O-phenylenediamine dihydrochloride was used as the substrate to 
produce readouts for the levels of antibody which was measurable via the 
absorbance at 490 nm. 
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11.3 Conclusions 
11.3.1 Pep-B 
The syntheses and purifications of Pep-B and Pep-P were successful and the 
reactivity in vitro was as expected. When added to cells no peptide could be 
detected; however, the in vitro translation suggested that the peptide was 
capable of crossing the ER membrane and of also being glycosylated. When used 
at a concentration of 1 mM the peptide could be detected from the lysate but 
since no oligosaccharides were detected it cannot be confirmed that this 
material was ever in the ER. From the work of Hwang et al. it may be that the 
amounts of peptide actually reaching the ER and being glycosylated are beyond 
the limit of detection of the analysis method. 
The hypothesis behind Pep-B was that by bypassing the need for the probe to 
react with SNAP-tag certain problems with the use of BGB would be overcome. 
HT SNAP cells were shown to lose expression following 10-15 passages. SNAP-B 
and SNAP-P were analysed in the BGB method and this requires conjugation to 
SNAP-tag. If the expression of SNAP-tag was low then the amount of SNAP-
B/SNAP-P would also be low, leading to poor reproducibility and sensitivity. By 
using a system that did not require conjugation with an endogenous protein, it 
was believed that the concentration of probe in the ER would be higher and 
therefore when analysed by MALDI-TOF the concentration of peptides would be 
higher, leading to the quality of results seen in vitro experiments. The other 
obvious advantage to the Pep-B system was that different cell lines could be 
used without the need for any kind of transfection. This would have meant that 
cell lines with either overexpressed or knocked down proteins involved in 
hydrogen peroxide production and removal in the ER could be used in 
experiments easily. 
Recovery and analysis by MALDI-TOF proved problematic. This was for different 
reasons than had been the case for BGB but perhaps confirmed the need for a 
different analysis method. MALDI-TOF can be used for quantification analysis and 
was successfully shown to do so for the in vitro experiments; however what has 
been shown is that to be successful in quantification MALDI-TOF requires fairly 
high concentrations of analyte which cannot be produced from in cellulo 
samples. 
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11.3.2 Anti-SNAP-P 
The synthesis of the hapten required for the antibody production was successful 
and this was shown to bind to KLH. The process itself of producing an antibody 
against a small molecule was also a successful one and the sera showed a strong 
response in the western blots performed with both SNAP-probe conjugates 
produced by overexpression of the protein in E.coli and mammalian cells. There 
was also relatively little in the way of background or non-specific bands in the 
western blots. 
The problem lay in the differential recognition of SNAP-B and SNAP-P. The 
hypothesis had been that the antibody would recognise SNAP-P and so a gradual 
increase in the antibody response would be seen as the levels of hydrogen 
peroxide increased either in vitro or in cellulo. When the aim of a project is 
method development then one of the most important factors to consider is ease 
of use and the change of analysis method from MALDI-TOF to western blot or 
other antibody technique would have represented a step forward in achieving 
such an aim. Anti-SNAP-P would have likely also provided a more sensitive 
analysis of SNAP-P and so allowed investigation of more endogenous conditions 
when compared to the addition of highly toxic concentrations of hydrogen 
peroxide to cells. 
It has not been possible to assess exactly what part of SNAP-B/SNAP-P, the 
antibody is recognising. This could be the whole modification of perhaps just the 
part which actually reacts with hydrogen peroxide. There is not a huge 
difference between the arylboronic acid of SNAP-B and the phenol of SNAP-P and 
so it is certainly possible that this is not enough for the antibody to 
differentiate. 
Though it was certainly disappointing that the antibody recognised SNAP-B and 
SNAP-P and that attempts to separate the forms by IEF and to purify the 
antibody sera were not successful many parts of this approach were successful. 
With that in mind the use of an antibody for analysis is something that could be 
developed further. If a modification could be made to SNAP-B that changed the 
structure to make it bulkier or different to SNAP-P then the antibody might well 
differentiate between them, and this would also likely be the most sensitive and 
reproducible method of analysing hydrogen peroxide in the ER. 
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12.0 General Discussion 
12.1 Hydrogen Peroxide as a Signalling Molecule and a Toxin 
Historically viewed as a dangerous toxin, hydrogen peroxide has come to be 
acknowledged as an important signalling molecule that affects many cellular 
processes [156]. The use of such a molecule requires careful regulation in order 
to avoid the acceleration of associated physiological diseases and aging.  
As discussed (5.2, 5.3, 5.4), the cell produces hydrogen peroxide from a number 
of sources. The Nox group of enzymes is the only enzyme family that produces 
reactive oxygen species as the main function. Other sources are produced as a 
by-product of the enzymes main function. The fact that such a ubiquitously 
expressed group of proteins as the Nox enzymes exists, alludes to the 
importance of hydrogen peroxide [157].  
One of the other sources of hydrogen peroxide is the electron transport chain in 
the mitochondria and occurs as part of respiration. Most reactive oxygen species 
that are produced in the mitochondria come from complexes I and II when 
electrons from NADH and FADH2 are leaked and react with molecular oxygen. It 
is not possible to estimate accurately the levels of hydrogen peroxide produced 
from this process, but it has been found that in isolated mitochondria that up to 
2% of oxygen consumption is diverted into the production of hydrogen peroxide 
[158]. 
Within the ER, sources of hydrogen peroxide are the enzymes, Ero1 and Nox4. 
When PDI catalyses the formation of a disulfide bond in a newly formed protein, 
the active site becomes reduced and so requires to be reoxidised in order to 
continue the catalytic cycle. Ero1 acts as a source of disulfides for the 
reoxidation of PDI and couples this oxidation with the reduction of molecular 
oxygen, forming a molecule of hydrogen peroxide. Therefore, one molecule of 
hydrogen peroxide is formed for every new disulfide [159]. Combined with the 
production from the mitochondrial electron transport chain and the Nox 
enzymes, this is a substantial amount being released into the cell. Without 
mechanisms for removing this hydrogen peroxide the amount would far exceed 
that required for signalling and rapidly result in irreparable damage to the 
contents of the cell. 
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The cell employs a range of tactics to protect itself from the dangers of 
oxidative stress. Antioxidant enzymes play a vital role in protecting the cell from 
such dangers [5]. Catalase is present in most organisms exposed to oxygen and 
has one of the highest enzyme turnover numbers. It is capable of converting 
millions of hydrogen peroxide molecules to water and oxygen every second [30]. 
The efficiency and ubiquitous expression indicate the importance of its position 
in the cellular defence against reactive oxygen species. 
It has been shown that under conditions of oxidative stress in the ER, glutathione 
synthesis is increased [160]. Glutathione itself is capable of scavenging reactive 
oxygen species but also acts in conjunction with the GPx group of enzymes, two 
of which are resident in the ER. The GPxs contain a cysteine residue reactive 
towards hydrogen peroxide [161]. This results in the formation of a selenenic 
acid intermediate which is resolved by formation of a disulfide between the 
enzyme and glutathione. The disulfide can be reduced by a second molecule of 
glutathione. 
Also at work in defending the cell from excess hydrogen peroxide are the Prx 
enzymes. The Prxs contain a cysteine residue, known as the peroxidatic cysteine 
which is reactive to hydrogen peroxide and forms a sulfenic acid, as with the 
GPxs. However unlike the GPxs this is resolved by another cysteine residue 
within the protein, known as the resolving cysteine, resulting in a disulfide. It 
has also been shown the within the ER, PrxIV is capable of de novo disulfide 
bond formation by acting as a source of oxidising equivalents to PDI [37]. Prxs 
are also capable of hyperoxidation. That is once the sulfenic acid is formed, 
rather than being resolved it can go on to form sulfinic acid (SO2H) and sulfonic 
acid (SO3H). This only occurs in times of high oxidative stress and is perhaps an 
indication of when hydrogen peroxide concentrations increase enough that it 
loses its role as a signalling molecule and becomes an instigator of cell death by 
apoptosis or necrosis [162].  
It is the occasions that the role of hydrogen peroxide changes from signaller to 
toxin that are less well understood. With regards to the ER, it would be of great 
benefit to measure hydrogen peroxide and provide a greater understanding of 
the mechanisms involved in protein folding. By studying hydrogen peroxide levels 
in the ER when cells are placed under various stresses or when the expression of 
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proteins involved in disulfide bond formation is either increased or reduced that 
a greater understanding of the role that hydrogen peroxide plays in the ER could 
be garnered. 
12.2 Different Ways to Measure Hydrogen Peroxide 
Within the cell there are two ways by which it is possible to measure hydrogen 
peroxide: a protein based method or a small molecule based method. As 
previously described (5.9), one protein based method to have been used was 
HyPer [67].  
HyPer consists of a cpYFP inserted into the regulatory domain of the bacterial 
protein OxyR. OxyR is a hydrogen peroxide sensing protein that undergoes a 
conformational change after reaction with hydrogen peroxide [163]. A cysteine 
residue within OxyR reacts with hydrogen peroxide to form a sulfenic acid which 
then goes onto form a disulfide with another cysteine residue within the active 
site. Since HyPer is a protein based method it is possible to express the protein 
within mammalian cells and target it to various organelles by incorporating 
signal sequences. It is also possible to express HyPer as an ER located sensor by 
use of the ER retention sequence, KDEL. Upon oxidation the fluorescence of 
HyPer at 500 nm increases and the excitation peak at 420 nm decreases. 
The advantage of HyPer lies in the fact that it can be expressed within the cell 
at the organelle of choice. There are however a number of disadvantages with 
such a method. As with most circularly permuted proteins, HyPer is pH sensitive, 
so any local changes in the pH of the cell will lead to an alteration in the 
fluorescence of HyPer [70]. By relying on a protein to assess changes, there is 
always the possibility that cellular factors will affect the readout. When HyPer 
becomes oxidised it forms a disulfide bond, this disulfide could be reduced 
either by other proteins or by glutathione, which would again affect the 
readout. Therefore, the danger of using a protein based methodology lies in the 
fact that it is in a cell full of other proteins affecting a range of processes, which 
could include the very process being used to assess hydrogen peroxide levels. 
Another protein based method developed was the probe Orp1-roGFP2. This 
works in a similar method to Hyper in that a redox sensitive protein was coupled 
to a fluorescent one. Orp1 is a thioredoxin dependant protein with two cysteines 
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within the active site. The peroxidatic cysteine reacts with hydrogen peroxide to 
form a sulfenic acid. This can be resolved by forming a disulfide with the 
resolving cysteine. When coupled to roGFP2, this results in a measurable 
fluorescence change [164]. 
With regards to small molecule probes there have been a number of different 
probes used. One of the earlier and widely used probes was DCF. This relies on 
oxidation to induce the change from non-fluorescent to fluorescent compound. 
As a simple and quick method for looking at oxidation changes, DCF could 
provide what is required but if a more specific answer is desired it is not 
suitable. This is due to lack of specificity for hydrogen peroxide over other 
reactive oxygen species. It is an OFF-ON probe, so it only indicates a general 
increase in oxidation rather than something that can be quantified accurately, 
which would require a ratiometric method [165]. 
Since DCF, the field of small molecule probes has shown a remarkable 
improvement, chiefly with regards to the reactivity towards hydrogen peroxide. 
The use of boronate esters as the hydrogen peroxide reactive moiety created the 
specificity that DCF lacked. Boronates have been shown to be selective for 
hydrogen peroxide over other reactive oxygen species and have since been used 
widely in hydrogen peroxide sensors. Most sensors have been fluorescent with 
the exception of MitoB, a mass spectrometry probe for the mitochondria [166].  
Fluorescent boronate based probes have been developed with a wide range of 
spectral properties. Change and co-workers created a suite of three probes, 
Peroxyresorufin-1 (PR1), Peroxyfluor-1 (PF1) and Peroxyxanthone-1 (PX1) [82]. 
PR1, PF1 and PX1 emitted red, green and blue fluorescence respectively, upon 
oxidation by hydrogen peroxide. By using the boronate, which provided the 
desired specificity lacking in previous small molecule probes and which was 
immune to the cellular factors that affected HyPer it meant that the research 
focus could shift to further developing the best spectral qualities. 
Therefore, when it came to decide on the approach to take when designing our 
own probes it was firmly believed a small molecule probe would provide the 
greatest chance of success. HyPer’s downfall was perhaps that it was a protein 
that was susceptible to endogenous metabolic processes. It was reasoned that 
whatever hydrogen peroxide reactive protein construct chosen, whether OxyR or 
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another hydrogen peroxide reactive protein, it would be subject to cellular 
pressures that would be difficult to predict. In order to offer a significant 
improvement on HyPer, there would need to be some guarantee that the 
reactive protein would not be affected by anything other than hydrogen 
peroxide, something which would have been difficult to predict. This led us to 
believe that the future of hydrogen peroxide sensitive probes was in the field of 
small molecules. 
When designing the probes BG-Fura-B, BGB and Pep-B there was no debate over 
whether or not to utilise the boronate as the hydrogen peroxide reactive moiety. 
The literature has shown that it is a good choice and extensive work carried out 
previously within the group on mitochondrial probes substantiated this evidence. 
Unfortunately with regards to BG-Fura-B, the testing stage was never reached 
but with regards to BGB and Pep-B the in vitro tests confirmed that the 
reactivity of the probes was as desired. When compared to the most similar 
probe previously published, the fluorescent SPG1 synthesised by the Chang 
group, the reactivity was similar. The boronate provided a reliable and selective 
reaction mechanism, shown in the MALDI-TOF experiments carried out. The 
probes were capable of showing a measurable change down to low micromolar 
concentrations of hydrogen peroxide. Though this is perhaps still higher than 
steady state concentrations of hydrogen peroxide inside cells, this is likely to be 
akin to what cells experience under times of oxidative stress. This was what was 
desired as the aim of the project had been to create probes to aid understanding 
of the mechanism of protein folding in times of such stress. Another advantage 
of the boronate is that the reaction rate is conveniently measurable [166]. It 
can, therefore, be concluded that the reactivities of BGB and Pep-B could 
potentially have provided a successful measure of the likely conditions felt by 
mammalian cells during oxidative stress. 
12.3 Methods of Targeting Probes 
As previously discussed there are a number of different methods of targeting 
small molecule probes. Small molecule probes can be targeted to the 
mitochondrial matrix due to the existence of the membrane potential. If a 
charged group such as a TPP cation is used, then a concentration builds up in the 
matrix. If other areas of the mitochondria are to be studied then a different 
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method of targeting that is not purely small molecule based is required. Probes 
targeted to the ER also require some assistance from either a protein or peptide-
based method. 
The most utilised methods for targeting to the ER are protein based labelling 
methods. The SNAP-tag system involves the use of a mutated version of AGT 
which is a DNA repair protein. SNAP-tag specifically reacts with O6-(4-
aminomethyl)benzylguanine derivatives [93]. The mutation ensures that a 
covalent bond is formed between the substrate and protein in an irreversible 
reaction. 
SNAP-tag was the system chosen for BG-Fura-B and BGB. In order to be reactive 
to SNAP-tag BG-Fura-B and BGB required the incorporation of the O6-(4-
aminomethyl)benzylguanine moiety into the structures, though never realised 
for BG-Fura-B. The steps in the synthesis required to incorporate such a 
functionality did create some difficulty due to the lack of solubility of the 
moiety in most solvents. Even when conjugated to the rest of the probe for BGB, 
the solubility did not improve. However, the final probe was produced in a 
suitable quantity, though material was undoubtedly lost due to the difficulty of 
working with such a substrate.  
Both the in vitro and in cellulo testing of BGB showed successful labelling of 
SNAP-tag. The evidence provided from the western blot of unlabelled and 
labelled SNAP-tag from the HT SNAP ER cell line (Fig. 44) suggested quantitative 
labelling in 30 min with a 5 µM solution of the probe in medium. The reaction 
between probe and SNAP-tag proceeds with a fast and efficient rate. The in 
cellulo experiments with BGB also showed the addition of the O6-(4-
aminomethyl)benzylguanine moiety to the structure did not hamper the ability 
of the probe to cross both the cell and ER membranes. This was concordant with 
previous literature examples which had used SNAP-tag as a targeting method. 
With regards to peptide-based targeting systems, it was hypothesised that by 
using such a system some of the problems associated with SNAP-tag would be 
overcome. Peptide based targeting has been used successfully to target 
fluorophores, drugs and imaging agents to various organelles and it was believed 
that this would offer a viable alternative to the SNAP-tag system [104]. It was 
found that the SNAP-tag cell lines lost expression at low passage number and 
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since the method for BGB was very dependent on concentration, this affected 
the quality of the results produced. The peptide chosen for use in Pep-B, Ac-
NYTCKDEL, incorporated a glycosylation site and the ER retention sequence. The 
peptide incorporated both glycosylation and ER retention to create the best 
chance of a suitable concentration building up within the ER. 
Initial experiments failed to detect any peptide recovered from cells so an in 
vitro translation was carried out which suggested that the peptide was capable 
of crossing the ER membrane and of becoming glycosylated once having done so. 
Some recovery of the peptide was seen by MALDI-TOF when cells were treated 
with a millimolar concentration of the peptide, though no evidence of 
glycosylation, so it cannot be said whether the recovery seen was from ER or 
cytosol located peptide.  
It is likely that though some of the peptide was entering the cell and perhaps 
diffusing into the ER, the concentration that was doing so was too low to achieve 
reasonable results using MALDI-TOF.  
The evidence shows that SNAP-tag is the more successful of the two targeting 
techniques investigated. Peptide targeting may be of more use in a system which 
is not so sensitive to concentration, such as one which uses fluorescence as the 
method of analysis. 
12.4 Analysis Techniques of Probes 
The original aim of the project had been to develop a fluorescent and targetable 
probe for hydrogen peroxide in the ER. It was felt that the fluorescent 
properties of previous probes such as SPG1, which also utilised SNAP-tag and a 
boronate for hydrogen peroxide reactivity, could be improved upon. 
Since SPG1 used the same targeting system and reactive moiety, it was vital that 
any probe synthesised greatly improved upon this. SPG1 is mildly fluorescent 
before reaction and emits much greater fluorescence after reaction, but 
importantly it is not ratiometric as the fluorescence prior to reaction is too weak 
for detection. Therefore, it was imperative that a new fluorescent probe offered 
a significant improvement, and so we designed a probe to be fully ratiometric. 
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It was believed that by incorporating the fluorophore used in the calcium sensor, 
Fura-Red™, into the structure then this ratiometricity could be achieved. It can 
be difficult to achieve ratiometricity when using boronates, as the empty p 
orbital of the boron atom acts as a quencher of fluorescence. Therefore, the 
structure of BG-Fura-B was developed so that the boron was a suitable distance 
away from the fluorescent core of the molecule. It was hypothesised that the 
large Stokes shift of Fura-Red would also be observed in a hydrogen peroxide 
sensitive probe and that the structural change that would have occurred upon 
reaction of the probe with hydrogen peroxide would lead to a significant red-
shift in the absorption frequency. Thus, BG-Fura-B would offer full 
ratiometricity, and therefore, a significant improvement on the previously 
published probes. 
Unfortunately, due to the instability of a precursor analogue to BG-Fura-P, the 
synthesis was not completed. However, gratifyingly, the large Stokes shift was 
observed (9.2.6 Fig.39). Since it was unlikely that by synthesising a different 
fluorescent probe the desired property of ratiometricity would be achieved, a 
different method of analysis was considered. 
BGB offered something significantly different from other hydrogen peroxide 
probes targetable to the ER, in that it is a mass spectrometry probe. Mass 
spectrometry provides the guarantee of ratiometricity that the present 
fluorescent probes cannot. By deciding on a different technique of analysis it 
allowed a much quicker synthesis and the opportunity to develop a completely 
novel method of studying hydrogen peroxide in the ER. BGB was, therefore, still 
perceived to offer the same improvement as BG-Fura-B on all the previously 
published probes. 
The in vitro experiments analysed by MALDI-TOF using SNAP-B, BGB conjugated 
to recombinant SNAP-tag, showed repeatable reactivity with sensitivity to low 
micromolar concentrations. When experiments were carried out in HT SNAP ER 
and HT SNAP Cyto cells, the repeatability and sensitivity were not as good as the 
in vitro experiments. However, what could be seen was that there was reactivity 
and the level of SNAP-P increased over time. The fact that the increase in the 
level of SNAP-P in the cell line which expressed SNAP-tag in the cytosol was 
greater than that in the cell line which expressed SNAP-tag in the ER showed 
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that less exogenously added hydrogen peroxide reaches the ER than reaches the 
cytosol. This is in agreement with research into the transport of hydrogen 
peroxide through specific aquaporins, which showed that the movement of 
hydrogen peroxide is tightly regulated by the cell [167]. 
MALDI-TOF, the technique used for analysis of BGB, has rarely been used for 
such a purpose as it is mostly used for qualitative rather than quantitative 
results. This presented a challenge with regards to method development for use 
of BGB in cells. When it was discovered that the boronic acid did not fly using 
MALDI-TOF, a formula was developed to overcome this by using an internal 
standard which allowed this issue to be overcome to some extent. It was 
attempted to improve the quality of the results by using DHB as the matrix, 
rather than CHCA though this was found to offer no advantage. 
It has been shown that MALDI-TOF can in fact be used as a quantitative method 
of analysis though there are caveats to its use. The main one being that the 
concentration of the analyte must be fairly high in order to achieve data with 
low variability. It is also imperative that the MALDI-TOF conditions be developed 
specifically for the analyte in order to collect results. Nevertheless, the 
development of BGB has offered a completely novel way of analysing hydrogen 
peroxide in specific organelles. Though BGB was only targeted to the ER and 
cytosol it would be possible to utilise it in other organelles. 
The development of the polyclonal antibody, Anti-SNAP-P, was carried out in 
order to provide a further method of analysis which would allow for a more 
widespread use of BGB. Anybodies have been used successfully for recognition of 
a range of small molecules including fluorogenic dyes as well as protein 
modifications such as sulfotyrosine [168], [169]. This was to provide an 
advantage over the MALDI-TOF analysis method of BGB and all the previously 
published fluorescent probes as it meant a way of analysing the reactivity of BGB 
without the use of costly equipment such as mass spectrometers and confocal 
microscopes that require specialist knowledge. Though unfortunately, the 
antibody was not able to distinguish between SNAP-B and SNAP-P, it was 
certainly the first attempt at developing such a method of analysing hydrogen 
peroxide and is perhaps one which merits further attention in the future. 
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12.5 Summary Table of Probe Qualities 
The following table summarizes the different probes developed during the 
course of the project: 
Probe Method of 
Targeting 
Method of 
Detection  
Comments 
BG-Fura-B 
 
SNAP-tag – 
protein 
reactive to 
benzylguanine 
derivatives, 
can be 
expressed in 
ER 
Fluorescence- 
different 
fluorescence 
expected 
before and 
after reaction 
Target 
structure not 
synthesised 
due to 
instability of 
core structure 
BGB 
 
SNAP-tag – 
protein 
reactive to 
benzylguanine 
derivatives, 
can be 
expressed in 
ER 
MALDI-TOF 
mass 
spectrometry 
Successful 
targeting and 
measurement 
of H2O2 in ER, 
MALDI-TOF a 
source of 
variability 
Pep-B 
 
Peptide- 
including 
glycosylation 
site and ER 
retention 
sequence 
MALDI-TOF 
mass 
spectrometry 
Probe not 
detectable 
from cell 
lysate by 
MALDI-TOF 
 
Table 2 – Summary of the probes developed.  
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13.0 Future Work 
13.1 HT SNAP Cell Lines 
As discussed, it was found that the stably transfected HT SNAP cell lines were 
found to lose expression after a low passage number. This was inconvenient as it 
can cause delays to an experimentation plan. Cells stocks were made at low 
passage number and stored so in the event of currently cultured cells losing 
expression, more cells could be brought into culture from -80ºC storage. This, 
however, takes time as cells are often slow to grow just after being brought out 
of storage. 
Cells can sometimes lose expression of a protein that has been transfected in to 
create an overexpression cell line. This can occur when the protein being 
expressed causes a detrimental effect on the vital processes of the cell. It would 
not be advantageous to use transient transfection of SNAP-tag since this would 
add a lot of time onto every experiment. Therefore, an important step for the 
future would be to create inducible cell lines. The tetracycline system utilises 
the tetracycline repressor protein to generate a very efficient regulatory system 
for the expression of the desired protein [170]. If these cell lines were created 
then the expression of SNAP-tag could be induced prior to the experiment, 
doubtless saving time and preventing the discovery that the expression had 
dropped only after the experiment was carried out. 
13.2 O6-(4-Aminomethyl)benzylguanine Solubility 
The synthesis of BGB was somewhat complicated by the fact that the SNAP-tag 
substrate O6-(4-aminomethyl)benzylguanine was insoluble in most solvents. This 
meant that purification of the substrate and final probe became an inefficient 
procedure whereby a lot of material was lost and high purity was difficult to 
achieve. If the substrate was to be more soluble this would make the synthesis 
of BGB and any future SNAP-tag substrates simpler and higher yielding.  
Adding poly(ethyleneglycol) (PEG) units to organic compounds does have the 
ability to improve the solubility of some insoluble compounds. Risseeuw et al. 
synthesised compounds though not O6-(4-aminomethyl)benzylguanine but with a 
similar structure that were soluble in dichloromethane: methanol 93:7 (Fig. 76) 
[171].  
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Figure 76 – The compound synthesised by Risseeuw et al. which 
encorporated PEG units (n = 5). Though a different compound, the 
structure shares some similarities with O6-(4-
aminomethyl)benzylguanine. The incorporation of PEG units into 
the SNAP-tag structure may increase the solubility in standard 
solvents used in column chromatography. 
PEG units of varying lengths were incorporated into the structure by Risseeuw et 
al. and possibly aided the solubility. The incorporating of PEG units into O6-(4-
aminomethyl)benzylguanine may increase the solubility enough to allow an 
easier and more efficient synthesis. The proposed structure (Fig. 77) allows the 
addition of the PEG units and maintains the amine moiety used for conjugation 
to the active part of the probe, therefore no other alterations in synthesis would 
be required [99]. 
 
Figure 77 – The proposed SNAP-tag substrate incorporating PEG 
units (n = 5). It is hypothesised that the PEG units would increase 
solubility and so lead to a more efficient synthesis and purification 
of BGB and future probes for use with SNAP-tag. 
13.3 New Probes for Use with Anti-SNAP-P 
The hypothesis behind Anti-SNAP-P was that by developing an antibody for use 
with BGB then the method of analysis could be by western blot or ELISA, thus 
eliminating the requirement for MALDI-TOF and overcoming the associated 
issues. Unfortunately it was found that the antibody could not differentiate 
between SNAP-B and SNAP-P. One possibility would be to attempt to produce a 
new antibody that would be able to differentiate between the two. Instead of 
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raising the antibody against the phenol form of the probe it could be raised 
against the boronic acid. When devising the plan for the antibody this was 
decided against as the boronic acid is known to take different forms, i.e. the 
boronate ester.  
Another possibility would be to alter the structure of BGB itself to prevent the 
antibody recognising the boronic acid form. If an extra aryl ring was 
incorporated into the structure and a similar fragmentation reaction to that 
proposed for SNAP-Fura-B designed in, then it could be possible to form SNAP-P 
from a significantly different SNAP-conjugate. The positioning of the aryl 
boronate cage may make the unreacted structure bulky enough that the 
interaction between the probe and the antibody is prevented (Fig. 78). Further 
variation in the caging group would be possible, e.g. the boronate could be 
positioned at either the ortho or para position and other bulky or polar groups 
attached. 
 
Figure 78 - Proposed structures for second generation probes 88 
and 89. After reaction with hydrogen peroxide the boronate would 
be converted to a phenol which would lead to lose the phenyl ring 
upon which the boronate is located. This would produce the same 
phenol compound as that produced from the reaction of BGB with 
hydrogen peroxide. It is hypothesised that this may prevent the 
interaction between unreacted probe and antibody. 
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Once conjugated to SNAP-tag the second generation probes would likely 
equilibrate to the boronic acid form, as happened with SNAP-B, and the reaction 
with hydrogen peroxide would occur leading to the same product, SNAP-P, as 
produced by the original SNAP-B conjugate (Fig. 79). 
 
Figure 79 – The reactions of SNAP-B 62 and the two second 
generation SNAP-B (para and ortho) conjugates, 90 and 91 with 
hydrogen peroxide. With all three conjugates, the same product, 
SNAP-P 63, is produced. 
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14.0 Summary 
It is clear that a method of studying hydrogen peroxide in the ER would aid the 
understanding of the processes of protein folding and oxidative stress. It is only 
in recent years that the full plethora of roles hydrogen peroxide plays has begun 
to be appreciated. The data described have shown the development and use of a 
probe, BGB which can be successfully targeted to the ER and react with 
hydrogen peroxide. The method developed for use with BGB has demonstrated 
the use of quantitative MALDI-TOF and, therefore, does not require the 
incorporation of any fluorescent moieties, which often show sensitivity to other 
factors such as environment and the surrounding molecular structure. The 
development of the antibody, anti-SNAP-P has provided a further opening into 
novel methods of analysis of hydrogen peroxide probes and hopefully further 
development of this will provide a new a simple technique to aid the 
understanding of oxidative stress. 
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